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In adult vertebrates, cardiovascular regulation is accomplished by
numerous systems with neural, hormonal and local components responsible for
the majority of regulation.  These regulatory components work in concert to
maintain the essential function of blood perfusion to adult tissues.  Given the
essential nature of this function it is therefore surprising that the development of
cardiovascular regulation during gestation is poorly understood.  The majority of
what is known is based on a single vertebrate model, the fetal lamb.
The fetal lamb has been used in multiple studies due to the clear clinical
applications and has been pivotal in understanding the onset of regulation in
developing vertebrates.  However, study on the fetal lamb is limited to the latter
40% of gestation and has the added complication of an in-utero developmental
strategy.  Therefore the primary focus of this dissertation was to characterize
basic cardiovascular regulation in the chicken embryo to provided the needed
information for it’s use an alternative to the fetal lamb.
Developing chicken embryos rely on both alpha and beta adrenergic tones
to maintain normal heart rate and arterial blood pressure during incubation.
However, on day 21, just prior to hatch, these animals lose both tones on arterial
pressure suggesting the onset of adult regulation.  Cholinergic tone, however,
was absent throughout chicken development indicating that it must mature during
the neonatal life.
Adult cardiovascular reflexes become apparent late in chicken
development with a clear baroreflex specifically operating initially on day.
However, an adult response to changes in ambient gas tension was absent
during incubation suggesting embryos possess unique regulatory systems that
are absent in adult chickens.  This mechanism is comprised entirely of
adrenergic systems with no cholinergic action during change in ambient gas
tension.
Similar developmental patterns were determined in embryos of the desert
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Introduction to the Topic
Cardiovascular regulatory systems are separated into two major control
units, local control factors and central reflexive regulators (Persson 1996), that
can be further divided into systems responding hemodynamic stimuli, resulting in
an agonist or antagonistic affect on cardiovascular function (Persson 1996).
Each regulatory unit can work simultaneously, with the interaction resulting in an
optimization of hemodynamic performance under specific stress conditions.  As
an example, heart rate in a resting adult mammal is optimized by the summation
of parasympathetic and sympathetic input to the heart (Levy and Martin 1995).
During bouts of hemodynamic stress, one system will augment its action while
the other withdraws its action (Kirchheim 1976).  Additionally, each component
may centrally alter the activity of the opposing system adding to the complexity of
resting cardiovascular function (Levy and Martin 1995).  In extreme cases, this
regulation must function at close to optimal levels while the heart is cycling at a
rate of 25 Hz.  At these atypical levels, regulatory systems must ensure proper
pressure gradients are maintained allowing gas transfer to all tissues.  This
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situation, while extreme, emphasizes the importance of cardiovascular regulation
in adult mammals as well as the difficulties of developing a regulatory model.
 Selective analysis of individual components has been integral in
constructing a model of adult cardiovascular regulation (Persson 1996).
Selective analysis requires the isolation of individual components via
pharmacological blockade, surgical/chemical denervation or transgenic knockout
techniques (Persson 1996).  Cardiovascular responses to challenge will then
reflect the possible role of a given regulatory component, as well as its interaction
with other systems.  Investigations utilizing numerous experimental techniques
have combined to form the current "Guyton" model of cardiovascular regulation
in adults mammals (Guyton and Young 1979).  While the Guyton model of adult
cardiovascular regulation has been developed, the understanding of the
development of cardiovascular regulation remains poorly understood.
The majority of the understanding of cardiovascular regulation comes from
a single mammalian model, the fetal lamb.  Because of the clear clinical
applications several studies have been conducted on fetal sheep and have
provided important information of cardiovascular regulatory mechanisms during
mammalian ontogeny (Assali et al. 1978). In addition, studies on fetal sheep
have delineated critical periods when regulatory systems become operative
during gestation (Assali et al. 1978, Shinebourne et al. 1972, Segar et al. 1992,
Giussani et al. 1994).  In summation, numerous investigations have shown that
autonomic nervous control becomes operational and is integral for the
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maintenance of cardiovascular function in the last third of sheep gestation.
Further, several locally released vasoactive substances and humoral
components play an important role in fetal cardiovascular regulation (Giussani et
al. 1994).  While the fetal lamb has been an important model, working with this
animal limits the period of analysis to the latter 40% of incubation as well as
possessing the added complication of in-utero development.  Therefore, an
alternative model needs to be explored which allows agreater greater window of
analysis as well as eliminate the in-utero complication.
An ideal candidate is the chicken embryo and would allow analysis of
regulatory systems before cardiovasuclar innervation occurs as well as
eliminating the extensive protocols needed for in-utero studies.  In addition, using
the chicken embryo would have the added advantage of ease of environmental
manipulation.  Several studies have been conducted on developing chicken
embryos and have focused on cellular and anatomical characteristics of
cardiovascular regulation.  These classical studies determined a time line for the
presence of cellular receptors, as well as physical contact between the
autonomic nervous system and the developing cardiovascular system (Romanoff
1967, Pappano 1977).   While these investigations established the period during
which physical integrity of regulatory systems were complete, the operation of
cardiovascular regulation was undetermined.  Later pharmacological studies
attempted to address to determine the operation of cardiovascular regulation
utilizing selective autonomic agonist and antagonists.  These works
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characterized cardiovascular response to numerous autonomic receptor agonists
and provided important essential about the functional integrity of the regulatory
mechanisms (Tazawa 1981a, Tazawa et al. 1985, Tazawa et al. 1992, Girard
1973a).  However, the resting influence of these receptors on cardiovascular
function was unknown.
Pappano first recognized this analytical deficiency and attempted to
determine windows of developmental time when neuro-stimulation could elicit
changes in cardiovascular function in embryonic chickens (Pappano 1977).
Utilizing atrial field stimulation in combination with autonomic drugs, his work
established a developmental window when centrally mediated parasympathetic
and sympathetic action was possible in embryonic chickens.  However, the
importance of autonomic tonic input and possible autonomic role in
cardiovascular response to hemodynamic challenges during development was
undetermined.
Given our general lack of knowledge of cardiovascular regulation during
development the primary focus of my research was to characterize basis
regulatory mechanism embryonic chickens.  The first step was to characterize
autonomic tone on the developing cardiovascular system.  Autonomic tone in
adult chickens is a sum of both sympathetic and parasympathetic action of the
cardiovascular system maintaing function within so range.  Given the importance
of the autonomic system in adult chickens, I determined that a thorough
investigation into the onset of tone needed to be completed.  Once I had
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completed this work, I then choose to focus on the sympathetic division to
determine when it became functionally viable.  Following completion of the
autonomic analysis, I then needed to determine when adult cardiovascular
reflexes became operational specifically the baroreflex and the chemoreflex.
Once I had determined when these reflexes became operational, I then choose
to determine mechanisms that were responsible for any chemoreflex reactions
followed by an isolation of any possible autonomic mechanisms.  Finally I choose
to do a similar analysis on embryos of the desert tortoise (Gopherus agassizii) for
comparative purposes.
This thesis is divided into chapters based on hypothesises, presented
below, that I constructed to address each of the steps described in the previous
paragraph.
Hypothesis 1 addressed in Chapter 2.
• During the development of chickens, tonic autonomic control of
cardiovascular function will not become operative soon after the initial neural
branches reach the heart.
As described in Chapter 2, a clear adrenergic tone was present early in
development while cholinergic systems remain inactive.  Once adrenergic tone
was established, it became necessary to determine if hemodynamic stress could
induce cholinergic action as well as the augmentation of existing adrenergic
influence.
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Hypothesis 2 addressed in Chapter 3.
• Baroreflex control of cardiovascular function will not become operational
during the latter half of chicken incubation.
As evident in Chapter 3, baroreflex control of cardiovascular function
became sporadically functional in the latter 3 days of chicken development.  In
addition, the gain in embryos was below that known to occur in adults.  Further
cholinergic responses were limited during chicken development.  Again,
adrenergic action seemed to be the predominant mechanism for alteration of
cardiovascular function in embryonic chickens.  The integrity of sympathetic
nervous innervation of the heart then needed to be addressed.  This would
determine if a lack of reaction to presser challenge was due to an immature
mechanism.
Hypothesis 3 addressed in Chapter 4.
• Sympathetic integrity will not be complete by day 19 of a 21-day incubation
period.
Hypothesis 3 was rejected as indicated in Chapter 4 however, the
anticipated maturation of response intensity to tyramine was absent.  Therefore,
the results in Chapter 4 further suggested that a significant portion of maturation
must occur in post-hatch life.  To solidify the findings suggested thus far,
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changes in ambient gas levels were applied to assure that reflex regulation
remained inactive during the majority of chicken incubation.
Hypothesis 4 addressed in Chapter 5.
• Chemoreflex control of cardiovascular function will not exhibit a similar
developmental pattern to that described for the baroreflex.  Adult responses
will not be active until late in chicken development.
While chemoreflex responses appeared as anticipated in the latter 4 days
of chicken incubation, these responses were distinctly embryonic as they were
lacking the well-documented adult responses.   It was, therefore, necessary to
determine if embryonic changes in cardiovascular function were due to any
central regulatory component.
Hypothesis 5 addressed in Chapter 6.
• Central regulation has no part in cardiovascular responses to change in
ambient gas composition during chicken development.
Given the absence of a classical hypotensive tachycardia, known to occur
in adults throughout chicken incubation, it was anticipated that regulatory
systems played no role in embryonic responses.  Pharmacological manipulation,
however, revealed an important adrenergic response to hypoxia was present in
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embryos at 18 days of incubation and older.  Thus, it was necessary to determine
the origin of this hypoxic adrenergic action.
Hypothesis 6 addressed in Chapter 7.
• Chemical sympathectomy and ganglionic blockade will not reveal that direct
sympathetic action on the cardiovascular system during hypoxia is possible
initially on day 18 of chicken development.
As discussed in Chapter 7, chemical sympathectomy and ganglionic
blockade revealed that sympathetic action during hypoxia produced a mild
chronotropic response.  However, the majority of cardiovascular reactions
appeared to be via other mechanisms.  These studies have quantified regulation
of ex-utero development in a single species of vertebrates, thus similarities in
responses from a different vertebrate group needed to be tested.
Hypothesis 7 addressed in Chapter 8.
• Embryonic cardiovascular responses to pharmacological manipulation in a
reptilian species, the desert tortoise, will not exhibit distinct characteristic in
comparison to chicken embryos given differences in reproductive strategies.
These tests indicated that reptiles share some of the characteristics found
in chicken embryos, while exhibiting others that were distinctly reptilian.
9
Techniques and experimental protocols have been discussed within each
chapter with differences in manipulations noted.  In addition, each chapter has




ONTOGENY OF AUTONOMIC CONTROL OF CARDIOVASCULAR FUNCTION
IN THE DOMESTIC CHICKEN, Gallus gallus
Introduction
The chicken embryo has long been a primary model for the study and
understanding of cardiorespiratory function during the ontogeny of vertebrates
(Keller 1997). Although many studies have concentrated on the initiation and
maturation of autonomic cardiovascular regulation, little is known of its functional
significance during embryonic development. In addition, autonomic control of
peripheral vascular beds, essential for blood pressure regulation in adults, is
vaguely understood at best. Early studies established the presence of muscarinic
and adrenergic sensitive receptors in the heart of chicken embryos during the
first quarter of incubation (Berry 1950, Cullis and Lewis 1936).  In addition,
previous studies found that neurotransmitter anabolic and catabolic enzymes
were also present in the embryonic chicken heart by day 5 (Gifford et al. 1973,
Ignarro and Shideman 1968, Zachs 1954). Together with morphological data,
these studies provided the foundations for determining the ontogenetic sequence
leading to cardiac autonomic regulation.  However, they did not establish levels
of autonomic influence on the developing cardiovascular system.
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A functional assessment of autonomic efferents that modulate heart rate
was carried out by Pappano et al. (1977) using field stimulation methods.
Changes in embryonic heart rate following atrial field stimulation indicated that
parasympathetic release of acetylcholine can be elicited on day 12 of incubation,
while sympathetic release of noradrenaline is possible on day 21(Pappano and
Loffelholz 1974). While this demonstrates the functional integrity of autonomic
efferent pathways, it does not imply the existence of an autonomic tone on the
cardiovascular (CV) system.  A functional autonomic tone requires the maturation
of afferent and central elements which may not occur until later in development.
The objectives of this study were to determine when the tonic autonomic
regulation of CV function in developing chicken embryos became operational.
Results were compared with existing data from other species in an effort to
establish possible trends in CV development of vertebrates.
Materials and Methods
Animals and incubation conditions
Plymouth chicken eggs of the Russ208 strain were purchased from
Fællesrugeriet (Randers, Denmark) and transported under constant temperature
conditions, 30°C, to the Department of Zoophysiology, University of Aarhus. On
arrival, eggs were placed in an incubator at 38 °C and turned manually twice a
day until day 18 of incubation.
Measurement of blood pressure and heart rate
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At selected developmental ages, eggs were removed from the incubator,
candled to trace the major chorioallantoic arteries with a soft pencil and placed in
a vermiculite bath (38 °C). A chorioallantoic artery was exposed by removal of a
small portion of eggshell. The smallest branching vessel was occlusively
cannulated with a polyethylene catheter (PE-90 1.27 mm OD / 0.86 mm ID, Clay-
Adams) with the tip heat pulled to an outer diameter of 0.5 mm under a Leitz
dissection microscope. Silk suture was used to secure the catheter to the vessel
after careful alignment of the two, and the catheter was glued to the eggshell with
cyanoacrylic glue (VetBond 3M).  Blood pressure traces were obtained via the
fluid filled catheter connected to a Statham pressure transducer (P23), which was
calibrated against a static water column. The transducer was connected to a
Beckman recorder (R511A) for proper amplification of the signal before being
sampled at 500 Hz by a computer via a Data Translation card (DT2801A) and
LabView custom-made acquisition software. Heart rate (fH) was obtained from
the pressure signal. Details on the frequency response of the catheter-filled
system as well as the zero pressure reference are discussed in chapter 3.
Experimental protocol
Blood pressures were allowed to stabilize for 5-10 min prior to each
experimental treatment. The autonomic antagonists atropine, propranolol and
prazosin were subsequently injected and their effects recorded until arterial
pressure and fH had stabilized. Injection volumes were normalized for each
embryonic age group to 5% of the total blood volume based on literature data
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(Romanoff 1967). Drug dosages were calculated taking into account the total
mass of living tissue in the egg (including total embryonic wet mass as well as
the total mass of the egg membranes (Romanoff 1967)). The following doses
were used: atropine - 1mg·kg-1 (SIGMA); propranolol - 3 mg·kg-1 (SIGMA);
prazosin - 1 mg·kg-1 (SIGMA); (see Table 1).  The efficacy of these dosages was
tested in preliminary experiments, as the antagonist blocked the effects of a
subsequent injection of the agonist (Figure 1). Special care was taken to avoid
large volumes of dead space in injection lines with each drug administration.
Double bored catheters were utilized in day 8 embryos to insure that flush
volumes would be sufficient without exceeding a total injection volume of 5% total
volume of blood.
Catecholamine Analysis
A blood sample was obtained from each embryo following the completion
of an experimental protocol, for later catecholamine analysis. Blood was allowed
to flow freely from the arterial catheter due to suction induced occlusion of the
CAM vasculature. Blood samples were mixed with 5 µL of an EGTA/glutathione
solution (0.2M/0.2M) to prevent catecholamine oxidation and immediately spun
down to separate the plasma. Samples were maintained at -70 °C until analysis
was carried out (within 1 month).  HPLC analysis of plasma catecholamines was
performed as previously described (Fritsche and Nilsson 1990).
Statistics
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A paired Student t-test was used to access significant differences between
pre and post drug injection for all variables measured on each day of
development.  A one-way ANOVA was employed to determine significant
differences in arcsine transformed percentage change in heart rate (fH) and mean
arterial pressure (Map) between days of incubation.  Fisher’s LSD post-hoc
comparison was used to isolate significant differences between days of
incubation.  The fiduciary level of significance for all tests was taken at p<0.05.
All data are presented as mean ± 1 s.e.m..  For all days of study n=5 eggs were
used to determine cardiovacular responses.
Results
General pharmacological effects
General effects of each antagonist on cardiovascular function are
presented in Figure 2.2, which demonstrates the impact of atropine, propranolol
and prazosin in a day 19 chicken embryo.  At this stage, propranolol clearly
reduces fH while elevating Map (B), followed by a reduction in Map and fH after
prazosin treatment (C).  In addition, atropine produced no change in blood
pressure or heart rate (A).
The values of fH, systolic pressure (Sys), diastolic pressure (Dia) and
mean arterial pressure (Map) before and after injection of the antagonist on a
given day of incubation are presented in Tables 2.2-2.4. Blood pressure was in
general agreement with that of prior research in embryos at similar stages of
development (Girard 1973, Hoffman and Van Mierop 1971, Tazawa 1981a, Van
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Mierop and  Bertuch 1967). However, fH was lower compared to that of prior work
(Tazawa 1981), which could be attributed to differences in the control of
temperature as well as the chicken strains.   Atropine injection had no significant
effect on any tested variable, with the exception of fH on day 12. Propranolol
exhibited a clear negative effect on fH at all stages tested, with a mean reduction
of 33 ± 5 beat·min-1. In addition, Map was significantly elevated by propranolol
injection (average of 0.25±0.06 kPa) on all days of incubation, with the exception
of day 21. Prazosin induced a significant reduction in Map from day 8 to 20
(pressure decrease of 0.031 ± 0.01 kPa to 1.27 ± 0.29 kPa at day 8 and 20
respectively), while reducing fH on days 12, 15, and 19.
Developmental Differences
Atropine had little effect on fH and Map at all stages of development (Table
2.2); thus, there were no significant differences between stages (Fig.2.3). The
pattern of sensitivity to propranolol was constant through development, reducing
fH by an average of 16 -18% (Fig.2.4A). Map on day 21 was not affected by
propranolol, a result significantly different from the elevation found on days 12,
15 and 20 (Table 2.3 and Fig.2.4B). An ontogenetic change in prazosin
sensitivity was also evident in both Map and fH during incubation. The reduction
in both fH and Map was significantly greater Fig.2.5) on day 19 than all other
days, with the exception of day 20. Similar results were exhibited on day 20 of
incubation, with Map falling significantly more than on all other days (Fig.2.5),
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with the exception of days 12, 15 and 19. In addition, heart rate changes on day
20 were significantly different (Fig.2.5) than those found on days 8,15 and 21.
Catecholamines levels during development
Noradrenaline (NA), adrenaline (A), and dopamine (D) concentrations
showed a significant change as embryonic maturation progressed (Table 2.5).
Noradrenaline concentration peaked on day 19 at 169.4 ± 52.0 ng·ml-1, a level
significantly higher than that on earlier stages (p<0.05). Adrenaline exhibited a
similar increasing to 80.6 ± 23.2 ng·ml -1 on day 19, again significantly higher than
that of earlier stages (p<0.05). Finally, dopamine peaked at 9.1±1.3ng·ml-1 on
day 20, significantly higher than that of earlier stages (p<0.05).
Discussion
Tonic regulation of the cardiovascular system during chicken development
exhibits distinct characteristics suggesting that embryonic and adult regulatory
mechanisms are unique during the latter half of incubation. The profound
importance of adrenoreceptors in maintaining cardiovascular function
demonstrated in this study, suggests that humoral control prevails over neural
control during embryonic life.  This point was further illustrated by the notable
absence of muscarinic tone on the cardiovascular system over the same
developmental period. The role of each regulatory system during avian
development, as well as how these findings compare to other vertebrate groups,
will now be discussed.
Cardiac Vagal Tone
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Parasympathetic tone was absent throughout the stages studied, as
indicated by the lack of a chronotropic reaction following atropine injection
(Fig.2.3). This finding is in general agreement with other studies in which atropine
injection produced no effect on embryos from 13 to 16 day of incubation (Haque
et al. 1995, Tazawa et al. 1992).
The absencesof parasympathetic tone indicates that a considerable delay
exists between the presence of components required for functional efferent
cholinergic output (Pappano and Loffelholz 1974) and the onset of cholinergic
tone. It is well established that muscarinic receptors are present in chicken
embryos between days 2-3 of development (Cullis and Lewis 1936), as are the
enzymatic components necessary for the synthesis and degradation of
acetylcholine (Gifford et al. 1973, Zachs 1954). Cardiac cholinergic innervation
via the sinal branch of the vagus nerve also appears during the first week of
embryonic development (Kuratani and Tanaka 1990). Finally, studies utilizing
atrial field stimulation further illustrate the potential for parasympathetic activity as
early as day 12 of development (Pappano and Loffelholz 1974). However,
although the functional components of this tone are present from 50% of
development, they appear inactive and no vagal tone appears until neonate life.
It could be argued that embryonic muscarinic receptors are insensitive to
atropine during development, but this is highly unlikely considering that the
chronotropic effects of acetylcholine could be successfully eliminated via pre-
treatment with atropine (Fig.2.1).
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Collectively, these results suggest that normal CV development occurs in
the absence of tonic vagal input.  The potential presence of a vagal tone under
specific circumstances was not addressed in this work and should be considered.
Indeed, long-term recordings of instantaneous heart rate in embryos between 14-
17 days have documented fast decelerations of heart rate, which could be the
result of brief vagal activation (Haque et al. 1995, Hochel et al. 1998). However,
these studies showed opposite effects and lacked statistical treatment; thus,
conclusions must be drawn with caution. In chapter 3 it was demonstrated that
hypertensive stress was insufficient to induce vagal action until external pipping
(19-20 d), indicating that the parasympathetic system is not functional during
chicken ontogeny.
A non-function parasympathetic system has also been noted during the
ontogeny of the African clawed frog (Xenopus leivis), that possess no vagal tone
from NF stages 33/34 to 54 (Fritsche, personal communication) and the desert
tortoise (Gopherus agassizii) (Crossley, unpublished results). Thus, vagal tone
may be absent in several terrestrial vertebrate groups which exhibit ex-utero
embryonic development.  The data available for the fetal lamb is less clear, with
some studies producing no effects of atropine (Reller et al. 1989, Thornburg and
Morton 1986, Thornburg and Morton 1983) while others have reported an
increasing cholinergic tone (Wakatsuki et al. 1992, Walker et al. 1978). Given this
confusion, statements related to vagal function in vertebrates with uterine
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development are limited; however, vagal tone in developing birds and possibly
other ex-utero developing species systems is absent.
Cardiac and Vascular β-adrenergic Tone
A clear β-adrenergic chronotropic tone on the heart was demonstrated via
propranolol injections during all stages studied, inducing on average an 18%
reduction in embryonic fH (Fig. 2.4). These results agree with those of Tazawa et
al.  (1992), who found similar responses to β-antagonist injection in chicken
embryos from day 13 to 16. This reaction to β-blockade was unchanged
throughout development suggesting that cardiac β-adrenergic regulation is
constant from day 8 of incubation.  This was also the case for Map throughout
incubation, with the notable exception of day 21, which demonstrated no
treatment effect.
Thus, the resulting cardiovascular response is one typical of a β-
adrenergic antagonist as can be seen from the dynamic changes in Figure 2.2B.
The blockade of vascular β-adrenoceptors caused vasoconstriction and the
blockade of cardiac β-adrenoceptors lowered fH. Although fH stayed low, stroke
volume must have increased to compensate for the transient drop in cardiac
output and maintained pressure. This, in turn, unmasked the vasoconstriction
associated with β-blockade.
The existence of β-adrenergic receptors in the vasculature has been
previously suggested in chicken embryos at 6 and 13 to 16 days of age (Koide
and Taun 1989, Tazawa et al. 1992). Similar effects have been elicited in
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embryos during day 6 and 14 of incubation (Koide and Taun 1989, Saint-Petery
and Van Mierop 1974).  Although the present pharmacological protocol does not
allow a proper distinction between cardiac and vascular changes, it is clear that
the chicken embryo responds to β-adrenergic blockade in a fashion similar to that
in most other vertebrates. While a cardiac β-adrenergic tone seems to be almost
universal in vertebrates, the degree of hemodynamic changes due to β-
adrenoreceptor vasodilation might be accentuated in embryos, especially if the
chorioallantoic vasculature has an active population of β-adrenergic receptors.
This has been suggested for the placenta of the fetal lamb during the later third
of gestation (Carter 1993).  Therefore, β-adrenergic receptors may have
important consequences for the regulation of shunting and blood oxygenation
during vertebrate development.
Adrenergic Tone: α−receptor mediated
The pattern of α−adrenergic sensitivity varied substantially throughout
embryonic development.  A strong α−adrenergic tone on Map was demonstrated
in chick embryos from 12 to 20 days of development (Table 2.4), with day 19
and 20 embryos exhibiting a heightened sensitivity to injection (Fig 2.5). Similar
results have been reported in embryonic chickens from day 6 -16 (Koide and
Taun 1989, Saint-Petery and Van Mierop 1974). Changes in CV sensitivity were
not addressed in the aforementioned studies, limiting the extent of any
comparison. Similar results have been obtained in fetal sheep, which show an
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increase in α−adrenergic tone, with a magnitude that peaks at the end of
gestation (Assali et al. 1977).
α−Blockade decreased fH from day 12 to 19, with a marked effect on day
19 (Fig.2.4). Several studies have noted a lack in α−mediated chronotropic
effects on the CVS in chicken embryos from day 6 to day 16 (Koide and Taun
1989, Saint-Petery and Van Mierop 1974). The negative chronotropic effects
demonstrated in the current study may therefore be the result of vasodilation and
reduced venous return followed by a reduced fH.  A peak in Map coinciding with
the peak in fH on day 19 further supports this explanation.
Humoral versus neural Adrenergic control
A proper understanding of the effects of adrenergic blockade (both β- and
α−) requires the distinction between humoral and neural effectors. The
participation of sympathetic efferents in CV function during the last days of
chicken incubation has been controversial.  However, it is generally accepted
that adrenergic fibers are inactive until, at least, day 18 of chicken incubation
(Higgins and Pappano 1981, Pappano and Loffelholz 1974). As such, it appears
that humoral catecholamines support cardiovascular function via cardiac and
vascular β -adrenoceptors and via vascular α−adrenoceptors. Interestingly, the
plasmatic levels of catecholamines change dramatically over embryonic
maturation. As indicated in Table 2.5, the plasma levels of noradrenaline and
adrenaline changed 10 and 600 fold respectively throughout ontogeny, with the
ratio of A to NA rising as well.  While the levels determined in this study are
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elevated in comparison to previous work (Dragon et al. 1996), the developmental
pattern is similar.
The rise in plasma catecholamine levels is not paralleled by an increased
cardiac sensitivity to propranolol. This finding has a physiological relevance to
prevent the supramaximal stimulation of the heart that would result otherwise.
On days 17-19 the pacemaker tissue and the ventricle exhibit a decreased
sensitivity to catecholamines (Higgins and Pappano 1981, Loffelholz and
Pappano 1974), probably due to the saturation of the receptors, down regulation
or desensitization. In this regard, the activity of catabolic enzymes responsible for
their inactivation also peak on days 19-20 in cardiac tissue of chickens, with
catechol-o-methyl transferase reaching 0.7 mmol·h-1·mg protein-1 and
monoamine oxidase reaching 50 mmol·h-1·mg protein-1 (Ignarro and Shideman
1968).
If not related to cardiac stimulation, the progressive rise of catecholamine
levels raises the question of whether there is an alternative physiological
purpose? The established increase in catecholamine concentration may be
instrumental in the improvement of blood oxygenation via an increase in
synthesis of carbonic anhydrase and 2,3-DPG (Dragon et al. 1996). If this was a
primary function of elevated catecholamines, it could be pivotal in maintaining
oxygen transport during the period when diffusive gas exchange is becoming
progressively limited. Catecholamines are also important for changes in blood
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oxygen affinity as well as the transition to ATP as the main allosteric modulator of
the hemoglobin in embryonic chickens (Dragon et al. 1996).
In addition, it is interesting that plasma catecholamine levels also rise
during the latter third of development in fetal sheep (Cheung 1990, Jones 1980,
Lewis et al. 1982), which suggests that this is a general trend in vertebrate
development. Moreover, the ratio of A to NA rises during late ontogeny in the
chicks, a finding also demonstrated in fetal sheep (Cohen et al. 1984, Lewis et al.
1982, Lewis and Sischo 1985, Widmark et al. 1989).
Thus, catecholamines may be involved in the timing of internal pipping by
regulating the blood flow to the extra−embryonic circulation and insuring
adequate perfusion pressures to maintain gas exchange. As the CAM begins to
regress, prior to the onset of lung ventilation, the tonic contribution of
α−adrenoreceptors would be more important than that from β -adrenoreceptors,
increasing resistance and reducing extra-embryonic blood volume. This
hypothesis agrees with earlier data indicating that catecholamine effects are
maximal at day 19 (Girard 1973) and, while definitive proof requires further study,
it seems highly plausible.
Conclusion
A progressive maturation of autonomic cardiovascular control coordinated
with morphological development has been the classical picture of cardiovascular
ontogeny. In this general framework, parasympathetic control is assumed to
precede sympathetic regulation, while the role of humoral catecholamines is
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vaguely understood. This study, however, has revealed several flaws in the
classical understanding of this system in birds, which could be extended to
cardiovascular development in other vertebrate species. Data from the present
study indicate the following: 1) Vagal tone is absent through the ontogeny of
chickens. 2) Circulating catecholamines exhibit profound maturation changes in
both concentration and the ratio of adrenaline: noradrenaline. 3) β -Adrenergic
tone is present at 8 days of development with no further maturation of function. 4)
α−Adrenergic tone is present at day 8, primarily affecting vascular tone, with an
increase in magnitude as development progressed.  Clearly each component of
CV regulation undergoes a unique ontogenetic sequence with the adrenergic
system composing the principal functional system during embryonic life.
Basal CV performance and maturation is achieved without tonic vagal input
during chicken development. This is in sharp contrast to adults, which exhibit a
pronounced vagal tone (Bagshaw and Cox 1986, Butler and Jones 1968, Jones
and Johansen 1972). It must be assumed that CV function comes under vagal
influence at "birth" with maturation occurring during postnatal development.
Evidence for this post-natal onset of regulation is found in Chapter 3 work in
which baroreflex activity is present at external egg piping. This trait, or lack of,
has also been found in embryos of the desert tortoise Gopherus agassizii
(D.Crossley, Chapter 8), suggesting that at least one reptilian species exhibit a
similar ontogenic pattern. In addition, several studies have shown no or limited
vagal tone on the CVS in fetal lambs in the latter third of gestation (Reller et al.
25
1989, Thornburg and Morton 1986, Thornburg and Morton 1983).
Parasympathetic tone may therefore be of little importance to CV development in
all vertebrates. Expansion of this experimental approach to other vertebrates will
determine if vagal function is equally absent in other groups.
While this study and others have eliminated vagal input from basal CV
function, the adrenergic system is operative in at least chickens and desert
tortoise. As described here, chicken embryos rely on adrenergic tone to maintain
basal CV function throughout development. Since there is a lack of sympathetic
neural activity during ontogeny, adrenergic tone must be accomplished via
circulating catecholamines (Pappano and Loffelholz 1974). The correlation
between catecholamine concentrations and peak in CV sensitivity further
supports their role in basal CV function of embryonic chickens. Similar
characteristics are apparent in fetal lamb, which exhibit predominantly
α−adrenergic activity with catecholamine levels peaking at term (Assali et al.
1977, Giussani et al. 1994, Reller et al. 1989). Collectively, these data suggest
that embryonic vertebrates depend on hormonal adrenergic influence to control
CV activity and possibly assure successful embryonic life.
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TABLE 2.1
Drug amounts and injection volumes utilized at each stage of development.
8d 12d 15d 19d 20d 21d
Vblood 
a 0.52 1.61 2.35 2.9 2.81 2.61
WMembryo
 b 1.1 5 12.5 22.1 25.8 28.4
WMmembranes 
c 1.8 3.9 5.2 4.9 4.6 4.5
Vinj,total 
d 30 80 120 150 150 135
Atropine e 2.9 8.9 17.7 27 30.4 32.9
Propranolol f 8.7 26.7 53.2 80.9 91.3 98.7
Prazosin g 2.9 8.9 17.7 27 30.4 32.9
a Vblood - estimated volume of blood (µL) (Romanoff 1967)
b WMembryo - wet mass of the embryo (g) (Romanoff 1967)
c WMmembranes - wet mass of extraembryonic membranes including chorioallantoic
and yolk membranes (g) (Romanoff 1967)
d Vinj,total - total volume injected (µL) = 1/3 drug + 2/3 flush volume
e Atropine (mg) - dose = 1 mg·kg-1;
f Propranolol (mg) - dose =  3 mg·kg-1
g Prazosin (mg) - dose = 1 mg·kg-1
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TABLE 2.2
Heart rate and blood pressure data before (C) and after injection (T) of atropine.
fH Sys Dia Map
8d C 199±13 0.44±0.06 0.24±0.04 0.30±0.05
T 196±7 0.41±0.06 0.21±0.04 0.28±0.05
12d C 214±8 0.87±0.04 0.41±0.05 0.57±0.04
T 205±10* 0.88±0.04 0.39±0.05 0.56±0.04
15d C 227±6 2.25±0.13 1.10±0.13 1.49±0.12
T 225±5 2.30±0.11 1.06±0.13 1.47±0.12
19d C 206±9 3.21±0.09 1.86±0.07 2.31±0.05
T 207±9 3.35±0.17 1.78±0.12 2.30±0.13
20d C 251±9 3.39±0.22 2.19±0.15 2.59±0.15
T 259±5 3.56±0.38 2.27±0.22 2.70±0.27
21d C 260±9 4.60±0.58 2.57±0.15 3.25±0.25
T 270±11 4.72±0.53 2.47±0.22 3.22±0.26
Data as mean ± s.e.m.. fH – heart rate (beat·min
-1); Sys - systolic pressure (kPa);
Dia - diastolic pressure (kPa); Map – mean arterial pressure (kPa).   Asterisk (*) -
significant difference after injection (p< 0.05).
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TABLE 2.3
Heart rate and blood pressure data before (C) and after injection (T) of
propranolol.
fH Sys Dia Map
8d C 191±5 0.38±0.04 0.20±0.04 0.26±0.04
T 165±6* 0.44±0.05* 0.23±0.04 0.30±0.05*
12d C 183±11 0.84±0.04 0.37±0.07 0.53±0.06
T 161±13* 1.02±0.07* 0.48±0.1* 0.66±0.09*
15d C 223±11 2.14±0.09 1.00±0.09 1.38±0.08
T 188±14* 2.65±0.04* 1.14±0.08** 1.64±0.06*
19d C 200±14 3.42±0.18 1.85±0.15 2.38±0.14
T 169±15* 3.94±0.27* 2.05±0.22 2.68±0.23*
20d C 256±6 3.41±0.20 2.08±0.14 2.52±0.15
T 207±4* 3.97±0.24** 2.19±0.22* 2.78±0.21*
21d C 251±14 4.39±0.50 2.47±0.15 3.11±0.25
T 227±10* 4.64±0.51 2.40±0.14 3.15±0.23
Data as mean ± s.e.m.. Abbreviations as in Table 2.  Asterisk (*) - significant
difference after injection (p< 0.05).
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TABLE 2.4
Heart rate and blood pressure data before (C) and after injection (T) of prazosin
fH Sys Dia Map
8d C 150±14 0.58±0.07 0.30±0.06 0.39±0.06
T 145±13 0.53±0.07* 0.28±0.06 0.36±0.07*
12d C 189±11 1.02±0.10 0.53±0.10 0.69±0.10
T 179±10* 0.84±0.11* 0.43±0.10* 0.57±0.10*
15d C 212±5 2.60±0.05 1.17±0.08 1.65±0.04
T 202±7* 2.11±0.03* 0.81±0.06* 1.24±0.03*
19d C 169±11 3.79±0.23 1.88±0.18 2.52±0.18
T 114±20* 1.85±0.25* 0.75±0.06* 1.11±0.10*
20d C 209±4 3.85±0.23 2.07±0.20 2.66±0.19
T 194±7 2.81±0.22* 1.27±0.21* 1.78±0.20*
21d C 233±11 4.83±0.36 2.38±0.25 3.20±0.25
T 229±12 4.09±0.39 1.71±0.18 2.50±0.24
Data as mean ± s.e.m.. Abbreviations as in Table 2.  Asterisk (*) - significant
difference after injection (p< 0.05).
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TABLE 2.5.
Plasma catecholamine concentrations (ng·ml-1) at each day of incubation tested.
NA A D
8d 17.7±3.9a 0.1±0.1a 0.8±0.2a
12d 65.0±8.5a 2.3±0.3a 3.2±0.4b
15d 55.7±12.6a 2.4±0.8a 1.1±0.3a
19d 169.4±52.0b 80.5±1.0b 5.4±0.8b
20d 137.0±15.9b 71.2±8.8b 9.1±1.3c
21d 97.3±40.2a 51.2±19.9b 3.2±1.0b





A) Effects of acetylcholine pre- and post-atropine administration on blood
pressure in a day 18 embryo. Notice that the immediate bradycardic effect of
acetylcholine (the heart stopped and pressure dropped below 1 kPa, and
recovered immediately thereafter) disappear after atropine. B) Effects of
isoprenaline pre- and post-propranolol administration on blood pressure in a day
15 embryo. Notice the hypotensive effect of isoprenaline disappearing when the
embryo is pre-treated with propranolol.
Figure 2.2
An illustration of the experimental protocol used throughout the study displaying
an original trace taken from embryo #5 at day19 of incubation. Changes in
pulsatile pressure and fH are shown pre and post injection (at the arrows) of
atropine (A), propranolol (B) and prazosin (C).
Figure 2.3
Effects of 1 mg·kg-1 atropine injection on embryonic heart rate (A) and mean
arterial pressure (B) at each day of development tested.  Data plotted as mean
percentage change ± 1s.e.m.. Asterisk (*) represent significant differences
induced by the antagonist (p<0.05).
Figure 2.4
Effects of 3 mg·kg-1 propranolol injection on embryonic heart rate (A) and mean
arterial pressure (B) at each day of development tested.  Data plotted as mean
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percentage change  ± 1s.e.m..  Asterisk (*) represent significant differences
induced by the antagonist (p<0.05).  Common letters indicate similar effects of
drug injection between developmental stages as determined by a one way
ANOVA on arcsine transformed percentage changes.
Figure 2.5
Effects of 1 mg·kg-1 prazosin injection on embryonic heart rate (A) and mean
arterial pressure (B) at each day of development tested. Data plotted as mean
percentage change  ± 1s.e.m..  Asterisk (*) represents significant differences
(p<0.05). Common letters indicate similar effects of drug injection between














CONTROL OF BLOOD PRESSURE MEDIATED BY BAROREFLEX CHANGES
OF HEART RATE IN THE CHICKEN EMBRYO (Gallus gallus)
Introduction
Pressure differences between the arterial and venous sides of the
cardiovascular system provide the necessary driving force to ensure adequate
gas, as well as other essential components, are transfered to tissues. Alterations
in arterial pressure that may compromise gas transfer are counteracted by both
central and local homeostatic mechanisms. These mechanisms offset the
perturbation, thereby avoiding hypertensive or hypotensive episodes and the
myriad of pathologies these conditions could induce (Van Vliet and West 1994).
Among regulatory systems, the baroreflex is the most prominent short-
term compensatory mechanism utilized during arterial pressure challenges. This
compensatory system results in alterations of cardiac output and peripheral
resistance via the cardiac and peripheral limb of the baroreflex respectively.
Although baroreflex responses are well characterized in a variety of adult
vertebrates (Altimiras et al. 1998), little is known of the maturation of this
mechanism.
In the fetal lamb, the standard mammalian model, an unequivocal
baroreflex response is present during the final trimester of gestation  (Dawes et
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al. 1980, Maloney et al. 1977, Segar et al. 1992, Shinebourne et al. 1972). While
this model is attractive for its link to clinical pediatrics, an alternative experimental
model with short extra-uterine development would be instrumental in exploring
the course of baroreflex maturation at different organizational levels. Such a
model would also be important to the construction of a generalized picture of the
ontogeny of cardiovascular regulation in vertebrates.
The chicken embryo may be such a vertebrate model, with the advantage
of a shortened gestational time andease of embryonic manipulation.  In addition,
mammalian-like circulation of the chicken embryo with an extra-embryonic circuit
involved in gas exchange (the chorioallantois) analogous to the placenta make
findings applicable to mammalian development (Metcalfe and Stock 1993).
Further, its use in the analysis of chemoreflex cardiovascular regulation has been
recently shown (Mulder et al. 1998).
Finally, the maturation of many physiological processes is well
characterized in chicken embryos, providing essential information for an in-depth
study. From previous studies on autonomic cardiovascular regulation, functional
vagal innervation appears on day 12 of development (Pappano and Loffelholz
1974), implying that a hypertensive baroreflex could be operational during the
latter half of chicken ontogeny. This work sought to test the hypothesis that
baroreflex function appears during incubation as it occurs in the fetal lamb.
Materials and Methods
Animals and incubation conditions
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Experiments were conducted in two separate locations. Chicken embryos
up to 19 days of incubation were studied at the Department of Biological
Sciences, University of Nevada, Las Vegas (referred to as LAB1). Chicken
embryos from 19-21 days of incubation as well as hatchlings were studied at the
Department of Zoophysiology, University of Aarhus (referred to as LAB2).
LAB1 studies utilized White Leghorn chicken eggs of the Hyline II strain
purchased from Hyline (LakeView, CA) and incubated in a walk-in environmental
chamber (Labline Instruments Inc., Melrose Park, IL). LAB2 studies utilized
Plymouth chicken eggs of the Russ 208 strain purchased from Fællesrugeriet
(Randers, Denmark) and incubated in a custom made incubator. In both cases
incubation temperature was maintained at 38±0.5 °C and 60% humidity.
Cannulation procedures
At selected developmental ages, eggs were removed from the incubator
and candled to locate a major chorioallantoic artery. For each day of study a
minimum of 5 eggs were used for study.  Arteries were distinguished from veins
based on their course under the shell and the direction of vessel branching. Once
the course of the artery had been traced, it was exposed by opening a small
window (smaller than 10 x 10 mm) in the eggshell and peeling off the underlying
shell membranes. A fluid-filled, polyethylene cannula (PE-90 1.27 mm OD / 0.86
mm ID, Clay-Adams) heat pulled to a tip diameter smaller than 0.5 mm OD was
used to occlusively catheterize the smallest branching artery. The operation was
carried out under a dissection microscope with the aid of fine microsurgery
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instruments under temperature controlled conditions.  In all cases surgical
procedures were completed within 15 minutes. Special care was taken to avoid
bleeding due to the extensive anastomosed chorio-allantoic membrane (CAM)
circulation. In all procedures, a ligature was placed downstream to eliminate
retrograde flow and heat cauterization was used for smaller vessels. The
catheter was then carefully aligned with the vessel and glued to the eggshell with
tissue glue (VetBond 3M). Following completion of the procedure, eggs were
placed in a temperature controlled vermiculite bath (38 °C) for the duration of
each study, commonly less than one hour.
Studies on recently-hatched chicks were conducted on day 2 post-hatch
under halothane anesthesia. The animals were anaesthetized with halothane in a
closed chamber until righting and corneal reflexes disappeared. Halothane, 0.5-
1%, (in air) was delivered thereafter through a plastic gas flow chamber adjusted
to the head of the animal. The level of anesthesia was carefully maintained to
allow spontaneous ventilation and prevent pedal reflexes. The right femoral
artery was occlusively cannulated for blood pressure and heart rate recording.
Blood pressure measurement and calibration
Blood pressure traces were obtained via the fluid filled catheter connected
to a P23 Statham pressure transducer, which was calibrated against a static
water column. Heart rate (fH) was obtained from the pressure signal.
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Pressure transducers were connected to a recorder (Narco Biotrace or Beckman
R21) for proper amplification and sampled at 250 Hz by a computer via an AD
card and LabView custom-made acquisition software.
The small diameter of the catheter heat-pulled tip was observed to
dampen the frequency-response of the pressure recording system in earlier
embryos, when CAM circulation is still poorly developed (9 and 12 days of
incubation). Since the goal of the study was the analysis of baroreflex responses
induced by alteration of mean blood pressure, no attempt was made to correct
for the frequency response of the catheter. In all cases, data are reported as
mean arterial pressure (Map).
In previous studies where blood pressure was characterized during
development in chicken embryos, there has been no mention of a reference point
of circulatory pressures (Girard 1973, Tazawa 1981a). Studies in the fetal lamb
have used the pressure in the amniotic sac or the pericardium as reference
(Dawes et al. 1980, Reller 1989, Shinebourne et al. 1972). Both approaches
would involve a more extensive surgery if employed in chicken embryos. Thus,
the problem was solved in two steps. During the experimental protocol, zero
pressure was arbitrarily set at the top edge of the eggshell (Figure 1). Once the
experiment was completed, the animal was euthanized and quickly frozen at –20
°C.  Following this procedure, the egg was cut along the longitudinal axis to
determine the relative position of the embryo and the heart. The distance from
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the heart to the eggshell was then taken as a pressure head (error) offsetting the
measured values.
Experimental protocol and drug infusion
The experimental protocol consisted of the pharmacological manipulation
of mean blood pressure via a dose-related alteration of peripheral resistances.
The α−adrenoceptor agonist phenylephrine (PHE) was used to increase Map by
inducing a generalized vasoconstriction of the peripheral vasculature, while
sodium nitroprusside (SNP) induced general vasodilation by the release of nitric
oxide. A representative trace of drug effects in early (9d) and late embryos (21d)
is shown in Figure 2.
All injection volumes were normalized to 5% of the total blood volume
(Vblood) at a given embryonic age as determined from literature data (Romanoff
1967, see chapter 2 for details). Preliminary experiments demonstrated that a 5%
Vblood bolus of saline had no apparent cardiovascular effects.
Drug concentrations were based on preliminary tests to establish the
degree of vasoactivity. All dosages were normalized to the total wet mass of the
embryos and egg membranes, and ranged between 20-100 mg·kg-1 for SNP and
PHE.  Progressively greater concentrations of one randomly selected drug was
injected into each embryo, with cardiovascular effects recorded. The entire
protocol lasted less than 60 minutes to avoid secondary alterations in hydration
conditions when the eggshell was opened. Embryos were then euthanized with
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xylocaine (5 mg) before freezing. Hatchlings were euthanized with Halothane as
well as injection of potassium chloride through the femoral catheter.
Calculations and statistics
The gain of the baroreflex was calculated as:
Gain = (-1)* ∆fH/∆Map
And expressed as beats·min-1·kPa-1
Since a baroreflex is characterized by reciprocal responses between heart rate
and blood pressure, the slope of this response would be negative, while the gain
is positive.
To establish meaningful intra-specific and inter-specific comparisons, gain was
normalized with respect to control Map and fH as:
Normalized Gain = Gain * Map / fH
And expressed as %∆fH·%Map-1
Resting blood pressures between stages were compared using a one-way
ANOVA and the Newman-Keuls posthoc test. fH-Map sensitivity was analyzed
using common linear regression methods. Tests were carried out using Statistica
statistical software.
A zero gain (µ=0) would be predicted if fH and Map were totally
independent of each other. Thus, the experimental gain at each stage was tested
against µ=0 with the two-tailed t-distribution.  Data are shown as mean ± s.e.m.
Significant differences were all taken at the fiduciary level p<0.05.
Results
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Map shows a consistent increase during incubation, from 1.01 ± 0.02 kPa
at day 9 to 3.18 ± 0.28 kPa during external pipping (21d), (Table 3.1). Blood
pressure in earlier stages (9d, 12d and 15d) was significantly lower than in later
stages (p<0.05). No differences in blood pressure were observed between the
two strains of chickens used at day19 (2.68 ± 0.29 kPa WL vs. 2.40 ± 0.21 kPa
Ply).
In early embryos, the patterns of change in heart rate and blood pressure
were similar as vascular tension was manipulated. This trend was altered in late
embryos, which exhibited a reciprocal relation between parameters, i.e.
increased pressure inducing a bradycardia while decreased pressure resulted in
a tachycardia (Fig. 3.2).  Changes in fH-Map sensitivity over development are
detailed in Table 3.2. Utilizing 139 pharmacological injections in 54 embryos, fH-
Map sensitivity can be estimated as the average slope (Fig. 3.3). Slope of the fH-
Map curve was positive during early development up to day 19, indicating a lack
of baroreflex responses. The largest slope of 204 beats·min-1·kPa-1 was observed
on day 9, and decreased to 9 beats·min-1·kPa-1 at day 19. The coefficient of
determination (r2), i.e., the amount of variance explained by a linear relationship
between both variables decreased likewise from 88% at day 9 to 17% at day19,
see Table 2). In late embryos, (21d) and 2-day old hatchlings fH-Map were
reciprocal, indicating active baroreflex function. This was best shown by
excluding those drug trials where fH and Map varied concurrently, thus providing
a maximal estimate of the fH-Map slope when only baroreflex responses
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occurred. In this case, the maximum slope was negative from day 18 onwards,
and peaked on day 20 at –34 beats·min-1·kPa-1 (p<0.05; Table 2).
These results were mirrored when calculated per animal basis as shown in
Figure 3.4A and Table 3.3. The average baroreflex gain (Gain) was negative
during early development up to day 19, with a minimum value of -246 ± 75
beats·min-1·kPa-1 at day 15 and increased progressively to -37 ± 0 beats·min-
1·kPa-1 at day 19 (Fig.3.4A). Values from day 9 and 15 were significantly different
from all other stages (p<0.05). Later in development, gain became positive,
oscillating between 25 ± 19 beats·min-1·kPa-1 at day 20 to 53 ± 43 beats·min-
1·kPa-1 at day 21. Only the highest sensitivity on day 15 was shown significantly
different from zero (p<0.05).
The maximal gain of the baroreflex (Gainmax), obtained by averaging the gain of
the animals that showed the response was positive from day18 to the end of
development.  Gain values increased progressively from 13 ± 7 beats·min-1·kPa-1
at day 18 to 105 ± 83 beats·min-1·kPa-1 in two day hatchlings.  In Figure 4B the
relative proportion of animals with prevalent baroreflex responses are shown.
Responses with sensitivities between ± 10 beats·min -1·kPa-1 were considered
uncertain. No animals had a prevalent baroreflex until day 18. The frequency
increased to 33% at day 19, 44% at day 20and 56% at day 21.
Discussion
The present investigation was undertaken in an effort to establish the
critical period at which baroreflex regulation becomes operational in chicken
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embryos.  In addition, change in gain was determined to establish the pattern of
of baroreflex development during embryonic life. The data definitely show that
this reflex is inactive throughout 90% of incubation, and it demonstrates a
increase in gain for late embryonic development to early neonatal life.
Critique of method
The absolute blood pressures reported are based on heart position as
determined after freezing. This approach could have resulted in a displacement
of the embryo during freezing, altering the overall calibration.  This is a legitimate
concern considering the heterogeneous nature of an egg, with an aqueous
albumen phase and a lipid yolk phase. However, the potential error is relatively
unimportant considering the reduced dimensions of the egg (4 cm as an estimate
for the short axis) and the embryonic age used in this study. The maximal error if
the zero was set at a fixed point along the midline would be  ± 0.2 kPa,
equivalent to a range of ±20- ±6% difference in pressure from day 9 to 21.  A
similar method has also been utilized in the fetal lamb by adjusting the zero
reference to the midline of the uterus (Shinebourne et al. 1972). Therefore, the
reference method proposed here or an alternative should be considered if
working with embryos prior to 9 days of age.
An additional criticism could be the use of pharmacological tools to
manipulate peripheral resistance in an attempt to invoke the cardiac limb of the
reflex. This experimental approach eliminates the ability of the embryo to alter
peripheral resistance known to be an important component of the baroreflex and
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potentially could bias our conclusions. Indeed, several studies in the fetal lamb
have established that the use of phenylephrine to load the baroreceptors render
higher gains in comparison to the use of vascular occluders (Dawes et al. 1980,
Maloney et al. 1977). It is important to recognize that while sensitivities of the
cardiac limb might be overestimated, a reflex was not masked by
pharmacological challenge in the fetal lamb, indicating that this approach is valid.
Data Comparisons
Blood pressure values reported in this study are in good agreement with
previous work on chicken embryos (Fig. 3.5), and display a progressive rise
throughout development. No significant pressure differences were evident
between the two strains of chicken used (White Leghorn and Plymouth) at day19
of incubation (Table 3.1). Subsequently, the results were pooled and the two
strains considered identical in relation to blood pressure.
Arterial pressures measured in neonates (2 days post hatching) in this study
were considerably lower than previously measured in non-anaesthetized animals
(Girard 1973). This could be attributed to a depression in cardiac function usually
associated with halothane anesthesia (Biscoe and Millar 1964).
Onset of baroreflex function
As shown in Figure 3.2, cardiovascular responses were markedly different
between early and late embryos. Late embryos demonstrated a reaction
consistent with a functional adult baroreflex response. This response appeared
progressively, starting at day 18 of incubation. However, considering the low
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gains of the baroreflex at this stage (Table 3.3), the onset of baroreflex regulation
should be considered at day 19 of incubation. This is equivalent to 90% of
incubation in chicken embryos, which is within the range of baroreflex onset in
several mammalian species. It should be noted, however, that little information
could be gained from a direct comparison, since the range between species is
from 60% of gestation in the fetal lamb (Shinebourne et al. 1972) to neonatal
appearance in the rabbit (Gootman et al. 1979).
In chicken embryos, the baroreflex activation at 90% incubation time does
not appear as an all or none event i.e. some embryos had a reflex while others
lacked it at all times. Activation in chicken embryos was progressive with the
percentage demonstrating a baroreflex gradually increasing over the last 10% of
development. Mild reflexive responses were first evident in day 18 embryos,
while the average slope ∆fH/∆Map was positive due to the limited number
showing a negative slope. If positive slopes were excluded, the average gain in
day 18 embryos would be positive at 13± 7 beats·min-1·kPa-1. By day 19, 33% of
the embryos showed consistent baroreflex responses and this proportion
increased at day 20 and 21. This finding was similar to what has been reported in
the fetal lamb (Shinebourne et al. 1972), with the frequency of animals displaying
baroreflex responses increased from 60% to 80%. The variability of activation
appearance between individuals was unexpectedly wide. This variablity suggests
that onset is less reliant on developmental age, possibly indicating that other
50
factors such as mean arterial pressure, the onset of lung ventilation or the
relative contribution of each limb may varying between individuals.
Data from the fetal lamb provide evidence for the importance of other
factors determining the onset of baroreflex.  Results from the fetal lamb have
shown that the baroreflex is triggered when the set point for arterial pressure is
reached while the operational set point increases with development,
simultaneously to blood pressure increases (Blanco et al. 1988, Segar et al.
1992). Hence, it is possible that individual differences in resting arterial pressure
could explain the absence of baroreflex responses. However, there appears to
be no correlation between reflex gain and control Map. Thus, this may not
explain the variation in onset age demonstrated in embryonic chickens. The
possible coupling between the onset of lung ventilation and the onset of
baroreflex control is unlikely. In the fetal lamb, baroreflex activity is present prior
to respiration. Further, 20% of chicken embryos during days 20 and 21 showed
no baroreflex activity, despite the fact that the animals were already ventilating.
A change in the relative contribution of each limb of the baroreflex between
embryos remains a viable possibility, but without new experimental data, this is
only a speculation. It is possible that embryos relying on the peripheral limb of
the reflex show a diminished heart rate effect. In fact, studies in the fetal lamb
have suggested that the baroreflex is more dependent on peripheral resistance
than on heart rate (Blanco et al. 1988). Clearly, this could be the case in chicken
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embryos but, as stated, extensive experimentation is necessary to clarify this
issue.
Mechanisms of blood pressure control
Although a functional vagal component is present by day 12 of incubation
(Pappano and Loffelholz 1974), our results suggest no activation by pressure
changes until day 19. In Chapter 2, it was demonstrated that atropine has no
chronotropic effect throughout incubation, a finding in direct conflict with the
current results. It is proposed that the vagus is functional but inactive during
normal beat-to-beat cardiovascular regulation. However, during periods of
vascular stress in late stages of development, at least those induced with
hypotensive or hypertensive drugs, the vagus could be transiently operational.
This hypothesis, while not directly tested in these studies, has support from
circumstantial experimental data discussed in Chapter 2 and remains a viable
scenario.
A second possible explaination for the existence of baroreflex responses
without a tonic efferent vagal activity could involve sympathetic efferents.
However, this possibility is less likely considering that in mammals, sympathetic
innervation is only involved in hypotensive episodes and that functional
chronotropic adrenergic innervation is not operative until 21 days of incubation
(Pappano and Loffelholz 1974).  Again, further experimentation is required to
clarify this issue during the ontogeny in chickens.
Pre- and post-natal maturation of the baroreflex
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A clear reflex maturation occurred prior to hatching as illustrated in Figure
3.4. ∆fH/∆Map slope was initially positive, indicating a feed-forward influence of
arterial pressure on heart rate. This feed-forward effect can be explained by
mechanical properties of the system.  Increased Map results in an increased
venous return, thus decreasing filling time as well as raising the degree of SA
stretch, elevating heart rate.
A similar phenomenon was observed in the fetal lamb (Faber et al. 1974).
The inverse scenario explains cardiac events that follow infusion of SNP in early
embryos. These effects included a reduction in heart rate, which followed SNP
induced reduction in arterial pressure. Overall, these reactions are clearly non-
homeostatic given the lack of pressure recovery following the administration of
vasoactive drugs in early chicken embryos. In addition, they unveil the limited
physiological repertoire early embryos have to compensate for acute stress, as
previously shown during anoxia (Mulder et al. 1998) or hypoxia (Tazawa 1981a).
Feed-forward effects were less accentuated in day 18 embryos and older, which
could be attributed to the appearance of reflex cardiovascular regulation via
baroreflex as well as chemoreflex regulation as recently suggested (Mulder et al.
1998). The degree of baroreflex maturation from day 18 to hatching was less
definitive in the present study.  Based on average gain, there appeared to be no
significant difference from zero gain due to the level of data variability (Table
3.3).  If, however, an analysis is conducted on only those embryos that displayed
a prevalent baroreflex, the gain is significantly different from zero in day 19 and
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20 embryos. In addition, a steady increase in gain from day 18 to hatching is
demonstrated (Table 3.3); thereafter, there is a progressive maturation of the
cardiac limb of the baroreflex in chicken embryos. Utilizing literature values for
adult chickens this maturation is incomplete at hatch and must continue to reach
a normalized gain of 0.92 %∆fH·%Map-1 (Bagshaw and Cox 1986) from 0.55
%∆fH·%Map-1 at day 21. Although the recorded gain in 2 day post-hatching
chickens were also similar to adult baroreflex gain (Table 3.3), such high values
could be simply related with depressed mean arterial pressure due to anaesthetic
effects. Clearly, data on non-anaesthetized post-hatched chicks is needed to
further verify if baroreflex maturation is complete 2 days after hatching.
Although the maturation of the reflex prior to hatching was expected,
previous studies in the fetal lamb provided different conclusions. Several authors
have indicated that baroreflex gain increases (Dawes et al. 1980, Shinebourne et
al. 1972) while other have shown no change (Maloney et al. 1977) or even a
decrease (Faber et al 1974). Thus, it appears unlikely that baroreflex maturation
follows a similar pattern in different vertebrate species.  This statement is based
on a single comparison of the development of arterial pressure and the
appearance of baroreflex regulation in the chicken embryo and the fetal lamb. As
shown in Figure 3.5, the appearance of a baroreflex in the lamb occurs when
arterial pressure is 50% of adult blood pressure, while in chicken embryos blood
pressure is only 21% of the adult arterial pressure. This conclusion has been
formulated before (Gootman et al. 1979) but it is not demonstrated, which
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prompts for more detailed inter-specific studies to understand the driving forces
of cardiovascular regulation.
Conclusion
Relevance of Baroreflex Activity in ovo
This work has provided the basis for two conclusions. First, there is a late
onset of baroreflex regulation and second, the gain of the reflex exhibits
maturation over the final 3 days of incubation in the chicken embryo.
Although the maturation of baroreflex CVS control is clearly significant for newly
hatched precocial chicks, its late appearance questions its importance in ovo.
Indeed, the pharmacological manipulation of blood pressure shows the potential
for embryonic baroreflex regulation, but fails to reveal if baroreceptors are active
during normal development.
This shortcoming has been addressed in the fetal lamb with recordings
from baroreceptor afferents. There is an increased activity in the carotid nerve in
synchrony with the pressure pulse (Blanco et al. 1988), showing that
baroreceptors are loaded. In addition, studies in lambs with baroreceptor
denervation revealed an increased variability in blood pressure, suggesting that
blood pressure homeostasis was impaired without baroreflex feedback (Itskovitz
et al. 1983, Yardley et al. 1983). Thus, baroreflex control of blood pressure is
relevant for the correct development of peripheral resistance (Itskovitz et al.
1983) and aid in the proper development of organ systems (Dutton et al. 1978).
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Finally, baroreflex control has been implicated in cardiovascular homeostasis
during fetal movements, specifically fetal breathing movements (Dawes et al.
1972, Fouron et al. 1975). Although movements in the chicken embryo occur as
early as day 5 and increase substantially at the end of development (Kou 1932),
distinct individualized movements of the thoracic muscles do not occur until 17-
18 days of incubation (Kou 1937). Given the space restriction due to the size of
the embryo, the compression of vessels and sudden changes in cardiovascular
resistance would be more likely at those late stages. In addition, the initiation of
increased pulmonary blood flow, which must occur during internal and external
pipping, could result in resistance changes requiring fast regulation from the
baroreflex.  The correlation between baroreflex onset, as well as gain, and




Control mean arterial pressures at different stages of incubation
Strain Map            N
9d WL 1.01± 0.02 (3) a
12d WL 1.08± 0.08 (4) a
15d WL 1.15± 0.08 (5) a
18d WL 2.22± 0.17 (6) b
19d WL 2.68± 0.29 (4) b
19d Ply 2.40± 0.21 (8) b
20d Ply 2.80± 0.13 (9) b
21d Ply 3.18± 0.28 (9) b
Hatch Ply 2.40± 0.33 (5) b
Data as mean ± s.e.m. (N). MAP – mean arterial pressure (kPa); WL – White




fH-Map sensitivity at different stages of development based on the analysis of the
fH-Map slope per trial.
 Slope r Slopemax r
9d 204 (7) 0.94 * - -
12d 91 (7) 0.76 * - -
15d 160 (8) 0.83 * - -
18d 16 (9) 0.73 * -2 (2) -
19d 9 (33) 0.41 * -25 (7) 0.92 *
20d 0 (36) 0 -34 (12) 0.74 *
21d -5 (31) 0.26 -16 (14) 0.56 *
Hatch -21 (8) 0.44 -13 (4) 0.28
Slope - fH-Map slope (beats·min
-1·kPa-1). Number of trials in parentheses. r
indicates the goodness-of-fit to a linear regression of the data. Slopemax - fH-
Map slope when only baroreflex responses were considered. * - significant
differences from zero sensitivity (p<0.05). N=5 for all analyses unless noted.
58
TABLE 3.3
Baroreflex gain in the latest stages of development.
 Gain % Gain Gainmax %Gainmax
18d -10±8 (6) -0.09 13±7  (2) 0.06
19d -37±0 (12) -0.41 21±7  (4) * 0.22
20d 25±19 (9) 0.25 40±21(7) * 0.44
21d 53±43 (9) 0.48 60±48(8) 0.55
Hatch 40±38 (5) 0.34 105±83(2) 0.93
Adult 0.92
Data as mean ± s.e.m.. Gain - Average baroreflex gain (beats·min-1·kPa-1); %
Gain - Normalized  (unitless variable); Gainmax – maximal baroreflex gain (see
text for details) (beats·min-1·kPa-1); %Gainmax – normalized maximal baroreflex





Schematic drawing of the experimental setup. In particular, notice the zero
pressure reference point is the eggshell, not the level of the embryonic atrium.
Subsequently pressures were corrected by adding an offset factor as described
in the Material & Methods section.
Figure 3.2
Changes in blood pressure (kPa) and heart rate (beat·min-1) after injection of
sodium nitroprusside and phenylephrinein a 9 day embryo (dotted line) and 21
day embryo (continuous line).
Figure 3.3
Plot of the heart rate changes induced by pharmacological alteration of blood
pressure at different stages of development. From top-to-bottom and left-to-right:
9d (n=7), 12d (n=7), 15d (n=8), 18d (n=9), 19d (n=33), 20d (n=36), 21d (n=31)
and 2d hatchlings (n=8). Each data point corresponds to one pharmacological
trial from the number of trials specified above at each stage. Solid lines represent
the best linear fit through the entire data set, dotted lines represent the best
linear fit through those trials with a positive baroreflex response (Slopemax).
Figure 3.4
A) The average gain for the relationship between heart rate and on each day of
development. Data as mean ± s.e.m.
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B) Relative frequency of animals showing a prevalent baroreflex response. Open
bars – non-reciprocal heart rate-blood pressure change; closed bars – baroreflex
response (reciprocal heart rate-blood pressure change) and shaded bars –
uncertain responses (see text for description).
Figure 3.5
Comparison between mean blood pressure and baroreflex gain in chicken and
sheep from the start of incubation to adulthood. Pressure data in circles and
crosses tracked by a dotted line. Data from this study shown as open circles
(mean ± s.e.m.) in the chicken plot; notice that most of the error bars are
inscribed within the symbols. Closed triangles tracked by a broken line represent
baroreflex gain. Map data obtained from previous studies (Girard 1973, Hochel et
al. 1998, Tazawa 1981, Van Mierop and Bertuch 1967). Data on baroreflex gain
based on results from this study and previous literature (Bagshaw and Cox 1986,
Dawes et al 1980, Maloney et al. 1977, Segar et al. 1992, Shinebourne et al.













ASSESSMENT OF SYMPATHETIC VIABILITY DURING DEVELOPMENT IN
THE DOMESTIC CHICKEN, Gallus gallus.
Introduction
In adult chickens, the homeostatic mechanisms that maintain
cardiovascular function during periods of environmental stress have been
thoroughly characterized (see classic studies of Butler 1967, Ray and Fedde
1969).  When exposed to reduced ambient oxygen levels, chickens exhibit a
pronounced tachycardia due, in part, to sympathetic augmentation of
cardiovascular function (Butler 1967).  While the importance of sympathetic
influence on cardiovascular function is understood in adult chickens, its role
during development is unknown.  A recent study has indicated that a strong
adrenergic tone is evident during the latter half of chicken incubation (Crossley
Ch 2).  Thus, during chicken development an adrenergic neurohumoral system is
essential for the maintenance of resting cardiovascular function, but the extent of
sympathetic contribution to this system is unknown.
Structural components of the sympathetic nervous system that contact the
cardiovascular system have been relatively well characterized during the
development of chickens.  Adrenergic receptors are present on the heart and
respond to stimulation during the first quarter of embryonic chicken development
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(Cullis and Lucas 1936, Berry 1950).  In addition, catabolic enzymes necessary
for the production and oxidation of catecholamines are active within a similar time
frame (Gifford 1973, Ignarro and Shideman 1968, Zachs, 1954).  Morphological
analysis of embryonic cardiovascular innervation also has demonstrated that
sympathetic nerves reach the heart between days 11 and 12 of incubation.
These studies have provided information on the anatomical integrity of the
system, but the functional integrity of the sympathetic system was not addressed.
Pappano and colleagues (1974) first addressed this deficiency
demonstrating that adrenergic activity could be induced via atrial field stimulation
on day 19 of chicken incubation.  Thus, during the later 15% of development
sympathetic regulatory systems have the necessary intracellular components for
activity.  As noted in Chapter 2, adrenergic influence could originate from either
neural and/or humoral sources that could not be separated utilizing the
pharmacological approach employed in this study.  Thus, sympathetic integrity
acting primarily on peripheral vasculature may be established much earlier than
previously determined with cardiac effects developing later.
Considering the gap between field stimulation data (Pappano 1976) and
pharmacological assessment, the present work was undertaken to determine the
origins of adrenergic actions on the embryonic cardiovascular system.  Tyramine,
was used during the later half of embryonic development: 1) to establish the
origin of adrenergic tone, 2) determine the onset of sympathetic integrity and 3)
determine maturation patterns during the development of chickens.  In addition,
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chemical sympathectomy with 6-hydroxydopamine was utilized to clarify the
source of tyramine-induced cardiovascular change.
Materials and Methods
Eggs of the domestic chicken, Gallus gallus, were shipped by bus in lots
of 10 dozen from the University of Texas A&M poultry farm over the period
February 1999 to April 1999.  A total of 90 dozen eggs were shipped to the
University of North Texas, Department of Biological Sciences, and set in
incubation in a Lyon electronics ProfHi incubator.  Eggs were set at 38±0.5 °C
with a relative humidity of 60% to 70% and automatically rotated 90° at a three
hour interval to ensure maximal viability.
Catheterization Procedure
Eggs were selected from incubation on days 12,15,18,19,20 and 21 of a
21-day embryonic period. Three day intervals were used early is the study based
on anatomical integrity of the sympathetic innervation to the heart with
successive days utilized during late development to detect changes coordinated
with the onset of lung ventilation.  Prior to experimentation, eggs were candled to
locate a major chorioallontoic membrane (CAM) artery.  Once located, eggs were
placed in a water-jacketed temperature control chamber to maintain an
environment close to incubation conditions.  A small hole was then made in the
shell with a 21-gauge needle, allowing the removal of a 1-cm square section of
shell.  A branch of an underling artery was then encircled with three 6-00 silk
ligatures to act as catheter anchors.  The distal ligature was then tightened
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occluding blood flow followed by proximal ligature closure limiting flow.  Micro-
fine scissors were then used to cut the vessel to allow anterograde insertion of a
saline filled polyethylene catheter.  Catheters were constructed of PE-90 (1.27
mm OD / 0.86 mm ID, Clay-Adams) heat pulled to a tip outer diameter smaller
than 0.5 mm.  Following successful cannulation the intermediate ligature was
tightened and the proximal ligature was removed.  The catheter was then fixed to
the shell with cyanoacrylic glue, plugged with a pin occluder, and the egg then
moved to an experimental chamber.
Each experimental chamber consisted of a water-jacketed 300-ml glass
container fitted with a glass lid.  Each lid contained three holes allowing gas
exposure as well as catheter connection to WPI type disposable blood pressure
transducers. Following the set up of four eggs, chambers were continually
flushed from the bottom up with water saturated room air.  Transducers were
then connected to Adinstruments MacLab data acquisition system with signals
processed with software on an 8500 Power Macintosh computer.  Pressure
transducers were calibrated against a static column of water, with the relative
zero determined as described in Chapter 3.
Study procedure
After a 30 min control period, a dosage of tyramine corrected for
embryonic mass (0.1 mg*kg
-1) was injected via a T joint in the pressure catheter.
Cardiovascular responses were assumed to occur within five minutes after initial
treatment (based on preliminary studies) and were allowed to recover for 10 min
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following return to control levels.  This procedure was repeated for dosages of
1.0 mg*kg
-1and 10 mg*kg
-1each followed by a recovery period.  Embryos were
then treated with the sympathectomizing agent 6-hydroxydopamine (6-OH) at a
dosage of 1 mg*kg
-1 followed by a second dosage of 20 mg*kg
-1.  A recovery
period of 20 min after return to control levels was allowed between each dosages
of 6-OH.  Upon completion of sympathectomy treatment, eggs were again
allowed to recovery for 20 min.  Tyramine injection of 1 mg*kg
-1 was then
repeated followed by repeated dosage of 20 mg*kg
-1 with recovery periods
allowed as indicated for pre 6-OH treatment. Total time elapsed between the 20
mg*kg
-1 6-OH treatment and the second dosage of 10 mg*kg
-1 tyramine averaged
68 min throughout the study.  This protocol was repeated for a minimum of 5
eggs on day 12, 15,18, 19, 20 and 21 of a 21 day-incubation period.
Statistical Analysis
A paired Student t-test was used to access significant differences between
pre- and post- drug infusion for all variables measured on each day of
development.  A one-way ANOVA was conducted on the arcsine transformed
percent difference between control and treatment levels in all variables to
determine significant changes between days of incubation.  Fisher’s LSD post-
hoc comparison was used to isolate significant differences between days of
incubation as well as to determine differences in dosage.  The fiduciary level of
significance for all tests was taken at p<0.05. All data are presented as mean ± 1
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s.e.m..  For each day of study, 5 eggs were used to determine cardiovacular
responses.
Results
Given that individual pressure parameters were consistently altered by a
given dosage of tyramine, further discussion will present mean arterial pressure
as representative of presser actions. Systolic and diastolic pressure responses to
each dosage of tyramine are presented in Table 4.1.  Tyramine produced
minimal responses at the lowest dosage, 0.1 mg*kg
-1.  Mean arterial pressure
(Map) was significantly elevated by an average of 0.8, 0.5 and 2.on days 12, 18
and 19 respectively (Fig. 4.2).
General Tyramine Effects
Treatment with 1.0 mg*kg
-1 and 10.0 mg*kg
-1 tyramine produced similar
cardiovascular responses on all days of study (p<0.6, p<0.9 for Map and fH) and
will be described collectively.  Mean arterial pressure rose an average of 2.3
mmHg from days 18 to 21 following tyramine injection (Fig 4.3 & 4.4).  In
addition, heart rate (fH) also rose following injection averaging an increase of 9
beat* min
-1 on all days tested with the exception of day 20 (Fig. 4.3 & 4.4).
Responses of Map to tyramine treatment on days 18 through 21 were consistent
(Table 4.2 a & b).  Mean arterial pressure responses during the final days of
incubation were significantly different from those on days 12 and 15 with the
exception of day 20 (Table 4.2 a & b).  Heart rate responses were constant
throughout development in the chicken embryo as shown in Table 4.2 a & b.
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Effects of Sympathectomy
Treatment with 20 mg*kg
-1 of 6-hydroxydopamine (6-OH) altered pressure
throughout embryonic development in chickens (Table 4.3).  Following injection
of 6-OH, Map exhibited an initial rise ranging from 0.3 to 8.0 mmHg on days 12 to
21 respectively (Table 4.3). Heart rate was also elevated by treatment with 20
mg*kg
-1 6-OH on day 18 to 21, with increases ranging from 7 to 19 beat*min
-1.  All
changes were significant with the exception of day 20 (Table 4.3).  All responses
dissipated over time and control values had recovered within 30 min of treatment
with 20.0 mg*kg
-1 of 6-OH.  Treatment with 1.0 mg*kg
-1 produced similar effects
on days 19 and 21 of incubation, but all reactions were dampened in comparison
to treatment with 20.0 mg*kg
-1.
A comparison of acute responses to 6-OH treatment between days of
incubation revealed cardiovascular reactions matured with development. Map
responses were significantly elevated (p<0.0001) in the final 3 days of
development (Table 4.4).  Heart rate response was consistent throughout the
majority of incubation, with a significant increase on day 21 that differed from
reaction on day 12 and 15 (Table 4.4).
Post 6-OH tyramine response
Heart rate reactions to tyramine injection (1.0 mg*kg
-1) were dampened by
sympathectomy on all days of incubation.  This reduction was significantly
(p<0.05) different on days 12 and 15 which averaged an increase of 10
beats*min
-1 pre-sympathectomy treatment with no change following sympathetic
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removal (Fig. 4.5).  All other cardiovascular variables responded similarly to
tyramine before and after 6-OH treatment throughout the days of study.
Following sympathectomy Map was unchanged by the initial treatment
with 10 mg*kg
-1 tyramine (Table 4.8).  Following the second injection of 10 mg*kg
-
1 tyramine Map increase an average of 0.85 mmHg on days 18-21 (Fig. 4.6).
This response differed from the 4.6 mmHg increase in pressure exhibited during
pre 6-OH tyramine treatment (Fig. 4.6). Heart rate exhibited a similar reaction to
the initial dosage of tyramine, with a non-significant reduction in rate following the
first post 6-OH tyramine injection (Table 4.8).   The second dosage of tyramine
produced an average increase in heart rate of 2.5 beats* min
-1 on days 19 and 20
of incubation.  This response was different than pre-6-OH treatment value, which
averaged an increase of 16 beats* min
-1 on these days (Fig. 4.6).
Discussion
Classical studies of cardiovascular regulation during chicken development
have determined that the sympathetic division of an adult regulatory mechanism
is immature until day 19 of chicken incubation (Pappano and Loffelholz 1974).  In
the present study, a clear positive chronotropic as well as hypertensive response
followed intra-arterial injection of the known adrenergic activator tyramine on 12
to 21 days of incubation.  This indicates that all sympathetic terminal components
necessary to induce changes in arterial pressure and heart rate are present over
the final 40% of development in chickens.  In addition, sympathetic response to
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tyramine activation increases until day 18, plateauing for the final 15% of
development.
Critique of Method
Conclusions drawn from this study have been developed under the
assumption that tyramine induces release of noradrenaline from postganglionic
terminals in chicken embryos.  While it is acknowledged that this study did not
determine the primary site of drug action, prior work in fetal and adult mammals
has established that post-ganglionic terminals are the sites of tyramine action.  In
addition, previous study has demonstrated that noradrenaline stores in the
adrenal medulla are not effected by tyramine, indicating that changes in CVS
function are strictly due to catecholamine release from sympathetic nerve
terminals.
Sympathectomy with 6-hydroxydopamine (6-OH) had been previously
conducted on a limited number of isolated preparations from newly hatched
chickens (Bennett and Malmfors 1974).  The current study was the first to
characterize cardiovascular responses of chicken embryos to in vivo treatment
with 6-OH.  Therefore, the present study’s dosage and timeframe required to
achieve some degree of sympathetic removal was based on fetal lamb literature
(Tabsh et al. 1982).  While it is acknowledged that assuming 6-OH dosages
known to be effective at eliminating fetal mammalian sympathetic action would
also be sufficient in embryonic chickens could be flawed, a number of
observations justify its use. Given the diverse protocols used in fetal sheep, all of
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which have resulted partial or total sympathectomy (Schuijers et al. 1986, Lewis
and Sischo 1985, Iwamoto et al. 1983, Tabsh et al. 1982, Lewis et al. 1984), the
6-OH dosage utilized in this work should be sufficient in chicken embryos as well.
Further, assessment of sympathectomy in the current study was with conducted
changes in the response to tyramine used as the indicator of sympathectomy by
6-OH treatment, as in studies on fetal sheep (Schuijers et al. 1986, Lewis and
Sischo 1985, Iwamoto et al. 1983, Tabsh et al. 1982, Lewis et al. 1984). It should
be noted that total 6-OH dosage used in this work was below that demonstrated
to achieve total sympathectomy in 2 to 6 week old chickens (Bennett and
Malmfors 1974).  Thus, while this procedure may not have achieved complete
sympathectomy, the alteration in cardiovascular reaction to tyramine would
suggest at least partial depletion of noradrenaline.
In addition to determining correct dosages, time intervals needed to
achieve complete or partial sympathectomy in chicken embryos needed to be
assumed.  In fact, the interval between final treatment with 6-OH and tyramine
assessment used in the present study was far shorter than that used in adult
chickens and fetal sheep (Bennett and Malmfors 1974, Schuijers et al. 1986,
Lewis and Sischo 1985, Iwamoto et al. 1983, Lewis et al. 1984). Yet, a previous
study in fetal sheep has also demonstrated that this protocol was sufficient to
eliminate the cardiovascular response to tyramine for up to 7 days after treatment
(Tabsh et al. 1982).  In addition, study in adult mammals has indicated that 6-OH
is taken into post-synaptic terminals via a membrane pump, suggesting a rapid
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action (Jonsson and Sachs 1975).  Hence, the potential speed of terminal uptake
as well as the sympathetic assessment with tyramine, assures that the protocol
used was sufficient for at least partial sympathetic terminal destruction.
Tyramine Responses
Tyramine injection of both 1.0 mg*kg
-1 and 10 mg*kg
-1 dosages caused a
consistent increase in Map and fH over the period of study, while the lowest
dosage (0.1 mg*kg
-1) resulted in sporadic attenuated reactions (Fig 4.2,4.3 &4.4).
The latter findings differed from those found in a prior study in which 0.1 mg*kg
-1
induced an increase in both inotropic and chronotropic action in isolated chicken
hearts from day 16 of incubation until hatch (Michal et al. 1967).  Fundamental
differences between isolated preparations and in vivo studies could account for
this discrepancy.  Further, as suggested in a previous study (Pappano 1976),
vascular responses to the lowest tyramine dosage on day 12 could be the result
of catecholamine release from sites other than adrenergic nerve terminals.  Thus,
the present study reports maximal cardiovascular responses with an injection of
1 mg*kg
-1 tyramine with vascular reactions to treatment beginning between day
15 and 18 of chicken incubation.
Pressure rises caused by treatment with either 1 mg*kg
-1 or 10 mg*kg
-1 of
tyramine were significant over the later four days of embryonic development (Fig
4.3, 4.4).  This agrees with prior work on isolated heart preparations that
demonstrated a stimulatory action of tyramine beginning on day 16 of incubation
(Michal et al. 1967).  Thus, the cardiovascular system is innervated by potentially
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functional sympathetic efferent nerves between days 15 and 18 of chicken
incubation.  In addition, pressure response to tyramine remained constant over
the final four days of chicken incubation for each dosage (Table 4.2), indicating a
lack of further maturation of sympathetic terminals.  This finding differed from
those determined in previous studies in which tyramine treatment exhibited an
increase in action with development (Michal et al. 1967, Pappano 1976).  These
studies while informative, utilized isolated heart preparations which could partially
account for differences from the current study.  This point is illustrated when
comparisons are conducted between responses found in earlier days of
development.  Michal et al. (1967) found a negative inotropic action of tyramine
on isolated embryonic chicken hearts on day 14 of incubation, a finding absent in
this study (Fig 4.3 & 4.4).  Thus, while previous data support the onset of positive
inotropic action over the later stages of chicken development in vivo, the current
study found no significant change in pressure response during this period.
Chronotropic responses to treatment with either 1 mg*kg
-1 or 10 mg*kg
-1 of
tyramine were constant throughout the period of study, further indicating maximal
cardiovascular reactions are induced by 1 mg*kg
-1 of tyramine (Table 4.2 a & b).
In addition, 1 mg*kg
-1 tyramine elevated heart rate significantly on day 12 and 15
suggesting that cardiac sympathetic innervation is operational soon after reaches
the embryonic heart.  Importantly, heart rate was unaffected by either dosage of
tyramine on day 20, a finding markedly different from that demonstrated in prior
studies (Pappano 1974, Michal et al. 1967).  Again, this may reflect innate
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differences between isolated preparations and in vivo studies in which peripheral
vascular and cardiac responses interact to produce the measured change.  Why
this transient loss of chronotropic sensitivity occurs on day 20 is unclear.
However this pattern mirrors that previously determined for sino-atrial adrenergic
sensitivity which peaks on day 18 and then falls on days 19 to 20 of chicken
embryo incubation (Pappano and Loffelholz 1974).  Sensitivity then recovered on
day 21(Loffelholz and Pappano 1974) as confirmed in the present work from
tyramine actions.  Loffelholz and Pappano (1974) attributed their findings to an
overall hypoxic state in embryos during the last 3 days of incubation, resulting in
an acidosis and decrease in cardiac sensitivity (Girard 1973).  Additionally, a
peak in cardiac catechol-O-methyltransferase activity on days 19 and 20 (Ignarro
and Shideman 1968) has been suggested to account for the decrease in cardiac
response on day 20 of incubation (Loffelholz and Pappano 1974).  Thus,
numerous changes may account for the transient loss of chronotropic action on
day 20 and further study is needed to definitively determine the origin of this
change.
6-Hydroxydopamine
The acute actions of 6-hydroxydopamine on heart function further suggest
sympathetic integrity is established by day 18 of chicken development (Table
4.3).  In addition, cardiac response to 6-OH was constant over the final 20% of
development, indicating that sympathetic components are unchanged a finding
also suggested by tyramine treatments. The lack of a significant chronotropic
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response on days 12 and 15 was unexpected given the previously established
actions of tyramine on these days (Fig 4.3).  However, each embryo was
exposed to tyramine prior to sympathectomy, possibly accounting for this finding
due to an inability of sympathetic terminals to regenerate noradrenaline.
Regardless, these findings validate the apparent integrity by day 18 of cardiac
sympathetic regulatory components as illustrated by tyramine treatment (Fig 4.3).
The selective mechanism responsible 6-OH transport into post-synaptic terminals
further assures that noradrenaline released from sympathetic efferents causes
the positive chronotropic action (Jonsson and Sachs 1975, Kostrzewa and
Jocobowitz 1974). Thus, noradrenaline released from sympathetic terminals can
augment cardiac function by day 18 on chicken development.
Sympathetic terminal release of noradrenaline may be capable of
alteration of peripheral resistance as early as day 12 of chicken incubation (Table
4.3).  As suggested by Table 4.4, pressure response is constant until day 18 of
incubation, followed by an increase over the final three days of incubation, both
events suggesting a late maturation of function.  These data, in conjunction with
pressure responses to tyramine on day 12 suggest that sympathetic action on
peripheral resistance is possible by 60% of chicken embryo incubation.  In view
of this possibility, the lack of cardiac responses on day 12 and 15 following 6-OH
treatment are difficult to explain.  Further experimentation is needed to clarify
sites of 6-OH action on developing chicken cardiovascular systems.
Tyramine Post 6-OH
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Injections with 1 mg*kg
-1 of tyramine produced cardiovascular reactions
similar to pre sympathectomy values.  This finding could be due to the time frame
needed to achieve maximal sympathectomy following the initial treatment.
Alternatively, it is possible that this dosage of 6-OH was insufficient to achieve
the needed degree of catecholamine depletion.  Prior research has demonstrated
that catecholamine must be depleted to extreme levels to produce detectable
differences (Ungerstedt and Marchall, 1975).  However, the second dosage of 10
mg*kg
-1 tyramine did exhibit a decrease in ability to increase cardiovascular
function, indicating that time period is a principle factor in conducting chemical
sympathectomy is time period.
Dampening of pressure responses following sympathectomy treatment
were first evident following the second dosage of 10 mg*kg
-1 tyramine on day 18
of incubation (Fig. 4.6).  Therefore, the protocol used was sufficient to produce
partial or total sympathectomy in chicken embryos.  In addition, this verifies that
cardiovascular responses to tyramine over the final four days of incubation were
due to noradrenaline release from sympathetic terminals.
Chronotropic responses following the secondary dosage of tyramine
indicated that while peripheral sympathectomy is possible over the final 4 days of
incubation, cardiac innervation is partially resistant.  Chronotropic responses to
tyramine were altered only on days 18 and 19 (Table 4.5).  However, given that
significant chronotropic responses to tyramine were absent on day 20,
sympathectomy would be expected to produce no change in reaction.  Therefore,
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clear cardiac denervation was achieved only on days 18 and 19, suggesting that
either a long time interval or a greater 6-OH dosage is needed to achieve cardiac
sympathectomy.
Conclusion
While past study has demonstrated that both adrenergic receptors and
sympathetic innervation of the heart are present on day 12 of incubation, little
had been determined about sympathetic activity (Pappano 1977).  Utilizing
isolated preps and field stimulation, Pappano and colleagues (1974) have
determined that sympathetically derived increase in cardiac function was present
as of day 19.  The present study has expanded the window of potential
sympathetic regulation of the cardiovascular system to include day 18 of chicken
incubation.  In addition, day 20 represents a critical period when cardiac tissue
becomes desensitized to sympathetic stimulation.  Thus, adrenergic regulation
mediated by the sympathetic nervous system undergoes a series of
transformations during the internal pipping period in chicken embryos.
Anticipated augmentation of cardiovascular responses were absent during late
development, indicating a significant portion of regulatory maturation must take
place during the neonatal period and that sympathetic regulation is quiescent
until hatching.
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Table 4.1. Systolic (Sys) and diastolic (Dia) pressures responses to 0.1, 1.0 and
10 mg*kg
-1 tyramine during development. Asterisk indicates treatment (T) was
significantly (p< 0.05) different from control (C) as determined by a paired T-test.





Day Sys Dia Sys Dia Sys Dia
12 C 14.9±1.2 9.9±0.8 14.5±1.0 9.8±0.8 13.0±0.9 8.9±0.9
T 15.8±1.1 * 10.2±0.9 14.8±1.0 * 9.7±0.7 13.4±0.9 8.7±0.8
15 C 20.9±1.6 14.0±1.0 22.3±2.1 14.5±1.6 20.8±2.0 13.8±1.6
T 21.7±1.7 14.0±1.1 22.2±2.3 14.5±1.8 22.4±2.3 14.3±1.6
18 C 23.5±1.1 13.6±0.8 22.2±0.9 13.4±0.8 22.2±0.7 12.9±0.9
T 24.4±1.1 * 14.2±0.9 * 23.6±1.0 * 14.5±0.8 23.7±1.0 * 14.1±0.8 *
19 C 28.1±1.2 18.2±1.1 27.1±1.3 16.6±0.9 27.0±1.3 16.9±1.2
T 29.6±1.1 * 19.3±0.9 30.4±1.5 * 19.4±1.3 * 30.4±1.4 * 20.4±1.3 *
20 C 31.7±0.8 21.5±0.9 31.7±0.8 21.7±0.9 29.0±1.3 20.4±1.3
T 33.6±1.1 23.6±1.2 34.7±1.1 * 24.9±1.3 * 34.6±2.3 * 25.1±1.5 *
21 C 41.0±2.4 26.0±2.0 39.6±2.2 26.0±1.9 39.8±2.5 25.8±1.9
T 42.3±1.8 28.8±1.7 42.3±2.4 * 28.7±2.1 * 44.5±3.0 * 30.9±2.2 *
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Table 4.2.  A comparison of mean arterial pressure (Map) and heart rate (fH)
response between days of incubation of both 1.0 mg*kg
-1 and 10.0 mg*kg
-1
tyramine injection.  Lettering indicates days reacting similarly to a gives dosage
of tyramine.  Significant differences (p<0.05) as determined by ANOVA
conducted on the arcsine transformed percentage changes are represented as




Day Map fH Day Map fH
12 BC A 12 C A
15 C A 15 BC A
18 A A 18 A A
19 A A 19 AB A
20 AB A 20 A A
21 A A 21 A A
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Table 4.3. Differences in mean arterial (Map), systolic (Sys) diastolic (Dia)
pressures and heart rate (fH) response to two dosages of 6-hydroxydopamine 1
mg*kg
-1  (1) and 20 mg*kg
-1 (20).  Asterisk indicates significant difference in
parameter from control values (C). Data are presented as mean ± sem.  N=5 for
all analyses unless noted.
Day Map Sys Dia fH
12 C 11.1±0.8 13.6±0.9 9.1±0.7 211±9
1 11.1±0.8 13.7±0.8 9.0±0.8 208±9
C 11.0±0.8 13.3±1.0 9.1±0.8 211±8
20 11.3±0.8 * 13.9±0.9 * 9.2±0.8 * 210±8
15 C 16.1±1.4 19.9±1.6 13.1±1.2 225±14
1 16.4±1.5 20.1±1.9 13.4±1.3 227±13
C 16.0±1.5 19.9±1.8 12.7±1.3 222±12
20 16.5±1.5 * 20.7±1.7 * 13.1±1.3 223±13
18 C 18.3±1.0 22.9±1.2 13.9±0.8 245±4
1 19.1±1.1 24.0±1.2 * 14.5±0.9 251±4
C 18.0±1.2 23.0±1.5 13.6±0.9 242±4
20 19.0±1.1 * 23.6±1.2 14.7±1.0 * 249±4 *
19 C 22.7±1.0 27.8±1.1 18.1±1.0 239±6
1 23.5±1.2 * 28.5±1.4 18.6±1.3 243±6
C 22.2±1.0 27.1±1.1 17.7±1.1 239±5
20 24.2±1.2 * 29.5±1.4 * 19.1±1.2 * 248±5 *
20 C 24.4±2.1 29.0±2.1 20.1±2.2 260±7
1 26.0±2.3 31.0±2.3 21.5±2.4 265±5
C 24.1±2.4 28.9±2.5 19.6±2.4 256±6
20 28.9±2.1 * 34.8±1.8 * 24.1±2.3 * 267±6
21 C 29.9±2.1 36.0±2.7 24.6±1.7 290±17
1 31.8±2.1 * 38.5±2.4 * 25.7±2.0 * 297±15 *
C 28.7±1.5 35.0±1.5 22.9±1.4 289±14
20 36.7±2.6 * 45.2±3.1 * 29.6±1.4 * 308±12 *
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Table 4.4.  Comparison of acute mean arterial (Map), systolic (Sys) diastolic
(Dia) pressures and heart rate (fH) r responses to intravenous injection of 20
mg*kg
-1 6-OH.  Days with a like letter exhibited responses that were similar.
Unlike letters indicate significantly differing responses (p< 0.05) as indictated by
a one way ANOVA conducted on arcsine transformed percent changes. N=5 for
all analyses unless noted.
Day Map Sys Dia fH
12 A AB A A
15 A AB A A
18 AB AB B AB
19 B B B AB
20 C C C AB
21 C C C B
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Table 4.5. Change in mean arterial (Map), systolic (Sys) diastolic (Dia) pressures
and heart rate (fH) following injection of 10 mg*kg
-1 tyramine pre (C) post (10I)
and second post (10II) 6-OH treatment.  Asterisk indicates significance of at least
(p<0.05 ) between pre and post one and two treatment as indictated by a one
way ANOVA conducted on arcsine transformed percent changes.  N=5 for all
analyses unless noted.
Day Map Sys Dia fH
12 C 0.1±0.2 0.4±0.2 -0.3±0.2 2±6
10 I 0.3±0.1 0.6±0.3 0.1±0.1 6±2
10II 0.0±0.2 0.3±0.4 -0.1±0.1 0±4
15 C 1.1±0.4 1.6±0.7 0.5±0.3 14±6
10 I 3.0±2.5 0.9±0.2 0.5±0.3 4±5
18 CII 4.1±1.3 4.3±1.7 4.0±1.2 11±4
10 I 2.0±0.4 2.2±0.6 1.8±0.6 * 12±3
10II 0.7±0.2 * 0.8±0.2 0.8±0.3 * 3±2
19 C 3.3±0.3 3.3±0.6 3.5±0.4 21±2
10 I 2.0±0.3 2.4±0.3 1.8±0.4 * 13±3
10II 0.8±0.5 * 0.9±0.5 * 0.9±0.7 * 4±4 *
20 C 5.2±1.6 5.7±1.8 5.0±1.6 11±3
10 I 3.4±0.6 4.2±0.8 3.2±0.3 11±4
10II 0.2±0.6 * -0.3±1.2 0.3±0.5 * 1±2 *
21 C 5.9±1.4 4.9±1.8 5.4±1.3 15±4
10 I 4.8±1.2 5.9±1.4 4.0±1.0 12±5




Representative raw data traces illustrating the cardiovascular responses
following injection of 10 mg*kg
-1 tyramine (arrow).  Each panel shows arterial
pressure and heart rate responses on day 18 (A), 20 (B) and 21 (C) of
incubation.
Figure 4.2
The average cardiovascular reaction to 0.1 mg*kg
-1 tyramine injection in chicken
embryos during development.  Heart rate (fH) and mean arterial pressure are
presented as control (open bar) and treatment response (closed bar).  Asterisks
indicate significant difference (p<0.05) from control following tyramine injection.
Data are presented as mean ± s.e.m. with an n=5 for each mean.
Figure 4.3
The cardiovascular response to 1 mg*kg
-1 tyramine injection in chicken embryos
during development Heart rate (fH) and mean arterial pressure are presented as
control (open bar) and treatment response (closed bar).    Asterisk indicates
significant difference(p<0.05)  from control following tyramine injection.  Data are
presented as mean ± s.e.m. with an n=5 for each mean.
Figure 4.4
The cardiovascular response to 10 mg*kg
-1 tyramine injection in chicken embryos
during development. Heart rate (fH) and mean arterial pressure are presented as
control (open bar) and treatment response (closed bar).  Asterisk indicates
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significant difference (p<0.05)  from control following tyramine injection.  Data are
presented as mean ± s.e.m. with an n=5 for each mean.
Figure 4.5
The cardiovascular response to 1 mg*kg
-1 tyramine injection in chicken embryos
during development pre and post 6-hydroxydopamine treatment.  Data are
presented as control (first set open and closed bar) and post-treatment, (second
set open and closed bar) for both heart rate (fH) and mean arterial pressure
(Map).  Asterisk indicates significant difference (p<0.05)  in tyramine response
from pre 6-hydroxydopamine treatment.  Data are presented as mean ± s.e.m.
with an n=5 for each mean.
Figure 4.6
The cardiovascular response to 10 mg*kg
-1 tyramine injection in chicken embryos
during development pre and post 6-hydroxydopamine treatment. Data are
presented as control (first set open and closed bar) and post-treatment, (second
set open and closed bar) for both heart rate (fH) and mean arterial pressure
(Map).  Asterisk indicates significant difference (p<0.05)  in tyramine response
from pre 6-hydroxydopamine treatment. Data are presented as mean ± s.e.m.















THE DEVELOPMENT OF CARDIOVASCULAR CHEMOREFLEX ACTION IN
CHICKENS: RESPONSE TO ACUTE CHANGE IN AMBIENT GAS STRESS.
Introduction
The homeostatic balance of gas transfer to and from peripheral tissues is
mainly dependent on cardiovascular reflexes, with contributions from local
regulatory processes. Among the neural components, the chemoreflex plays an
important role in matching supply to demand by the different organs. In adult
vertebrates, a myriad of reactions occurs in response to chemoreceptor
activation, with hyperventilation and blood flow redistribution comprising the main
components.  While these adult responses have been well characterized in
several vertebrate groups, fetal development of this reflex in terrestrial
vertebrates has been addressed in relatively few studies utilizing primarily the
fetal lamb.
The fetal lamb has been the vertebrate model used in determining the
importance of chemoreflex function as well as its maturational pattern during fetal
development.  In fetal sheep, cardiovascular responses to alteration of blood gas
composition are due, in part, to a chemoreflex component. Under hypoxic
conditions a chemoreflex results in a transient bradycardia followed by a delayed
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progressive increase in arterial pressure. These responses are dependent on
central and local mechanisms respectively to alter cardiovascular function in fetal
sheep (Lewis and Sischo1982).  Hypercapnic stress produces primarily positive
chronotropic action with little pressure change in fetal sheep (Wood et al. 1990).
These reactions differ from those found in embryonic chickens, which exhibit a
general cardiovascular depression during hypoxia as well as hypercapnia,
suggesting fundamental regulatory differences between embryonic and adult
chickens (Tazawa 1981b, Van Golde et al. 1998, Mulder et al. 1997).
In embryonic chickens, acute exposure to low environmental oxygen
severly challenges to the cardiovascular system. Hypoxia causes a reduction in
both heart rate and blood pressure with redistribution of cardiac output to the
brain, heart and chorioallantoic membrane (Mulder et al. 1998, Tazawa 1981b).
The possible adaptive significance of a hypercapnic cardiovascular reaction in
chicken embryos has not been previously suggested.  However, hypoxic
alterations of cardiovascular functions are implicated in the protection of
embryonic chickens during periods of sub-ambient oxygen tension (Mulder et al.
1998).  Prior work has determined that autonomic control of the cardiovascular
system is inactive until day 16 of incubation (Pappano 1977).  Thus, under
resting conditions, central regulation is absent prior to day 16 of chicken
development.  However, acute periods of stress may induce activation of
compensatory regulation systems.
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In this  study I sought to test the hypothesis that chemoreflex-driven
changes in cardiovascular function are important during embryonic development
of chickens. A chemoreflex would allow the embryo to accommodate for periods
of reduced O2 or elevated CO2 levels. In addition, I hypothesized that the
response intensity would increase in parallel with the maturation of the autonomic
nervous system.
Materials and Methods
Domestic chicken eggs, Gallus gallus, of the white leghorn strain were
purchased from Texas A&M and shipped overnight to the University of North
Texas Department of Biological Sciences.  On arrival, eggs were placed in
incubation at 38 ± 0.5 °C, 60-70% relative humidity and turned automatically
every 3 hrs.  For the purposes of the study, experimental manipulation was
conducted on days 9, 12, 15 and18-21 of a 21-day incubation period.
Surgical Procedures
On the day of study, eggs were removed from the incubator, candled to
locate a chorioallantoic artery and placed in a temperature-controlled chamber at
38±0.5 °C.  A portion of the eggshell was removed exposing the previously
located artery, which was temporarily occluded up stream with a 6 zero silk
ligature and a second ligature was placed downstream to eliminate retrograde
flow following cannulation.  A small cut was then made in the artery and a heat-
pulled saline-filled catheter was then used to occlusively cannulate the vessel. All
the procedures were carried out under a dissection microscope (Wild M3Z).
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Once cannulation was completed the catheter was fixed to the shell with
cyanoacrylic glue and the egg was placed in the experimental chamber (see Ch
4 for description).
Signal recording and calibration
Each catheter was attached to a pressure transducer (WPI, type BLPR),
which in turn was connected to a bridge amplifier (CB Sciences, model ETH-400)
and the pressure trace stored in a computer using PowerLab data acquisitions
software.  Heart rate was continuously calculated from the pressure signal via an
acquisition tachograph.  In all cases, zero was initially set at the top of the
experimental bath, and all values were corrected after the experiment as
described in Chapter 2.
Experimental Protocol
Once were placed in the experimental chambers they were allowed 30
min to reach recovery from possible reactions to the canulation.  Once this time
period was complete a 5 min control period was recorded for comparisons to
experimental treatments.  Following this control period eggs were exposed to
15% O2 for 5 min and then returned to normoxia for 30 min.  This procedure was
repeated for 10 as well as 5% O2 exposures, with changes in heart rate and
arterial pressure recorded. This protocol was repeated for 3, 5 and 10% CO2
mixed with normoxic air concentration of normoxic hypercapnia as well as a
single exposure to 5% CO2 with 10% O2.  To limit possible adative effects of
multiple gas exposures, different experimental groups of eggs were used for
99
hypoxic and hypercapnic studies.  Once the protocol was finished, embryos were
euthanized with an overdose of xylocaine and KCl and frozen for later
determination of the pressure correction factor.
Statistical Analysis
A paired Student t-test was used to access significant differences between
control and hypoxic exposure for all levels. A one-way ANOVA was conducted on
the arcsine transformed percent difference between control and hypoxic
exposure levels in all variables to determine significant changes between days of
incubation.  A similar statistical analysis was conducted within day of incubation
to determine differences in reactions to changing levels of hypoxia.  Fisher’s LSD
post-hoc comparison was used to isolate significant differences between days of
incubation as well as to determine differences in hypoxia.  The fiduciary level of
significance for all tests was taken at p<0.05. All data are presented as mean ± 1




Hypoxic exposure caused chorioallantoic pressure and fH to fall in
embryos from day 9 to 19 (Fig. 5.1a).  Heart rate continued to exhibit this pattern
on day 20, but pressure was relatively unaffected by hypoxia at the late point in
development (Fig. 5.1b and Fig. 5.1c).
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Systolic and diastolic pressure responses to different degrees of hypoxia
are presented in Table 5.1.  Given that all pressure parameters responded
similarly during hypoxic exposure, further discussion will present mean arterial
pressure (Map) as representative of presser actions.  Five-minute exposures to
15% O2 result in significant change in all cardiovascular parameters on all days,
with the notable exception of days 20 and 21.  Map fell an average of 1.7 mmHg.
This reduction was significantly different on days 9 to 19 as well as day 21 (p
<0.05; Fig. 5.2). In addition, heart rate decreased significantly on days 9,15,18
and 19 (p<0.05).
Exposure to 10% O2 induced a general depression of cardiovascular
function on all days of incubation studied.  Map was significantly affected by
hypoxia on days 9 to 19 with an average fall in pressure of 2.3 mmHg (p< 0.05;
Fig. 5.3).  Heart rate was consistently affected, falling significantly an average of
34 beats·min-1 on all days of incubation (Fig. 5.3).
Embryonic exposure to 5% O2 also produced general depression of all
cardiovascular parameters measured.  Map fell an average of 4.2 mmHg during
exposure to 5% O2 compared to control levels (Fig.5.4).  In addition, heart rate
fell an average of 65 beats*min
-1 below control levels during exposure to 5% O2
as indicated throughout incubation (Fig.5.4).
Developmental differences
No differences between developmental stages were observed during
exposure to 15% and 5% hypoxia. However, some differences between days of
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incubation appeared during exposure to 10% O2.  Map change to 10% hypoxia
peaked on day 19, with a maximal decrease of 5.6 mmHg (Table 5.2). This
response was significantly different than that exhibited on days 18, 20 and 21
during hypoxia.  Heart rate exhibited a different pattern of response, with a
relatively constant reduction throughout incubation until days 20 and 21 (Table
5.2).  On day 20-21 the response was significantly dampened, with a change of
20 beats*min
-1 on days 20 and 21 versus 39 beats*min
-1 on average on days 9 to
19 (Table 5.2).
Difference between degree of hypoxia
A comparison of responses to each level of hypoxia revealed that the fH
decreased significantly more during exposure to 5% O2 (-67 beats*min
-1) than
during 15% O2 (-13 beats*min
-1) (Table 5.3). Chronotropic responses to 5% O2
were also significantly different than those exhibited during 10% O2 on days 15
and 18 of incubation (Table III).  In addition, fH reductions produced by 10% O2
were significantly different than those during 15% O2, on the majority of
incubation days studied  (Table 5.3).
Map changes induced during 5% O2 were significantly greater than those
produced by 15% O2 exposure on the majority of incubation days tested (Table
5.3).  In addition, 5% O2 responses differed from those found during 10% O2
exposure on day 12 of incubation (Table 5.3).  Pressure responses to 10% O2
and 15% O2 were similar on all days with the exception of day 20 (Table 5.3).
Response to Hypercapnia
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Cardiovacular reactions to various hypercapnic levels were inconsistant,
with only a limited effect on arterial pressure (Fig 5.5).   As indicated for hypoxic
exposures systolic and diastolic pressure changes essentially mirrored those
demonstrated for Map during graded hypercapnic treatments (Table 5.4).
Initial exposure to 3% CO2 produced sporadic responses with significant changes
in Map on days 18 (0.8 mmHg) and 21 (2.2 mmHg) only (Fig 5.6).  A weak
chronotropic response was also exhibit during 3% CO2 exposure with a
significant decrease on day 9 (18 beats*min
-1) (Fig 5.6).  Intermediate
concentrations of CO2 also induced slight cardiovascular responses with arterial
pressure remaining unchanged during exposures to 5% CO2 (Fig 5.7).  However,
this concentration did elicit a negative chronotropic reaction, with a significant
average fall of 16 beats*min
-1 on the majority of days studied (Fig 5.7).  Again,
arterial pressure responses during the extreme CO2 level tested (10%) were
inconsistent with significant alterations during exposure on days 12 (-0.4 mmHg)
and 21 (2.4 mmHg) of incubation (Fig 5.8). However, chronotropic responses to
10% CO2 exposure were substantial on all tested days of study with significant
reactions on days 9, 18, 19 and 21 (Fig 5.8).
Between Day Comparison
Arterial pressure responses to 3% and 10% CO2 exposures were
significantly (p< 0.05) different between each day of study (Table 5.5).  In
general, pressure fell during hypercapnic exposure early development, but
increased from days 15 to 21, (Table 5.5).  Maximal pressure change of 2.3
103
mmHg was evident on day 21 when embryos were exposed to 3% or 10% CO2
elevated pressure (Table 5.5).  Maximal fH reductions to 3% CO2 occurred on day
9 of incubation (18 beats*min
-1) a finding significantly different than all other days
(Table 5.5).  In addition, 10% CO2 exposure on day 21 produced a minimal but
significant reduction in heart rate, a finding that differed from the majority of
responses during development (Table 5.5).
Hypercapnic Comparison within Incubation Day
On each incubation day studied, pressure responses to all three CO2
levels were constant (Table 5.6). Heart rate reactions to hypercapnia were
accentuated as CO2 concentration was elevated, with the exception of day 9
(Table 5.6).  While on day 9 of incubation there was a constant effect of
hypercapnia regardless of degree, 10% CO2 produced negative chronotropic
action which differed from 3% CO2 on days 15 to 21 (Table 5.6).  Responses to
5% CO2 differed from 3% reactions on days 12, 15 and 19 (Table 5.6).
Hypoxic Hypercapnia
The combined exposure of 5% CO2 with 10% O2 produced results similar
to those caused by hypoxia alone (Fig 5.9). This was indicated by the results of a
two way ANOVA on arcsine transformed percentages which produce p values of
0.06 and 0.75 for changes in Map and fH, respectively. In addition, a between day
comparison revealed that all embryos reacted similarly to the combination of
gases with the exception of day 9.  Heart rate on day 9 of development was
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significantly (p<0.01) depressed in comparison to all other days of incubation
during combined exposure to 5% CO2 and 10% O2 (Fig 5.9).
Discussion
Chemoreflex control of cardiovascular function is an important
homeostatic mechanism for the maintenance of proper gas transport to and from
peripheral tissues in adult chickens (Butler 1967, Ray and Fedde 1969). Despite
the critical role this mechanism plays in adults, a chemoreflex is immature or
absent during the majority of chicken development (Van Golde et al 1997,
Tazawa 1981a&b, Girard 1973). The present study has extended the analysis
into the final days of incubation including the onset of lung ventilation in an effort
to detect maturation of a cardiovascular chemoreflex reaction.  Cardiovascular
responses characteristic of an adult chemoreflex during hypoxia and hypercapnia
were absent throughout the latter half of chicken development.  Additionally,
pressure responses to intermediate hypoxia were maximal over the final three
days of incubation while heart rate effects were minimized.  Hypercapnia
primarily altered heart rate while arterial pressure exhibited a relative tolerance to
increase in CO2 levels.  Therefore, those cardiovascular responses
characteristics of an adult chemoreflex are absent during embryonic
development in chickens.
Adult Responses
Adult chickens rely on chemoreflex action for the alteration of
cardiovascular function during periods of acute hypoxia or hypercapnia to
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maintain proper gas transport (Butler 1967, Butler and Taylor 1974, Ray and
Fedde 1969).  In adults, acute hypoxic exposure produces a hypotensive
tachycardia with rate changes ascribed to β-adrenergic action, while pressure
reduction is due to the direct response of vessels to a reduced O2 (Butler 1967).
Further, adult chickens are relatively tolerant of hypercapnia, but as levels
intensify, a hypertensive tachycardia develops (Ray and Fedde 1969). Given the
pronounced nature of these adult cardiovascular responses it was hypothesized
that during chicken development a chemoreflex would become evident and
mature until hatching.  This hypothesis must be rejected as embryonic chickens
at no time demonstrate reactions to hypoxia or hypercapnia that would typify an
adult chemoreflex.
Hypoxia
All control cardiovascular parameters were within the range established
previously during the ontogeny of chickens (Girard 1973; Tazawa 1981a).  In
addition, with the notable exception of days 20 and 21 all levels of hypoxia
produced quantitatively similar responses with an accentuation at 5% O2 (Table
5.3).
Acute hypoxia resulted in a pronounced bradycardia during the
developmental period studied (Table 5.3).   While at extreme levels of hypoxia
(5% O2) this reaction could be the result of reduced O2 delivery to the heart,
bradycardia at the remaining two hypoxic levels suggests possible central
regulation.  Data from fetal sheep indicate normal cardiac function can be
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maintained at a PO2 of 50% normoxic levels, further suggesting that responses in
the embryonic chicken could be mediated via central influences (Fisher et al.
1982).  Atrial field stimulation studies have demonstrated previously that
parasympathetic depression of heart rate is possible on day 12 of chicken
incubation (Pappano 1976, Higgins and Pappano 1981).  Thus, functional
components are present midway through embryonic development, with the
possibility for a central nervous system mediated change in heart rate during
hypoxia.  However, while regulatory components are known to be present, this
work indicates that during hypoxia they remain inactive in developing chickens.
Prior studies have suggested that the negative chronotropic actions of
hypoxia are due to direct inhibition of cardiac contraction as well as possible
release of vasoactive substances altering venous return (Tazawa 1981b, Van
Golde et al. 1997).  In addition, the present study has shown that negative
chronotropic responses were evident on day 9 prior to cardiac innervation by
either division of the autonomic nervous system.  Further, previous work has
noted a clear negative chronotropic reaction to hypoxia prior to day 9 of chicken
incubation, which was assumed to be mediated via mechanisms other than
parasympathetic action (Altimiras and Phu 1999).  Therefore, negative
chronotropic reactions during hypoxia in this study were caused by direct action
on the heart and/or alterations of venous return due to vasoactive substances,
with little action attributed to the parasympathetic innervation.
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Arterial pressure responses mimicked the chronotropic reactions during
the majority of incubation for all hypoxic levels used, with 5% O2 augmenting the
response.  These findings were similar to those demonstrated in previous studies
with the exception of pressure change on day 20 of incubation (Tazawa 1981b;
Girard 1973).  Despite this apparent discrepancy, all studies have indicated that
chicken embryos respond to acute hypoxia with a general hypotension, which is
a reaction similar to that shown in adults (Butler 1967, Ray and Fedde 1969).
Thus, embryonic chickens have a hypoxic pressure response similar to that
found in adults.  The majority of avian adult responses are due to direct inhibition
of peripheral vessels with no central mechanisms mediating hypoxic hypotension
(Butler 1967).  While the possibility of a fundamentally different regulatory system
during embryonic development exists, embryonic pressure responses appear to
be the result of direct action of hypoxia on the vessels.  Hence, humoral and local
vasoactive substances, as well as the direct affect of low O2 on vascular smooth
muscle, may account for hypoxic hypotension in embryos.
It is important to recognize that both the present and past studies have
attempted to determine hypoxic effects on the total vascular system.  This
approach, while informative, limits the ability to determine reaction of specific
vascular beds to hypoxia.  Thus, important centrally mediated changes in
vascular tone that may differ between organ systems are indiscernible using the
present measurement technique.  This point is illustrated in adult chickens in
which hypoxia produces an overall hypotension, but there is a noted α−
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adrenergic induced pulmonary vasoconstriction which accompany this
hypotension (Butler 1967, Besch and Kadono 1977).  Therefore, given the
importance of adrenergic cardiovascular tone during the latter half of chicken
development, differential vascular reaction may occur as in adults (see Ch 2).
The possibility of an adrenergic contribution to hypoxic hypotension in embryonic
chickens is further addressed in Chapter 6.
Hypercapnia
The negative chronotropic actions of graded hypercapnia demonstrated in
the present study were similar to those found in prior studies on chicken embryos
from days 14 to 16 of incubation (Tazawa 1981b, Girard 1973). In addition, the
aforementioned studies did not report the change in arterial pressure during
hypercapnia demonstrated in this study, which again differed from the reported
hypertension found in adults (Tazawa 1981b, Girard 1973).  Thus, embryonic
protective mechanisms may be absent or fundamentally different from adult
systems.
Negative chronotropic responses were evident during 5% and 10% CO2
exposures, suggesting chicken embryos are tolerant to low levels of hypercapnia.
While the lack of reaction to low levels of hypercapnia may be attributed to
possible buffering capacity of embryonic blood, mechanisms which underline the
negative chronotropic actions at higher CO2 levels are unknown.  As stated for
hypoxic exposure, parasympathetic function can be induced via field stimulation
by day 12 of incubation, implying the ability for centrally mediated change in
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heart rate (Pappano 1977).   However, negative chronotropic responses to
hypercapnia were evident prior to day 12 of incubation and, with the exception of
day 21, remained constant over incubation (Table V). Tazawa (1981b) had
previously attributed depressive hypercapnic responses to direct action on
cardiac tissue of embryos from 14 to 16 days of incubation.   Hence, direct
actions of hypercapnia over the latter half of incubation, as suggested for hypoxic
responses, may explain the findings in the present study.  Release of vasoactive
substances, resulting in reduced venous return as well as increased filling time
could also account for chronotropic reactions found in this study.  However,
additional pharmacological study is necessary to make definitive statements as
to the origin of hypercapnic action of embryonic heart rate.
Unlike embryonic heart rate, arterial pressure remained constant during
hypercapnic exposures throughout the majority of chicken incubation. This
finding was similar to that previously shown in chicken embryos from 14 to 16
days of incubation (Tazawa 1981a). Therefore, unlike adult chickens, which
exhibit a hypertension during hypercapnia, embryonic chickens maintain constant
arterial pressure alteration of CO2 levels.  This pattern was evident during the
majority of developmental days studied, but day 21 embryos exhibited a
significant hypertension during hypercapnia (Fig 5.8).  Mechanisms that underlie
this alteration of pressure responses are unclear.  However, the onset of an adult
chemoreflex may partially account for this change.
Hypoxic Hypercapnia
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As stated previously cardiovascular responses to 10% O2 were similar to
those determined during chick development (Tazawa 1981, Tazawa et al. 1985,
and Girard 1973).  Combined hypercapnic hypoxic exposures lack the
anticipated augmentation of cardiovascular reaction to hypoxia (Fig 5.9).  In adult
chickens acute exposure to hypoxia coupled with an elevated CO2 level
produces both hypertension as well as hypotension, with the precise nature of
the responses depending on technique and severity of exposure (Butler 1967,
Scheid and Piiper 1970).  Thus, direct comparisons between adult and
embryonic hypoxic hypercapnic cardiovascular responses are difficult.  However,
given that combined gas exposure produced reactions similar to hypoxia alone, it
is unlikely that addition of CO2 activated other regulatory mechanisms.
Chemoreflex Onset
Levels of both hypoxic and hypercapnic stress used in the present study
were equivalent to those previously determined to induce chemoreflex-driven
cardiovascular changes in adult chickens (Butler 1967, Ray and Fedde 1969,
Besch and Kadono 1977).  Thus, the absence of an adult-like reaction
throughout the majority of chicken incubation must be attributed to fundamental
differences between the two life stages.  However, as demonstrated for both
hypoxic and hypercapnic exposures, a transition to an adult regulation
mechanism may occur in the final days of chicken incubation.
As stated previously, embryonic arterial blood pressure was relatively
unaffected by exposure to 10% O2 while negative chronotropic actions were
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significantly dampened over the final two days of chicken incubation.  In addition,
cardiovascular responses to 10% CO2 on day 21 differed from all other days of
incubation.  Collectively, this information indicates that a critical period in chicken
development occurs in the final 2 days of incubation, during which an adult
chemoreflex may become functional.
Hypercapnic exposure on day 21 produced an increase in blood pressure,
a response that differed from all other days of incubation.  This reaction typifies
an adult cardiovascular response to elevated levels of CO2 implying that a
chemoreflex is operational on day 21. However, pressure responses to hypoxia
were unchanged on days 20 and 21 lacking the hypotension characteristic of
both embryonic and adult reactions.  Under both experimental conditions,
chronotropic responses on day 20 and 21 were unlike those characterized for
adult suggesting a chemoreflex is absent.  Therefore, the functional status of a
cardiovascular chemoreflex remains in question.  An adult chemoreflex requires
peripheral and central chemoreceptors as well as intact efferent connections to
the developing cardiovascular system.  During the final two days of chicken
incubation functional efferent connections to the cardiovascular system are well
established, thus this component of the adult chemoreflex is present in the
embryo (Pappano 1977).  While the operational status of chemoreceptors during
chicken incubation has not been well characterized, preliminary data with NaCN
suggest peripheral receptors are active on day 21 of incubation (Crossley and
Burggren in prep).  Collectively the data suggest that a hypercapnic chemoreflex
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becomes operational on day 21 of chicken incubation, but further study is needed
to determine how hypercapnia modulates this response.
Conclusion
Alteration of ambient gas composition produces dramatic physiological
and morphological changes in developing chicken embryos (Grabowski et al.
1969,  Altimiras and Phu In press,  Tazawa 1986).  Despite the potential
deleterious influences of low O2 or elevated CO2, chicken embryos lack an adult
cardiovascular chemoreflex during the majority of incubation.  It is important to
recognize that adult cardiovascular responses are accompanied by respiratory
changes.  Clearly, embryonic chickens lack the respiratory component
throughout the majority of development.  Thus, during development regulatory
mechanisms and cardiovascular responses may differ from those found in adult
chickens.  The final days of development may represent a period of “system
crossover” or transition, as embryonic regulation fades and adult regulation
becomes operational.  However, further pharmacological study is needed to
determine the mechanisms that modulate embryonic cardiovascular responses to
alteration of ambient gas composition.
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Table 5.1.  Systolic (Sys) and diastolic (Dia) pressure response to different levels
of hypoxia.  Asterisk indicates significance (p<0.05) as indicated by a paired
Student t-test of treatment (T) compared to control (N) levels on a given day of
incubation.  Data are presented as mean ± sem.  In all cases n = 5.
15% O2 10% O2 5% O2
Day Sys Dia Sys Dia Sys Dia
9 N 5.3±0.4 3.2±0.3 5.2±0.4 2.6±0.2 5.0±0.4 2.8±0.4
T 4.8±0.4 * 2.6±0.2 4.3±0.3 * 2.4±0.3 4.0±0.3 * 2.4±0.3
12 N 10.5±0.8 4.9±0.4 10.4±0.9 5.0±0.5 10±1.3 4.8±0.7
T 9.7±0.9 * 4.6±0.4 8.8±0.8 * 4.1±0.5 * 7.8±1.2 * 3.4±0.6 *
15 N 16.9±1.6 8.1±1.1 16.7±1.6 8.6 ±1.1 16.8±1.7 9.0±1.2
T 15.5±1.3 * 7.4±1.0 13.9±1.1 * 6.8 ±0.8 * 12.7±1.1 * 6.00±0.6 *
18 N 22.7±1.1 12.0±1.2 21.2±1.2 12.4±0.9 20.9±1.3 12.7±1.0
T 19.8 ±1.0 * 11.0±1.2 19.9±1.0 10.5±0.7 * 17.8±0.5 * 7.4±0.6 *
19 N 26.9±1.1 16.4±1.1 27.4±1.1 17.1±1.2 27.9±1.4 16.8±1.3
T 22.2±1.3 * 13.2±0.9 20.9 ±1.0 * 12.1±1.2 * 22.9±1.9 * 11.0±1.1 *
20 N 33.4±1.8 21.4±1.6 35.4±2.7 21.7±1 33.6±2.6 23.1±1.8
T 32.2±2.0 20.3±1.7 32.4±2.6 18.1±1.2 27.0±1.9 * 16.5±1.7 *
21 N 35.5±2.4 21.9±1.2 34.0±2.7 22.9±2.1 35.0±2.5 22.6±1.1
T 32.1±1.8 19.8±1.3 29.7±2.0 19.6±1.2 30.1±2.2 * 16.4±1.2 *
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Table 5.2. Difference in the effect of 10% O2 effects on mean arterial (Map)
systolic (Sys), diastolic (Dia) pressures and heart rate (fH) between days of
development.  All days with significantly different hypoxic response are identified
with a like letter. As determine with a two way ANOVA conducted on arcsine
transformed percentage changes (p<0.05).  In all cases n= 5.
Day Map Sys Dia fH
9 -0.5±0.5 AB -0.7±0.6 AC -0.1±0.4 A -30±20 AB
12 -1.4±0.1 A -1.6±0.2 A -0.9±0.1 A -45±8 A
15 -2.5±0.5 AB -2.9±0.7 AB -1.8±0.3 A -43±5 A
18 -1.6±0.7 B -1.3±0.7 B -1.9±0.8 A -38±8 AC
19 -5.6±0.9 A -6.5±1.0 A -5.0±0.7 A -39±5 A
20 -3.9±1.9 BD -4.4±2.0 AB -3.3±1.9 A -20±7 BC
21 -3.2±1.6 BD -3.0±1.7 BC -3.6±1.5 A -20±7 B
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Table 5.3.  A comparison of hypoxic treatments effects on mean arterial (Map)
systolic (Sys), diastolic (Dia) pressures and heart rate (fH) within a specific day of
incubation. Deltas indicate difference from other exposures as determine with a
two way ANOVA conducted on arcsine transformed percentage changes
(p<0.05). ∆∆∆ Differs from 15% only; ∆∆ differs from 15% and 10%; ∆ 10% and
5% differ from 15%. In all cases n = 5.
Day Map Sys Dia fH
9 15 -0.4±0.5 -0.4±0.7 -0.5±0.4 -13±13
10 -0.5±0.5 -0.7±0.6 -0.1±0.4 -30±20 ∆
5 -0.8±0.2 -1.0±0.2 -0.5±0.2 -78±13 ∆
12 15 -0.6±0.1 -0.8±0.1 -0.3±0.1 -21±10
10 -1.4±0.1 -1.6±0.2 -0.9±0.1 -45±8
5 -2.1±0.4 ∆∆ -2.7±0.6 ∆∆∆ -1.2±0.3 ∆∆ -65±16 ∆
15 15 -1.1±0.3 -1.4±0.5 -0.7±0.2 -20±6
10 -2.5±0.5 -2.9±0.7 -1.8±0.3 -43±5 ∆
5 -3.9±0.6 ∆∆∆ -4.1±0.9 ∆∆∆ -3.0±0.6 ∆∆ -78±7 ∆∆
18 15 -2.0±0.6 -2.9±1.0 -1.0±0.4 -13±4
10 -1.6±0.7 ∆ -1.3±0.7 -1.9±0.8 ∆ -38±8 ∆
5 -4.4±1.0 ∆ -3.1±1.1 -5.3±1.1 ∆ -77±8 ∆∆
19 15 -3.7±0.8 -4.7±1.0 -3.2±1.0 -18±5
10 -5.6±0.9 -6.5±1.0 -5.0±0.7 -39±5
5 -5.2±1.2 -5.1±1.5 -5.8±0.7 -53±6 ∆
20 15 -1.1±0.8 -1.2±1.1 -1.1±0.6 -3.0±3
10 -3.9±1.9 ∆ -4.4±2.0 -3.3±1.9 ∆ -20±7 ∆
5 -7.0±1.3 ∆ -6.6±2.1 ∆∆∆ -6.6±0.9 ∆ -65±15 ∆
21 15 -2.5±0.9 -3.4±1.6 -2.1±0.8 -7.0±7
10 -3.2±1.6 -3.0±1.7 -3.6±1.5 -20±7 ∆
5 -6.0±1.7 -4.9±2.0 -6.2±1.5 -53±8 ∆
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Table 5.4.  The effect of CO2 exposure (3%, 5% and 10%) on systolic (Sys) and
diastolic (Dia) pressures throughout development.  Data is presented as control
(N) treatment (T).  Days during which hypercapnia significantly (p<0.05) altered
pressure are indicated with asterisk.  In all cases n = 5.
Day 3% CO2 5% CO2 10% CO2
Sys Dia Sys Dia Sys Dia
9 N 6.6±0.9 4.7±0.8 6.0±0.8 4.1±0.8 5.9±0.8 4.1±0.8
T 6.4±0.8 4.4±0.8 * 6.0±0.8 4.1±0.8 5.9±0.8 4±0.9
12 N 8.7±0.9 5.1±1.0 8.6±1.2 5.3±1.1 8.5±1.2 5±0.9
T 8.6±1.1 5.4±1.0 8.4±1.1 5.0±0.8 8.1±1.2 * 4.9±0.9
15 N 19.9±1.2 10.6±0.7 18.8±1.4 10.9±1.1 18.9±1.6 10.6±1.2
T 20.1±1.3 10.9±1.0 19.0±1.4 10.3±1.3 19.3±1.6 9.4±1.0
18 N 22.6±1.9 13.2±1.1 22.6±1.3 13.3±1.0 22.5±1.4 14.2±0.9
T 24.0±1.9 13.9±1.2 * 23.3±1.5 13.5±1.3 23.5±1.5 14±1.0
19 N 24.2±1.0 14.3±0.5 24.3±1.2 14.7±0.7 24.7±1.2 15.5±0.8 *
T 25.1±1.2 14.6±0.7 24.0±1.1 14.0±0.6 24.8±1.5 14.7±0.8
20 N 28.2±2.7 19.1±1.8 30.1±2.5 19.2±1.5 28.9±2.5 19.2±1.3
T 30.4±2.5 19.6±1.0 30.6±2.2 19.8±1.2 27.7±1.2 19.7±0.7
21 N 31.5±1.9 19.3±0.9 34.4±1.8 20.3±0.7 32.0±1.2 19±0.4 *
T 34.4±2.0 * 20.6±0.9 35.4±1.6 19.8±0.5 34.0±1.3 * 20.5±0.6
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Table 5.5. Difference in the effect of CO2 exposures (3%, 5% and10%) between
days of development on mean arterial pressure (Map) and heart rate (fH).  All
days of incubation which reacted similarly to CO2 are indicated by like lettering,
as determined with a two way ANOVA conducted on arcsine transformed
percentage changes (p<0.05).  In all cases n= 5.
3% 5% 10%
Day Map fH Map fH Map fH
9 -0.3±0.1 A -18±4 A -0.1±0.1 A -22±6 A 0±0.1 A -30±4 A
12 -0.1±0.2 AE -3±7 AB -0.3±0.3 A -23±11 A -0.3±0.1 A -18±8 AB
15 0.1±0.4 AC 1±6 B -0.3±0.4 A -14±4 A -0.4±0.3 AC -25±1 A
18 0.9±0.3 CD -3±3 B 0.7±0.4 A -9±2 AB 0.4±0.2 BC -21±1 AB
19 0.5±0.3 CE -6±3 B -0.6±0.4 A -19±3 A -0.4±0.5 A -34±5 A
20 0.9±0.8 CDE 0±3 B 0.5±0.3 A -14±11 AB -0.4±1.5 AB -22±8 AB
21 2.3±0.1 D 5±2 B 0.8±0.7 A -4±6 B 2.4±0.7 B -12±4 B
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Table 5.6.  The differences in mean arterial pressure (Map), systolic pressure
(Sys), diastolic pressure (Dia) and heart rate (fH) during exposure to three levels
of hypercapnia. Deltas indicate significant (p<0.05) difference from other
exposures, ∆∆∆ differs from 3% only; ∆∆ differs from 5% and 3%; ∆ deltas 5%
and 10% differ from 3%.  In all cases n = 5.
Day Map Sys Dia fH
9 3 -0.3±0.1 -0.2±0.1 -0.3±0.1 -18±4
5 -0.1±0.1 0±0.1 0±0.1 -22±6
10 0.0±0.1 0±0.1 0±0.1 -30±4
12 3 -0.1±0.2 -0.1±0.2 0.2±0.3 -3±7
5 -0.3±0.3 -0.1±0.0 -0.2±0.3 -23±11 ∆
10 -0.3±0.1 -0.4±0.1 -0.1±0.1 -18±8
15 3 0.1±0.4 0.2±0.3 0.3±0.4 1±6
5 -0.3±0.4 0.3±0.5 -0.6±0.3 -14±4 ∆
10 -0.4±0.3 0.4±0.6 -1.2±0.3 ∆∆∆ -25±1 ∆
18 3 0.9±0.3 1.4±0.6 0.7±0.2 -3±3
5 0.7±0.4 0.8±0.4 0.2±0.5 -9±2
10 0.4±0.2 1±0.4 -0.2±0.3 -21±1 ∆∆∆
19 3 0.5±0.3 0.9±0.5 0.3±0.3 -6±3
5 -0.6±0.4 -0.2±0.7 -0.6±0.4 ∆ -19±3 ∆
10 -0.4±0.1 0.1±0.9 -0.8±0.3 ∆ -34±5 ∆
20 3 0.9±0.8 2.3±0.1 0.4±0.9 0±3
5 0.5±0.3 0.4±0.8 0.6±0.8 -14±11
10 -0.4±1.5 -1.2±2.0 0.5±1.1 -22±8 ∆∆∆
21 3 2.3±0.1 2.9±0.6 1.3±0.6 5±2
5 0.8±0.7 1.1±0.7 -0.5±1.5 -4±6
10 2.4±0.7 3.3±1.0 1.8±0.6 -12.5±4 ∆∆∆
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Table 5.7.  The effect of 10% O2 exposure (10) and 5% CO2 with 10% O2 (5/10)
on systolic (Sys) and diastolic (Dia) pressures throughout development.  Data is
presented as control (N) treatment (T).  Days during which treatment altered
cardiovascular function compared to control are indicated with Asterisk (p<0.05).
In all cases n= 5.
10% O2 5 CO2 10% O2
Day Sys Dia Sys Dia
9 N 6±0.7 4.1±0.8 6±0.7 4.3±0.8
T 5.1±0.7 * 3.5±0.8 * 4.8±0.6 * 3.5±0.9 *
12 N 9±1.2 5.7±1.0 9±1.3 5.9±1.1
T 7.4±0.9 * 4.9±0.9 * 6.8±0.9 * 5±0.9
15 N 19.8±1.5 11.2±1.1 20.1±1.4 12.3±1.2
T 15.5±1 * 8.7±1.2 * 15.9±0.9 * 9.3±1.6 *
18 N 23.6±1.8 14±1.4 23±1.6 14.6±1
T 19.6±1.6 * 11.2±0.8 20.3±1.3 * 12.1±1 *
19 N 25.6±1 15.3±0.6 26.5±0.9 17.2±0.5
T 22.9±1.2 * 10.6±0.5 * 23.6±0.7 13±0.7 *
20 N 27.3±2.2 18.5±0.9 30.5±3.1 21±1.8
T 26.1±1.9 16.3±0.5 26±1.6 17.5±0.7
21 N 32.3±2.2 18.6±1.2 32.5±2.2 20.2±1.3




Representative raw data traces depicting arterial pressure (P) and heart rate (fH)
responses to 10% O2 from embryos of 19 (A), 20 (B) and 21 (C) days of
incubation.  Bar indicates a 5-min hypoxic exposure.
Figure 5.2
The cardiovascular reaction to 15% O2 in chicken embryos during development.
Heart rate(fH) and mean arterial pressure are presented as control (open column)
and treatment (filled column) response.  Asterisk indicates significant difference
(p<0.05) in parameter from control.  Data are presented as mean ± sem. In all
cases n= 5.
Figure 5.3
The cardiovascular reaction to 10% O2 in chicken embryos during development.
Heart rate (fH) and mean arterial pressure are presented as control (open
column) and treatment (filled column) response. Asterisk indicates significant
difference (p<0.05) in parameter from control.  Data are presented as mean ±
sem. In all cases n= 5.
Figure 5.4
The cardiovascular reaction to 5% O2 in chicken embryos during development.
Heart rate (fH) and mean arterial pressure are presented as control (open
column) and treatment (filled column) response. Asterisk indicates significant
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difference (p<0.05)  in parameter from control.  Data are presented as mean ±
sem. In all cases n= 5.
Figure 5.5
Representative traces demonstrating arterial pressure (P) and heart rate (fH)
responses to 5% CO2 from embryos of 19 (A), 20 (B) and 21 (C) days of
incubation.  Bar indicates a 5-min hypercapnic exposure.
Figure 5.6
The cardiovascular reaction to 5-min of 3% CO2 in chicken embryos during
development.  Heart rate (fH) and mean arterial pressure are presented as control
(open column) and treatment (filled column) response. Asterisk indicates
significant difference (p<0.05) in parameter from control.  Data are presented as
mean ± sem. In all cases n= 5.
Figure 5.7
The cardiovascular reaction to 5-min of 5% CO2 in chicken embryos during
development.  Heart rate (fH) and mean arterial pressure are presented as control
(open column) and treatment (filled column) response. Asterisk indicates
significant difference (p<0.05) in parameter from control.  Data are presented as
mean ± sem. In all cases n= 5.
Figure 5.8
The cardiovascular reaction to 5-min of 10% CO2 in chicken embryos during
development.  Heart rate(fH) and mean arterial pressure are presented as control
(open column) and treatment (filled column) response. Asterisk indicates
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significant difference (p<0.05) in parameter from control.  Data are presented as
mean ± sem. In all cases n= 5.
Figure 5.9
The cardiovascular reaction to 5-min of 5% CO2 and 10% O2 in chicken embryos
during development.  Heart rate (fH) and mean arterial pressure are presented as
control (open column) and treatment (filled column) response.  Asterisk indicates
significant difference (p<0.05) in parameter from control.  Data are presented as





















THE MATURATION OF AUTONOMIC ALTERATION IN CARDIOVASCULAR
FUNCTIONS DURING BOUTS OF ACUTE HYPOXIC STRESS IN THE
DOMESTIC CHICKEN Gallus gallus.
Introduction
 In adult chickens, cardiorespiratory responses to hypoxic conditions have
been thoroughly characterized (Butler 1967, Ray and Fedde 1969).
Normocapnic hypoxia induces a marked tachycardia in adult chickens which is
coupled with a hypotension, as well as an increase in ventilation rate and
amplitude when they are exposed to 10% or lower O2 concentrations (Butler
1967; Ray and Fedde 1969).  This tachycardia is mediated via peripheral
chemoreceptors, which in turn produces a chemoreflex resulting in an alteration
of cardiovascular function.  Embryonic chickens lack cardiovascular reactions
typified in adults during the majority of incubation (Tazawa 1981a, Girard 1973,
Van Golde 1997).  During hypoxic exposure, a general depression of embryonic
cardiovascular function has been shown in response to O2 levels previously
utilized in adults (Tazawa 1981a, Girard 1973, Van Golde 1997, see Chapter 5
this thesis).  While these studies have characterized general reactions to hypoxic
stress, mechanisms that underlie cardiovascular changes have been left to
speculation.  Mulder et al. (1998) suggest the maturation of a protective
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mechanism is present during the second half of development which maintains
blood flow to the brain, heart and chorioallontoic membrane during hypoxia.
Further, Van Golde et al. (1998) suggest that circulating catecholamines may
play an important role in modulating control of this system early when exposed to
hypoxia early in development.  Their data suggest a maturation of cardiovascular
responses to hypoxia with development implying activation of central control and
or chemoreflex regulation of the system.  Thus, while indirect evidence indicates
the central nervous system (CNS) may be involved in cardiovascular (CV)
responses to hypoxia, study of the how the CNS may change CV function has
not been conducted.
The sympathetic and parasympathetic arms of the autonomic nervous
systems reach the heart of embryonic chickens between days 11 to13, in
addition, cholinergic as well as adrenergic receptors are present on days 3 to 4,
(Pappano 1977).  Therefore, the physical components necessary for central
cardiovascular regulation are established at the midpoint of incubation and could
account for the hypoxic cardiovascular depression shown in Chapter 5.
The objective of this study was to establish the source of cardiovascular
response to hypoxia in chicken embryos.  Selective blockade of adrenergic and
cholinergic receptors would assess the ability of autonomic system to modulate
changes in cardiovascular function during periods of stress.  It was hypothesized
that the decrease in arterial pressure and rise in heart rate during hypoxia will be
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the result of simulation of cholinergic and adrenergic receptors iin the
cardiovascular system.
Materials and Methods
Domestic chicken eggs, Gallus gallus, of the White Leghorn strain were
purchased from Texas A&M and shipped overnight to the University of North
Texas Department of Biological Sciences.  On arrival, eggs were placed in
incubation at 38 ± 0.5 °C, 60-70% relative humidity and turned automatically
every 3 hrs.  For the purpose of the study, experimental manipulation was
conducted on days 9, 12, 15 and18-21 of a 21-day incubation period.
Surgical Procedures
On the day of the study, eggs were removed from the incubator, candled
to locate a chorioallantoic artery and placed in a temperature-controlled chamber.
A portion of the eggshell was removed exposing the previously located artery.
The artery was temporarily occluded up stream with a 6 zero silk ligature and a
second ligature was placed downstream to eliminate retrograde flow following
cannulation.  A small cut was then made in the artery and a heat-pulled saline-
filled catheter was then used to occlusively cannulate the vessel. All the
procedures were carried out under a dissection microscope (Wild M3Z). Once
cannulation was completed the catheter was fixed to the shell with cyanoacrylic
glue and the egg was placed in the experimental chamber (described in Chapter
4). Four embryos were studied simultaneously.
Signal recording and calibration
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Each catheter was attached to a pressure transducer (WPI, type BLPR),
which in turn was connected to a bridge amplifier (CB Sciences, model ETH-400)
and the pressure trace stored in a computer using PowerLab data acquisitions
software.  Heart rate was continuously determined from the arterial pressure
signal via an acquisition tachograph.  In all cases, ther arterial pressure
calibration zero was initially set at the top of the experimental bath, and all values
were corrected after the experiment as described in Chapter 2.
Experimental Protocol
Once placed in the experimental setup eggs were allowed to recover for
30 min followed by a 5 min control measurement period.  Following the control
period, eggs were exposed to a 5-min bouts of 10% O2, then returned to
normoxia for 30-min.  Following initial hypoxic exposure eggs where allowed an
addition 10-min to recover then 1 mg*kg
-1 of the cholinergic blocker atropine was
infused using the method as described in Chapter 2.   Arterial pressure and heart
rate were allowed to reach stable values followed by the onset of a new 30-min
control period.  Embryos were then exposed to 5 min of 10% O2 with
cardiovascular responses recorded.  This process was repeated for β-adrenergic
blocker 3 mg*kg-1 propranolol and the α−blocker phentolamine.  In each case
changes in arterial pressure and heart rate were monitored. Following the
completion of the study, eggs were euthanized with an overdose of xylocaine and
KCl then quickly frozen for later analysis.
Statistical Analysis
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A paired Student t-test was used to access significant differences between
control and hypoxic exposure for all levels.  This procedure was repeated for the
analysis of drug effects as well as the difference in pre- and post- drug hypoxia.
A two way ANOVA of the arcsine transformed percent changes with day of
incubation and before/after drug injection as independent variables. The fiduciary
level of significance for all tests was taken at p<0.05. All data are presented as
mean ± 1 s.e.m..  For all experimental procedures, a sample number of five eggs
was used unless otherwise specified.
Results
Cardiovascular reactions to 10% O2 exposures (that is, hypoxia without
drug treatment) where similar to those discussed in Chapter 4.  In addition,
cardiovascular responses to each antagonist were similar to those previously
discussed in Chapter 2.  For the purposes of this study, changes in mean arterial
pressure (Map) and embryonic heart rate (fH) will reflect cardiovascular
responses (Fig 6.1).
As previously established, atropine had little effect on cardiovascular
function throughout the period of study (Fig 6.1).  Propranolol treatment caused a
significant reduction in fH throughout the study, similar to the finding established
in chapter 2 (Fig 6.1).  Mean arterial pressure rose following injection of
propranolol, a reaction that was significant (p<0.05) on days 19 and 21(Fig 6.1).
Further phentolamine treatment also produced a fall in embryonic fH throughout
incubation with significant reductions caused on days 12, 18, 19 and 20 (Fig 6.1).
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These responses differed from those established in Chapter 2 and will be
addressed later. Mean arterial pressure was significantly reduced following
injection of phentolamine on days 12 to 20 of incubation (Fig 6.1) a pattern also
established in earlier works.
Post-Drug Hypoxic Responses
Following treatment with 1 mg*kg
-1 atropine, 10% O2 continued to
compromise cardiovascular function as established in earlier works (Fig 6.2).
Pressure responses were also unaltered by atropine treatment during the period
of study with the exception of day 18 in which atropine intensified the hypoxic
hypotension by 10% (Table II).  In addition, chronotropic hypoxic reactions were
unaffected by pre-treatment with atropine during the period of study (Table 6.2).
Pre-treatment with propranolol altered embryonic hypoxic cardiovascular
reactions late in development (Fig 6.3).  Mean arterial pressure response was
significantly altered by propranolol treatment on days 18 to 21 (Fig 6.3).  Over the
early period of study hypoxia with or without propranolol treatment reduced Map
an average of 16% (Fig 6.3).  From 18 to 21 days of incubation Map fell an
average of 13% during hypoxia allow while post propranolol treatment hypoxia
caused Map to rise 6% (Fig 6.3). Heart rate response to hypoxia was unaltered
by propranolol treatment with significantly different response occuring on day 20
only (Fig 6.3).
Phentolamine treatment significantly altered cardiovascular responses to
hypoxia in the final days of chicken incubation, as demonstrated following
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propranolol treatment.  Mean arterial pressure reductions during hypoxia were
significantly elevated (p< 0.05) on days 19, 20 and 21 of incubation (Fig 6.4).
During this developmental interval, Map changed from an 11% increase in
pressure during hypoxia to a 28% decrease following phentolamine treatment
(Fig 6.4). Chronotropic hypoxic reactions were unaffected by treatment with
phentolamine, with the exception of day 21 in which the negative action of
hypoxia were intensified (Fig 6.4).
Comparison Between Days of Incubation
Changes in cardiovascular response to hypoxia following cholinergic
blockade were statistically identical (Map and fH p<0.5) on all days of chicken
incubation studied.  In addition, a between-day comparison of chronotropic
responses following propranolol treatment revealed that all embryo changed
similarly (p<0.6) in response to hypoxia.  Mean arterial pressure responses to
hypoxia following β-blockade were also statistically similar on all days of
incubation.  However, the p value (p<0.059) and the marked difference within day
of incubation pressure responses (Fig 6.3) suggests that different days of
incubation may differ.
As indicated by the interaction between treatment and day of
development, Map response to hypoxia after phentolamine treatment changed
with incubation as older embryos exhibited a greater fall in pressure than early
embryos (p<0.0001) (Table 6.3). Heart rate responses to hypoxia following
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phentolamine injection were not significantly altered as embryos progressed in
development.
Discussion
The cardiovascular system of developing chickens performs a number of
functions most notable of which is the maintenance of proper gas transfer to and
from peripheral tissues.  Hypoxic challenges dramatically stress cardiovascular
function in developing chickens (Tazawa et al. 1985, Tazawa 1981a, Girard
1973, Van Golde et al. 1997, Grabowski et al. 1969).  While the general
depressive impact of hypoxia on cardiovascular function is well characterized,
the mechanisms which underlie these changes remain poorly understood. The
present study has established that an adrenergic mechanism is present during
chicken development that alters cardiovascular function in response to acute
hypoxic stress.  The mechanism becomes operational between days 15 and 18
of incubation and acts primarily on arterial pressure with an intensity that is
unchanged over the final 4 days of incubation.  Cholinergic mechanisms, which
play an important role in fetal lamb hypoxic responses, are absent throughout the
development of chickens suggesting fundamental differences between the two
species.  Further, regulatory mechanisms that are responsible for hypoxic
cardiovascular changes in embryos differ from those present in adult chickens.
Cholinergic Response
Cholinergic regulatory systems are of little importance to cardiovascular
function during acute hypoxia exposures in embryonic chickens (Fig 6.2).  In
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adult chickens, cholinergic action, specifically vagal activation, is a major
mechanism augmenting cardiovascular function during hypoxic exposure (Duree
and Sturkie 1963, Butler 1967).  Hypoxic stress is adult chickens elevates fH and
respiratory frequency both mediated via vagal influences (Duree and Sturkie
1963, Butler 1967). Thus, two scenarios must exist during embryonic
development: 1) embryonic chickens rely on unique non-adult systems during
bouts of hypoxia to maintain cardiovacular function or 2) embryonic chickens lack
regulatory system during development.  While these findings were unexpected,
Chapter 2 has demonstrated that cholinergic tone on the cardiovascular system
is also absent in development in chickens.  Further, as previously established in
Chapter 3, cholinergic system are also inactive during bouts of hypertensive
stress during development in chicken embryos.  Collectively these data suggest
the parasympathetic arm of the autonomic regulation of cardiovascular function is
quiescent throughout chicken development, becoming functional during the post-
hatch period.
β-Adrenergic Response
During hypoxic exposure, β-adrenergic systems are important in
regulating the cardiovascular system over the final 4 days of chicken incubation,
unlike cholinergic systems (Fig 6.3).  Following β-blockade, hypoxia resulted in a
dramatic hypertension from day 18 until hatch in chicken embryos (Fig 6.3).  This
cardiovascular response differed from that known to occur in adult chickens
during exposure to hypoxic stress.  As ambient O2 falls, adult chickens exhibit a
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hypotension, as well as a pronounced tachycardia (Durfee and Sturkie 1963,
Butler 1967, Richard and Sykes 1967, Ray and Fedde 1969).  The
aforementioned tachycardia was abolished in animals treated with the β-blocker
inderal, an antagonistic behavior which was absent during chicken development
(Fig 6.3) (Butler 1967).  Thus, as was suggested for cholinergic action, β-
adrenergic action in embryos during hypoxia differs from that known to occur in
adult chickens.
This difference in β-adrenergic action between embryonic and adult
animals could be attributed to additional vascular beds that are present in
embryos and lacking in adult chickens.  The chorioallontoic membrane (CAM)
serves as the gas exchange organ for developing birds and contains a
substantial portion of the overall embryonic blood volume (Romanoff 1967).  β-
Adrenergic systems could potentially vasodialate blood vessels in the CAM
during hypoxia to maintain perfusion pressure, thus countering the compromising
actions of low oxygen.  Umbilical blood flow in fetal sheep, which has been
suggested to be analogous to the CAM circulation, is dependent upon β-
adrenergic action during bouts of hypoxia to maintain blood flow (Cohn et al.
1978, Metcalfe and Stock 1993).  Therefore, chorioallantoic vascular beds of
chicken embryos may also rely on β-receptor induced vasodilatation during
hypoxia.  Without measuring accompanying changes in blood flow it is difficult to
determine resistance changes in the CAM vasculature during hypoxia with and
without β-blockade.   Preliminary study has demonstrated that the vasculature of
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the CAM vasodialates in response to the β-agonist isoproterenol while it remains
relatively unaffected by 10% O2 (Crossley, Altimiras and Burggren in prep).  This
would suggest that during hypoxia chicken embryos in the final four days of
development alter CAM vascular resistance via, in part, β-adrenergic
mechanisms to maintain perfusion pressure.  While it appears this systems is
integral in producing the characteristic cardiovascular hypoxic response late in
development, the reason for a lack of action prior to day 18 in unclear.
An assessment of cardiac output distributions during severe hypoxia has
previously indicated that regulatory mechanisms may become operational during
a developmental interval untested in the present study (Mulder et al. 1998).
Hypoxia caused a redistribution of cardiac output to the CAM, heart and brain in
the interval from 14 to16 days and to the heart and brain from 17 to 19 days of
chicken incubation (Mulder et al. 1998).  This redistribution was absent in
embryos from day 10 to 13 possibly suggesting the system was immature
(Mulder et al 1998). Therefore, an interval from day 15 to 18 may exist when
CAM vasculature becomes dependent on β-adrenergic systems during hypoxia
stress. This interval was not tested in the present study and cannot be verified.
β-adrenergic or other vasoactive substances may account for this redistribution
during hypoxia, but further study is needed to determine the origin cardiac output
alteration.
While the vascular responses to hypoxia consistently relied on β-
adrenergic stimulation, chronotropic actions were relatively independent of β-
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influences.  This reaction differed from that characterized in adult chickens that
exhibit a marked hypoxic tachycardia that is eliminated by β-blockade (Butler
1967).   An increase in fH was evident on day 20 of incubation, but hypertension
that accompanied hypoxia following β-blockade may account for this change.
Thus, the importance of β-adrenergic system in overall cardiovascular responses
to hypoxia differed dramatically between late stage embryos and adult chickens.
α−Adrenergic Response
The noted hypoxic hypotension during the final four days of incubation is
dependant on β-receptor stimulation, but the source of the post β-blockade
hypertension is clearly due to unopposed α−adrenergic action on peripheral
vessels (Fig 6.4).  Post β-blockade hypoxic hypertension can be attributed, in
part, to an α−adrenergic activation in embryonic chickens from day 19 to 21.
While systemic vasculature in hypoxic adult chickens is unaffected by
α−blockade hypoxic pulmonary vasoconstriction is eliminated by treatment with
an α−antagonist (Jones and Johansen 1972).  Therefore, total embryonic
pressure responses to hypoxia post β-blockade are similar to those of the adult
pulmonary circulation over the final 3 days of incubation.  However, given the
protocol used in the present investigation, it is difficult to localize specific
embryonic vascular beds that response to α−stimulation.
As suggested for β-adrenergic stimulation, a potential vascular bed for
α−adrenergic action during hypoxia could be the arteries of the CAM.  Without
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accompanied changes in blood flow, assessment of in vivo changes in vessel
resistances is impossible.  However, preliminary study on perfused CAM vessels
has demonstrated a clear increase in resistance following infusion of the
α−agonist phenylephrine suggesting this organ contain  α−ρeceptors.  Thus,
α−stimulation of CAM vessels may contribute to the overall embryonic hypoxic
hypertension during the final days of chicken development.
Hypoxic induce α−σtimulated chronotropic changes were absent, as
illustrated for β-stimulation, during chicken development, with the exception of
day 21 (Fig 6.4).  Since α−receptors play no role in the adult chronotropic
reaction to hypoxia and that the negative responses evident on day 21 were
coupled with a marked hypotension, it is conceivable that this reaction was
indirectly mediated.  Thus, as determined for β-adrenergic systems,
α−adrenergic systems exhibit no influence on embryonic chronotropic reactions
to hypoxia.
Conclusion
During chicken development, cardiovascular response to acute hypoxia
differed dramatically for those present in adult animals.  In addition, this study
has demonstrated that neural and or humoral mechanisms that coordinate these
changes also differ between life phases.
Cholinergic systems are non-responsive to hypoxic stress
throughoutchicken development, so they must mature in the neonatal period.
This apparent inactivity during hypoxia in chicken embryos differs from that
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demonstrated in the fetal lamb.  Upon initiation of hypoxic exposure, late stage
fetal sheep exhibit a transient bradycardia that has been attributed to vagal
activation (Cohn et al. 1978, Berman et al. 1976, Giussani et al. 1993, Martin
1985).  This characteristic, which is also present during the development of
llamas, suggests there is a fundamental difference in the onset of regulatory
components between birds and mammals (Giussani 1996).
In contrast to the noted lack of cholinergic response to hypoxia, adrenergic
actions are pronounced over the final four days of incubation producing primarily
vascular specific response.  While the vascular beds affected were undetermined
in the current study, previous studies in fetal sheep, which exhibit similar hypoxic
adrenergic importance, may provide some insight.  Vascular resistance within the
carcass, lungs and liver of fetal sheep are elevated during hypoxia, a response
that was eliminated by pre-treatment with an α−antagonist (Reuss et al. 1982).
The essential nature of this system to fetal sheep is evident in the 43% mortality
that occurs during hypoxia following α−blockade (Giussani et al. 1993). If one
assumes that the hypoxic redistribution of cardiac output in embryonic chickens
can be attributed to α−adrenergic systems as in fetal sheep, then adrenergic
components may be essential for distributing flow in the late stage chicken
embryo. While there are differences between the two systems, this provides a
possible explanation for the observed hypertension during late ontogeny in
chickens. Thus, the combined actions of β− and α− adrenergic mechanisms act
in an effort to maintain gas transport during bouts of embryonic hypoxia.  While
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the source of adrenergic action was undetermined in this work, both neural as
well as humoral catecholamines may contribute to observed responses
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Table 6.1. Systolic (Sys) and diastolic (Dia) pressure response to 10 % O2 pre
(C) and post (T) drug injection.  Asterisks represent significant (p<0.05)
difference between normoxic (N) and hypoxic (C or T) exposure as indicated by
the results of paired Student t-test. Data are presented as mean ± sem.  In all
cases n = 5 unless noted.
Atropine Propranolol Phentolamine
Day Sys Dia Sys Dia Sys Dia
12 N 11.4±1.6 5.5±1 11.6±1.6 * 6.2±0.9 * 11.3±1.4 6.3±0.5
C 9.6±1.4 * 4.5±0.9 * 8.8±1.3 4.9±0.9 9.1±1.5 * 5.3±0.4 *
N 11.9±1.9 5.4±1 11.5±1.7 * 6±1 * 10.1±1.9 6±0.6
T 9.1±1.7 * 4.1±0.9 * 9±1.8 5.1±0.9 7.1±1.1 * 4.7±0.5
15 N 18±1.8 9.6±1.2 23.6±1.9 14.2±1.3 23.3±1.7 12.8±1.3
C 14.4±1.5 * 7.5±0.9 * 18.6±2.1 * 10.9±1.4 * 21.7±2.1 * 10.2±1.4 *
N 18.9±2.3 10.4±1.6 22.7±2.9 13.6±1.6 20.9±1.8 11±1.6
T 13.8±1.9 * 7.3±1.2 * 19±2.5 * 11.7±1.4 16.4±1.8 * 8±1.4 *
18 N 21.2±1.2 12.4±0.9 24.4±2.6 14.3±1.5 25.6±0.8 13.4±0.6
C 19.9±1.0 10.5±0.7 19±1.1 * 9.1±0.8 * 24.9±1.6 11.9±0.6
N 23.6±1.2 13.4±1.2 25.3±1.6 13.5±1.3 16.3±2.2 6.6±0.9
T 18.2±1.0 * 8.6±0.7 * 23±2.5 11.5±1.5 12±1.2 * 4.8±1 *
19 N 27.1±1.3 16±1.3 29.7±1.4 18.1±1.3 30.2±1.4 17.8±1
C 21.8±1 * 11.8±1.6 * 22.9±1.7 * 12.4±1.2 * 32±1.2 18.4±1
N 29.7±1.4 18.1±1.3 31.1±1 17.7±1.1 22.4±1.7 11.4±1.7
T 22.9±1.7 * 12.4±1.2 * 30.9±1.7 17.1±1.4 15.8±1.1 * 7.7±0.7 *
20 N 34±2.7 22.9±2.1 31.8±3.3 22±1.5 37.1±2.4 21.6±1.8
C 29.7±2 19.6±1.2 30.8±2.5 20.3±1.4 43.5±3.1 * 26.4±2.1 *
N 33.9±2.3 21.7±1.8 36.7±2.7 23.5±1.8 31.5±2.5 18.4±1.9
T 30.5±1.9 * 18.5±1.5 * 40±2.7 * 27.3±2.1 * 23.6±3.3 * 14.2±2.2 *
21 N 34.5±2.2 21.5±1 38.4±2.4 21.91.6 39.2±3 20.9±2.4
C 30.4±1 17.4±1.4 34.5±2.4 19.5±1.4 * 43.7±4.4 25.1±3.6 *
N 36.3±2.3 20.3±1.4 42.2±2 25.3±2.5 38.1±5.8 22±4
T 32.4±2.9 17.7±1.8 46.7±3.3 28.6±2.3 28.8±3.8 * 16.4±0.5
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Table 6.2.  Difference in change of mean arterial (Map), systolic (Sys) diastolic
(Dia) pressures and heart rate (fH) responses to10% O2 following drug treatment.
Significance difference values of the ANOVA conducted on the arcsine
transformed percentage change between pre- and post- atropine (Atrop),
propranolol (Prop) and phentolamine (Ph) during 10% hypoxic exposure. Deltas
indicate level of significance ∆ = p<0.05, ∆∆ = p<0.001 and ∆∆∆ = p<0.0001.  In
all cases n = 5.
1mg*kg
-1 Atrop 3 mg*kg
-1 Prop 3 mg*kg
-1 Ph
Day Map Sys Dia fH Map Sys Dia fH Map Sys Dia fH
12
15
18 ∆ ∆ ∆ ∆ ∆ ∆
19 ∆∆ ∆ ∆∆ ∆∆∆ ∆∆∆ ∆∆∆
20 ∆∆ ∆ ∆∆ ∆ ∆∆∆ ∆∆∆ ∆∆∆
21 ∆∆ ∆∆ ∆∆ ∆∆∆ ∆∆∆ ∆∆∆ ∆
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Table 6.3. Maturation of 3 mg*kg
-1 phentolamine affects on mean arterial (Map),
systolic (Sys) diastolic (Dia) pressures and heart rate (fH) reactions to 10% O2.
Days of incubation with like letters were similar in response to 10% post hypoxia
those days which differ significantly (p < 0.05) from others are indicated with
different letters.  Data are presented as mean ± sem.  In all cases n = 5.
Day Map Sys Dia fH
12 N 8.1±1.2 10.1±1.9 6±0.6 182±11
10 5.9±0.5 A 7.1±1.1 A 4.7±0.5 A 146±5 A
15 N 15.6±1.7 20.9±1.8 11±1.6 180±9
10 11.3±1.7 AB 16.4±1.8 AB 8±1.4 AB 135±18 A
18 N 10.6±1.5 16.3±2.2 6.6±0.9 131±27
10 7.4±1.1 AB 12±1.2 AB 4.8±1 AB 84±24 A
19 N 16.1±1.6 22.4±1.7 11.4±1.7 194±19
10 10.9±0.9 CB 15.8±1.1 CB 7.7±0.7 CB 164±19 A
20 N 24.4±2.2 31.5±2.5 18.4±1.9 204±11
10 18.2±2.8 C 23.6±3.3 C 14.2±2.2 C 160±33 A
21 N 29.3±4.5 38.1±5.8 22±4 242±21




Collective cardiovascular responses to antagonist treatments.  Heart rate (A) and
pressure (B) responses to atropine (Atropine), propranolol (Prop) and
phentolamine (Phento). Asterisk indicate significant difference (p<0.05) between
control (open column) and treatment (filled column) over the developmental
period studied.
Figure 6.2
Heart rate (fH) and mean arterial pressure (Map) comparison between control
(open column) and response to 10% O2 (filled column) before (first column set)
and following (second column set) treatment with 1 mg*kg
-1 atropine. Asterisk
indicated significantly (p<0.05) different responses to hypoxia following drug
treatment as determined by the ANOVA conducted on the arcsine transformed %
change.
Figure 6.3
Heart rate (fH) and mean arterial pressure (Map) comparison between control
(open column) and response to 10% O2 (filled column) before (first column set)
and following (second column set) treatment with 3 mg*kg
-1 propranolol. Asterisk
indicated significantly different responses (p<0.05) to hypoxia following drug




Heart rate (fH) and mean arterial pressure (Map) comparison between control
(open column) and response to 10% O2 (filled column) before (first column set)
and following (second column set) treatment with 3 mg*kg
-1 phentolamine.
Asterisk indicated significantly different responses (p<0.05) to hypoxia following












CONTRIBUTION OF THE AUTONOMIC NERVOUS SYSTEM TO
CARDIOVASCULAR ADJUSTMENT DURING ACUTE HYPOXIA IN CHICKEN
EMBRYOS (Gallus gallus): THE EFFECT OF CHEMICAL SYMPATHECTOMY
AND GANGLIONIC BLOCKADE.
Introduction
Chicken embryos demonstrate dramatic alterations of normal
cardiovascular function during periods of reduction in ambient oxygen levels
throughout development.  These changes include a clear hypotensive
bradycardia over the majority of incubation, with a loss of pressure sensitivity late
in development (Tazawa 1981, Girard 1973, Van Golde et al 1998, Mulder et al
1997).  Adult respond to hypoxia in a markedly different manner than embryonic
chickens, with a pronounced tachycardia coupled with a decrease in arterial
pressure developing during hypoxic exposure (Butler 1967, Ray and Fedde
1969, Dufree and Stuckie 1963).  Adult reactions to low O2 have been attributed
to an increase in vagal activity as well as β-adrenergic reactions resulting in an
increase of heart rate, with the fall in pressure attributed to the direct action of O2
(Butler 1967).  While adult cardiovascular regulation during hypoxia is well
characterized, maturation of these regulatory mechanisms during development is
poorly understood.
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In Chapter 6 it was determined that embryonic chickens acquire some
cardiovascular regulatory ability during the final portion of incubation (Ch 6 this
thesis).  This regulatory mechanism is composed of adrenergic components
which, in the final 4 days of incubation, act on peripheral vessels resulting in
significant changes in arterial pressure during exposure to hypoxia.  However,
the origin of these catecholamines was previously undetermined in embryonic
chickens.  Fetal sheep are known to release catecholamines from sympathetic
terminals as well as the adrenal medulla during bouts of hypoxic stress, with both
direct action of low O2 and central stimulation responsible for catecholamine
release (Lewis et al. 1984).  Thus, the origin of adrenergic-induced
cardiovascular response to hypoxia in chicken embryos may be due to both
central as well as directly induced release of catecholamines.
The present investigation in chicken embryos sought to clarify the origin of
previously determined adrenergic regulation of cardiovascular function during
bouts of hypoxic stress.  Utilizing selective chemical sympathectomy, the role
and maturation of centrally mediated changes in cardiovascular function during
hypoxia was determined.  In addition, ganglionic blockade was used to specify
the efferent paths which chicken embryos utilize to induce adrenergic
augmentation of cardiovascular function.
Materials and Methods
Eggs of the domestic chicken, Gallus gallus, of the White Leghorn strain
were purchased from Texas A&M and shipped overnight to the University of
158
North Texas Department of Biological Sciences.  On arrival, eggs were placed in
incubation at 38 ± 0.5 °C, 60-70% relative humidity and turned automatically
every 3 hrs.  For the purpose of the study, experimental manipulation was
conducted on days 9, 12, 15 and18-21 of a 21-day incubation period.
Surgical Procedures
On the day of study, eggs were removed from the incubator, candled to
locate a chorioallantoic artery and placed in a temperature-controlled chamber.
A portion of the eggshell was removed exposing the previously located artery.
The artery was temporarily occluded up stream with a 6 zero silk ligature and a
second ligature was placed downstream to eliminate retrograde flow following
cannulation.  A small cut was then made in the artery and a heat-pulled, saline-
filled catheter was then used to occlusively cannulate the vessel. All the
procedures were carried out under a dissection microscope (Wild M3Z). Once
cannulation was completed the catheter was fixed to the shell with cyanoacrylic
glue and the egg was placed in the experimental chamber (described in Chapter
4). Four embryos were studied simultaneously.
Signal recording and calibration
Each catheter was attached to a pressure transducer (WPI, type BLPR),
which in turn was connected to a bridge amplifier (CB Sciences, model ETH-400)
and the pressure trace stored in a computer using PowerLab data acquisitions
software.  Heart rate was continuously calculated from the pressure signal via an
acquisition tachograph.  In all cases, zero was initially set at the top of the
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experimental bath, and all values were corrected after the experiment as
described in Chapter 2.
Experimental Protocol
Sympathectomy
During each of the study periods, eggs were allowed 30 min to reach
control values, defined as stable readings for 5 min.  Following the control period,
eggs were exposed to a 5-min of 10% O2 then returned to normoxia for 30 min.
Upon completion of initial exposures eggs where allowed an addition 10 min to
recover, after which 1 mg*kg
-1 of the sympathetomizing agent 6-
hydroxydopamine (6-OH) was injected as described in Ch 4.   Blood pressure
and heart rate were allowed to stabilized prior to the initiation of a 30-min control
period.  This control period was followed by a second dosage of 20 mg*kg
-1 6-OH
as explained in Ch 4.  A recovery period of 20 min after return to control levels
was allowed between each dosages of 6-OH.  Upon completion of
sympathectomy, embryos were again allowed to recovery for 20 min. In each
case changes in arterial pressure and heart rate were monitored. A second 5-min
exposure to 10% O2 was conducted upon completion of 6-OH treatment with
responses recorded as described above.  Following the completion of the study,
eggs were euathanized with an overdose of xylocaine and KCl then quickly
frozen for later analysis.
Ganglionic blockade
160
On each of the study periods eggs were allowed 30 min to reach control
values followed by a bout of 10% hypoxia as described for the sympathectomy
design. Upon completion of initial exposure eggs were allowed an addition 10
min to recover, after which 25 mg*kg
-1 ganglionic blocker hexamethonium was
injected as described in Ch 4.   Blood pressure and heart rate were allowed to
stabilized prior to the initiation of a 30-min control period.  This control period was
followed by a second 5-min exposure to 10% O2 with responses recorded as
described for sympathectomy.  Following the completion of the study, eggs were
euthanized with an overdose of xylocaine and KCl then quickly frozen for later
analysis
Statistical Analysis
A paired Student t-test was used to access significant differences between
control and hypoxic exposure for all levels.  A one-way ANOVA was conducted
on the arcsine transformed percent difference between control and hypoxic
exposure levels in all variables to determine significant changes between days of
incubation.  A similar analysis was conducted within a day of incubation to
determine differences in reactions to changing levels of hypoxia.  Fisher’s LSD
post-hoc comparison was used to isolate significant differences between days of
incubation as well as to determine differences in hypoxia.  The fiduciary level of
significance for all tests was taken at p<0.05. All data are presented as mean±




Initial exposure to 10% O2 produced similar cardiovascular responses to
those previously described in Ch 5 (Table 7.3) for both experimental treatments,
with the exceptions of days 20 and 21. In addition, 6-OH treatments produced
similar pressure and heart rate responses from days 19 to 21 to those described
in Ch 4 (Table 7.3).  For all treatments systolic and diastolic pressure changes
mirrored the changes in mean arterial pressure (Map), therefore these data are
presented alone with no specific description in Tables 7.1, 7.2, 7.4 and 7.6.
Sympathectomy
Initial injections of 20 mg*kg
-1 6-OH resulted in a transient increase in all
pressure parameters (Fig 7.1).  Heart rate was increased following treatment,
similar to that described in Chapter 4 on days 19 and 21 of incubation.  All
responses dissipated over time and control values returned within an average of
29 min after treatment.  In addition, treatment with 1.0 mg*kg
-1 altered pressure
values significantly on days 12 and 19 with heart rate altered on days 15 and 19
(Fig 7.1).
Hypoxic response
Control hypoxia resulted in characteristic changes in cardiovascular
function on all days of incubation, as discussed in Ch 5.  Briefly, from days 12 to
19 hypoxia resulted in a reduction in both arterial pressure and heart rate (Fig
7.2), This pattern differed on day 20 of incubation during which hypoxia was
ineffective in altering any pressure parameters (Fig 7.2).  Negative chronotropic
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actions were present on day 20 of incubation as shown in previous chapters (Fig
7.2).  Day 21 of incubation exhibited a significant negative pressure response to
hypoxia as previously demonstrated (Fig 7.2).  In addition, embryonic heart rate
was constant during control hypoxic treatment (Fig 7.2) in eggs at 21 days of
incubation.   Each of these responses differed from previously reported data in
Ch 5.
Post 6-OH Response
Sympathectomy treatment in eggs from day 12 to 18 of incubation was
ineffective at altering cardiovascular reactions to acute 10% O2 (Fig 7.2).  This
pattern was altered on day 19 which exhibited an accentuated negative
chronotropic response to hypoxia (p<0.05), from 37 to 48 beats*min
-1, following
6-OH treatment (Fig 7.2). Map changes during hypoxia post-6-OH treatment
were significantly different (p<0,05) on day 20 of incubation (Fig 7.2).  Heart rate
response also differed significantly (p<0.05) on day 20 during post-6-OH hypoxia
(Fig 7.4), falling an average of 23 beats*min
-1 more (Fig 7.2).  This trend was also
exhibited on day 21 of incubation with heart rate falling an average of 30
beats*min
-1 more during post-6-OH hypoxia (Fig 7.2).
Ganglionic blockade
Treatment with 25 beats*min
-1 hexamethonium produced little change in
cardiovascular function throughout the period of chicken incubation studied (Fig.
7.3).  A positive chronotropic response to hexamethonium treatment was evident
on day 12 of incubation resulting in a rise of 26 beats*min
-1 above control levels
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(Fig 7.3).  Hexamethonium also altered heart rate on day 19 of incubation, but
the response was dampened in comparison to that established on day 12, rising
only 4 beats*min
-1 (Fig 7.3).  Pressure parameters were altered only on day 20 of
incubation with a significant decrease in mean arterial pressure of 1.4 mmHg (Fig
7.3).
Between Stage comparison
Treatment with hexamethonium on all days of incubation produced varying
effects as indicated in Table 7.5.  Elevation in heart rate that followed treatment
on day 12 was significantly different from the reactions on all other days of
incubation (Table 7.5).  In addition a significant difference in Map reaction was
present between day 21, which responded with a slight elevation, and days 18 to
20 which decreased in response (Table 7.5).
Post-Treatment Hypoxia
Cardiovascular response to 10% O2 were unaffected by pre-treatment with
25 mg*kg
-1 of hexamethonium over the first 85% of incubation (Fig 7.5).  This
trend changed on days 20 and 21 with significant differences (p<0.05) in pre- and
post- treatment responses to hypoxia (Fig 7.5). During hypoxia, Map fell an
average of 1.2 mmHg on day 20 of incubation following ganglionic blockade (Fig
7.5) which differed from control responses. Hypoxic induced alterations in fH
following ganglionic blockade also differed on day 20, changing from an initial
average fall of 20 beats*min
-1 to 4 beats*min
-1 post blockade (Fig 7.5).  Pressure
response to hypoxia was also altered on day 21 as indicated in Figure 7.5.  Mean
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arterial pressure during hypoxic exposure prior to ganglionic blockade fell an
average of 5 mmHg.  However, following hexamethonium treatment Map was
relatively unaffected falling 1.4 mmHg on average (Fig 7.5).
Discussion
Acute hypoxic cardiovascular responses have been well characterized
over the duration of embryonic development in chickens (Tazawa 1981a, Tazawa
1985, Girard 1973, Van Golde et al. 1998, Mulder et al. 1997).  In general,
hypoxia induces a hypotensive bradycardia that is present throughout the
majority of development with pressure response lost in the final day’s incubation.
While these patterns have been thoroughly assessed in developing chickens, the
mechanisms that mediate these changes were previously left undetermined.
This thesis has established that hypoxia induced changes in cardiovascular
function during the final four days of chicken incubation are primarily due to
adrenergic systems, with cholinergic mechanisms remaining.  However, the
origin of this adrenergic response was unknown with the possibility of both
sympathetic and adrenal influences contributing to cardiovascular responses.
This study has established that a portion of these adrenergically induced hypoxic
changes in cardiovascular function is due to sympathetic activity in the final 3
days of incubation.  In addition, during the final 2 days of chicken development
adrenal secretion during hypoxia comes partially under central regulation.
During chicken development treatment with the sympathectomizing agent 6-
hydroxydopamine produced similar results to those reported previously in Ch 4 of
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this thesis during chicken development.  Further, embryonic cardiovascular
responses to acute hypoxic exposure were within the values previously reported
for chickens with the exception of day 21 reactions (Tazawa 1981 Tazawa 1985,
Van Golde et al. 1998, Mulder et al. 1997).  Given that experimental protocols
were conducted under identical conditions in this chapter as well as Ch 4-6, a
rationale for these differences is difficult to construct.  A possible cause could be
attributed to the difficulty of establishing the exact age of each externally piped
chick. However, with the limited knowledge of the final days of development in
birds, further research is needed to ascertain whether this is a viable explanation.
Sympathetic Hypoxic Action
Sympathetically mediated central regulation of cardiovascular responses
to hypoxia becomes operational over the final three days of chicken development
(Fig 7.3).  This sympatheticly originating adrenergic stimulation acts primarily on
the heart and is important for limiting the negative chronotropic actions that occur
during hypoxia in chicken embryos.  Previously in Ch 6 of this thesis selective
adrenergic receptor blockade suggested that the primary function of adrenergic
systems during hypoxia was to alter arterial pressure with no chronotropic
affects.  This apparent discrepancy may be ascribed to a predominant adrenergic
action on peripheral vessels.  Following β-blockade the overall elevation of
arterial pressure during hypoxia may mask any changes in fH that would
accompany blockade.  This masking could be the result of an increase in venous
return that would decrease heart-filling time and possibly accommodate for any
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chronotropic changes potentially caused by β-blockade.  The findings presented
here strongly suggest that this occurs during hypoxia in late stage embryonic
chickens.  In addition, since adult chickens possess a strong β-adrenergic
mediated hypoxic tachycardia, this late embryonic sympathetic cardiovascular
action may represent the onset of an adult regulatory mechanism (Butler 1967).
It is acknowledged that, due to the possibility of incomplete removal, the
developmental window for sympathetic importance in the hypoxic response may
be extended.  However, given the findings in this work, sympathetic action during
hypoxic is important for heart rate responses during the final 3 days of chicken
development.
Arterial pressure responses to hypoxia on day 20 of incubation were
strongly affected by sympathetic removal.  While the transient nature of this
response is difficult to ascribe to a specific phenomenon, it may indicate
sympathetic action on peripheral vessels.  Day 20 embryos thus rely on
sympathetic adrenergic systems to maintain perfusion pressure during hypoxic
stress.  The pronounced nature of this reaction may be buffered on day 21 of
incubation due to the maturation of other regulatory mechanisms.  Due to the
transient nature of this response as well as the absence of blood flow
determinations during hypoxia, statements on central control of peripheral
vascular beds should be limited.  Further study is needed to determine whether
differential changes in vascular resistance during hypoxia are mediated via
sympathetic action on day 20 of chicken incubation.
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Ganglionic blockade
Treatment with hexamethonium produced little cardiovascular response
throughout the period of chicken incubation studied.  These results were similar
to those previously reported in chicken embryos from days 13 to 16 (Tazawa et
al. 1992).  Thus, resting embryonic cardiovascular function is maintained without
centrally mediated release of adrenal catecholamines during chicken
development.
Adrenergic systems are an important regulator of cardiovascular
responses to acute hypoxia during the final 4 days of chicken incubation (Ch 6).
Sympathetically mediated catecholamine secretion from the adrenal glands may
comprise a portion of this response on the final 2 days of incubation (Fig 4). The
transient pattern evident on day 20 and 21 may reflect the onset of neural control
of adrenal catecholamine output during hypoxic stress.  The differences in
hypoxic cardiovascular responses between days 20 and 21 following ganglionic
blockade are difficult to explain.  However, the maturation of multiple regulatory
systems during this short window of chicken development limits the information
that can be drawn from the data.  Further study is needed to establish the role
catecholamines play in the final days of incubation and possible transition of their
action on the cardiovascular system.
Conclusions
Hypoxia produces clear changes in cardiovascular function during the
development of chickens.  As demonstrated in Ch 6 catecholamines play an
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important role in hypoxic induced cardiovascular changes during the final 4 days
of chicken incubation.  The origin of these catecholamines and their actions on
the embryonic cardiovascular system differs during this final period.  Chapter 6
illustrated an important hypoxic vascular response that was the result of the
combined actions β-adrenergic vasodilatation and α−adrenergic constriction with
a dominating beta driven dilation.  The current chapter has shown a
sympathetically mediated increase in heart rate during hypoxia on days 19 to 21,
with vascular reactions on day 20 only.  This suggests that the majority of
vascular pressure changes are mediated via an increase in plasma
catecholamines during these final days of development. Ganglionic blockade has
revealed that these catecholamines are released via direct action of hypoxia on
the adrenal tissue without sympathetic mediation. Thus circulating
catecholamines initially results in an alteration of vascular pressure with an
augmentation of heart rate attributed to central regulation systems during
embryonic hypoxia.
The onset of sympathetically mediated changes in heart rate may
represent an adult hypoxic cardiovascular response.  As previously shown,
adults exhibit a marked tachycardia during acute bouts of hypoxic stress.  While
this response was absent in late stage embryos their ability to maintain heart rate
close to control levels may represent the maturation of an adult reaction.  Further
study is needed to fully address this issue, but there is a clear sympathetic role in
hypoxic heart rate adjustment during the final three days of chicken development.
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Table 7.1. Systolic (Sys) and diastolic (Dia) pressures responses to 1 mg*kg
-1 (1)
and 20 mg*kg
-1 (20) 6-OH treatment.  Asterisk indicates significant (p< 0.05) as
determined by a paired Student t-test. Data are presented as mean ± s.e.m..  In
all cases, five embryos were used for analysis unless noted.
1 mg*kg
-1 6-OH 20 mg*kg
-1 6-OH
Day Sys Dia Sys Dia
12 C 7.5±0.9 4.7±0.5 7.3±0.6 5.1±0.5
T 7.8±0.8 5±0.5 7.5±0.7 5±0.5
15 C 16±1.1 9.1±0.8 16±0.8 8.6±0.7
T 16.3±1.1 9.2±0.8 17.8±1.4 10±1
18 C 23.4±1.8 14.2±0.6 22.8±2.2 14.4±1.1
T 24.3±1.6 14.9±0.8 27.3±2.3 * 17.9±1.4 *
19 C 25.7±1.3 14.4±0.9 25.5±1.2 15.1±1.1
T 27.6±1.7 16.5±1.1 * 28.9±1.8 * 17.4±2.1
20 C 27.7±2 19.1±1.4 29.8±2.1 21.1±1.7
T 31±2.1 21±1.1 33.4±2.1 * 23.5±1.9
21 C 36.5±4.1 23.2±2.9 34.7±2.9 21.5±2.1
T 38.2±4 24.1±3.2 42.6±3.4 * 27.1±3.1 *
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Table 7.2. Systolic (Sys) and diastolic (Dia) pressures responses to hypoxia (10)
pre (C) and post (T) completion of sympathectomy.  Asterisk indicate significant
(p<0.05) difference from control values for each parameter as determined by the
paired Student t-test.  Data are presented as mean±s.e.m..  In all cases, 5
embryos were used for analysis unless noted.
C T
Day Sys Dia Sys Dia
12 N 8.6±1.2 5.1±0.6 7.4±0.7 4.9±0.5
10 6.6±0.7 * 4.1±0.6 * 5.6±0.6 * 4.1±0.5 *
15 N 17±0.7 9.2±0.4 16.4±1.1 8.9±0.8
10 14±0.7 * 6.8±0.4 * 13.9±1 * 7.1±0.7 *
18 N 23.6±1.8 14±1.4 21.8±2.7 13.9±1.6
10 19.6±1.6 * 11.2±0.8 19±2.5 * 11.9±1.3 *
19 N 25.8±1.1 15.3±0.7 27.5±1.2 17.6±0.8
10 22.8±1.3 * 12±0.8 * 24.8±1.3 * 13.6±1.2 *
20 N 26.9±1.7 16.3±0.7 30.1±2.3 20.4±1.2
10 27.5±1.5 16±1.2 27.1±2.1 * 15.3±0.8 *
21 N 31.7±2.4 20±1.7 35.1±2.4 21.7±2.2
10 27.7±1.7 * 16.2±1.3 * 29.4±1.3 * 17±1.1 *
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Table 7.3. Differences in mean arterial (Map), systolic (Sys) diastolic (Dia)
pressures and heart rate (fH) changes in response to10% O2 treatment.  Values
are the differences between control and hypoxia, pre- (1) and post- (2) 6-OH
injection.  Asterisk indicates significant differences (p<0.05) in responses
between pre- and post- values as determined by a one way ANOVA conducted
on the arcsine transformed percent changes. Data are presented as
mean±s.e.m.  In all cases, 5 embryos were used for analysis unless noted.
Day Map Sys Dia fH
12 1 -1.4±0.3 -2±0.6 -1±0.2 -61±17
2 -1.2±0.1 -1.8±0.3 -0.9±0.2 -82±19
15 1 -2.9±0.3 -3±0.3 -2.5±0.6 -42±10
2 -2.3±0.3 -2.5±0.6 -1.8±0.3 -44±8
18 1 -3.5±0.9 -4±1.1 -2.8±1.1 -30±10
2 -2.2±0.5 -2.8±0.6 -2±0.7 -51±6
19 1 -3.2±0.5 -3±0.7 -3.3±0.4 -38±5
2 -3.3±0.6 -2.7±0.6 -4±0.7 -47±4 *
20 1 0±1.1 0.6±1.6 -0.3±0.8 -39±9
2 -4±0.4 * -3.1±0.5 -5±0.8 * -62±13 *
21 1 -3.7±0.8 -4±1.1 -3.8±0.8 -7±12
2 -5.1±1.7 -5.7±2 -4.7±1.6 -30±10 *
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Table 7.4. Cardiovascular reaction to treatment with 25 mg*kg
-1 hexamethonium
(H) compared to control (N) values.  Asterisk indicate significant difference
(p<0.05) result of paired Student t-test. Data are presented as mean±s.e.m.  In
all cases, 5 embryos were used for analysis unless noted.
Day Sys Dia
12 N 8.4±0.5 5.6±0.3
H 8.5±0.5 5.6±0.4
15 N 18.4±1.8 10.4±1.3
H 18.3±1.6 10.4±1.1
18 N 21.7±1.5 12.2±0.7
H 21±1.3 11.6±0.6
19 N 23.2±1 15±0.9
H 23.5±0.8 13.9±0.5
20 N 29±1 19.9±0.6
H 27.3±0.8 18.3±0.5 *
21 N 30.7±1 16.6±1.2
H 31.4±0.8 17.8±1.3
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Table 7.5.  A comparison of the degree of change in cardiovascular function
induced by 25 mg*kg
-1 hexamethonium.  Days of incubation which reacted in
similar ways are noted with like lettering as dictated by the significant (p<0.05)
difference determined via an ANOVA.
Day Map Sys Dia fH
12 H 0.2±0.1 A 0.2±0.1 0±0.2 AB 26±6 A
15 H 0±0.2 A -0.1±0.2 0±0.3 A -2±1 B
18 H -0.7±0.3 B -0.8±0.4 -0.6±0.2 BC 0±3 B
19 H -0.3±0.3 AB 0.3±0.4 -1.1±0.5 C 4±1 B
20 H -1.5±0.5 B -1.7±0.7 -1.6±0.5 C -3±8 B
21 H 0.6±0.7 A 0.6±1.4 1.2±0.6 A 2±4 B
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Table 7.6. Systolic (Sys) and diastolic (Dia) pressures responses to hypoxia pre-
(C) and post- (H) 25 mg*kg
-1 hexamethonium treatment. Asterisk indicates
significant (p<0.05) difference from control values for each parameter as
determined by the paired Student t-test. Data are presented as mean ± sem.  In
all cases, five embryos were used for analysis unless noted.
C T
Day Sys Dia Sys Dia
12 -1.1±0.1 -0.5±0.1 -1.5±0.1 -0.5±0.2
15 -3.8±1.4 -1.9±0.6 -3.2±0.4 -2.2±0.4
18 -2.2±1.2 -3.1±0.8 -2.9±0.7 -3.4±0.9
19 -2.3±0.7 -2.7±0.9 -4.6±0.8 -3.8±0.5
20 0.1±0.8 1.3±0.3 -1.6±0.4 * -1±0.4 *




Collective responses of heart rate (A) and mean arterial pressure (B) to treatment
with 1 and 20 mg*kg
-1 6-hydroxydopamine.  Significant difference between
controls (open column) and treatments (filled column) are indicated by asterisk.
Figure 7.2
Heart rate (fH) and mean arterial pressure (Map) comparison between control
(open column) and response to 10% O2 (filled column) before (first column set)
and following (second column set) sympathectomy. Asterisk indicates
significantly different responses to hypoxia following drug treatment as
determined by the ANOVA conducted on the arcsine transformed percent
change.
Figure 7.3
Heart rate (fH) and mean arterial pressure (Map) responses to 25 mg*kg
-1
hexamethonium injection.  Significant difference between controls (open column)
and treatments (filled column) are indicated by asterisk.
Figure 7.4
Heart rate (fH) and mean arterial pressure (Map) comparison between control
(open column) and response to 10% O2 (filled column) before (first column set)
and following (second column set) ganglionic blockade. Asterisk indicates
significantly different responses to hypoxia following drug treatment as











MATURATION OF CARDIOVASCULAR FUNCTION IN EMBRYOS OF THE
DESERT TORTOISE Gopherus agassizii
Introduction
The embryonic cardiovascular (CV) system is the first functional organ
system in developing vertebrates, providing essential O2 as well as nutrients to
developing tissues.  These functions are accomplished while the CV system itself
undergoes a series of morphological and phyiological changes to reach the adult
form.  The majority of what is know of CV development in vertebrates has been
based on two models, fetal sheep and the embryonic chicken (Pappano 1977,
Lewis et al. 1984, Lewis and Sisho 1982, Tazawa 1981a, Tazawa et al 1985, Hu
and Clark 1989, Girard 1973).  Chicken embryos specifically have been used
extensively to determine developmental changes in hemodynamics, gas
transport properties and cardiovascular regulation.  However, the avian embryo
may not be the ideal model for understanding developmental changes in
vertebrates which utilize in-ovo development.  Reptilian eggs, specifically, are
potentially subject to developmental challenges that are absent in birds, possibly
necessitating differential development between the two groups.
Reptilian embryos experience different environmental and parental
conditions that may require the onset of regulatory mechanisms prior to those
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found in the avian embryo.  Typically, with few exceptions, reptiles place their
eggs in a given location and provide no further parental care.  The developing
animal must compensate for any alterations in the nest microenvironment without
parental assistance.  Given the established diurnal variability found within the
reptilian nests environment the potential for acute environmental challenge is
tremendous (Packard et al 1985).  Therefore, environmental stress could
adversely affect the cardiovascular system of reptilian embryos, necessitating
unique ontogenic patterns.
The goal of this study was to characterize developmental changes in
cardiovascular function in the desert tortoise Gopherus agasizzii, a
representative reptilian species.   Further, I sought to establish periods of
cardiovascular sensitivity to autonomic blockade in a reptilian embryo.  Finally, it
was hypothesized that autonomic regulation of the cardiovascular system will
develop prior to that known in avian embryos.
Materials and Methods
Donated eggs of the desert tortoise (Gopherus agassizii) from captive
females were collected following oviposition and returned to the Department of
Biological Sciences at the University of Nevada, Las Vegas.  In the lab 110 eggs
were numbered, weighed, randomly placed into plastic boxes and set in
incubator (Lyon electronics ProfHi) at 29±0.5 °C.  At experimental intervals of
10% incubation, five eggs where randomly selected for acute cardiovascular
study beginning at 30% of incubation time.
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Catheterization Procedure
Prior to experimentation, eggs were candled to locate a major
chorioallontoic membrane (CAM) artery.  Once located, eggs were placed in a
water-jacketed temperature control chamber to maintain an environment close to
incubation conditions.  A small hole was then made in the shell with a 21-gauge
needle, allowing the removal of a 1-cm square section of shell.  A branch of an
underling artery was then encircled with three 6-00 silk ligatures to act as
catheter anchors.  The distal ligature was then tightened, occluding blood flow,
followed by proximal ligature closure limiting flow.  Micro-fine scissors were then
used to cut the vessel to allow anterograde insertion of a saline filled
polyethylene catheter.  Catherters were constructed of PE-90 (1.27 mm OD /
0.86 mm ID, Clay-Adams) heat pulled to a tip outer diameter smaller than 0.5
mm OD.  Following successful cannulation, the intermediate ligature was
tightened followed by the removal of the proximal ligature.  The catheter was
then fixed to the shell with cyanoacrylic glue and plugged with a pin occluder.
Signal recording and calibration
Each catheter was attached to a pressure transducer (WPI, type BLPR),
which, in turn, was connected to a bridge amplifier (CB Sciences, model ETH-
400), and the pressure trace was stored in a computer using PowerLab data
acquisitions software.  Heart rate was continuously calculated from the pressure
signal via an acquisition tachograph.  In all cases, zero was initially set at the top
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of the temperature-controlled chamber set at 29±0.5 °C, and all values were
corrected after the experiment as described in chapter 2.
Acute Study Procedures
Following surgery, each embryo was allowed to recover for 30 min to
establish control conditions.  After the control period, a 20 µl infusion of 0.9 %
saline for egg ranging from 30-50% of incubation and 50 µl for eggs ranging from
60 to pre-hatch was used to determine the effects of volume loading.  Volume
loading tests were followed by the serial infusions of sodium nitroprusside,
phenylephrine, atropine, and propranolol. Concentrations of 10-5 M and 10-4 M
were used to establish maximal responses to each drug at a given period of
incubation. Following completion of the study, arterial blood samples were
collected for determination of hematocrit.  Temperature of each egg was then
taken, followed by an infusion of 1-percentage xylocaine and separation of the
egg components to determine wet and dry masses.
Statistical Analysis
A paired Student t-test was used to access significant differences between
pre- and post- drug infusion for all variables measured on each day of
development.  A one-way ANOVA was conducted on each cardiovascular
parameter with incubation to determine developmental changes. Fisher’s LSD
post-hoc comparison was used to isolate significant differences between days of
incubation.  The fiduciary level of significance for all tests was taken at p<0.05.
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All data are presented as mean ± 1 sem.  For all days of study n = 5 eggs, were
used to determine cardiovacular responses.
Results
Hematocrit values are presented in Table 8.1 with the exception that in the
first series of samples all levels were similar during embryonic development.
Mean arterial pressure (Map) changes during embryonic development were
indicative of all pressure parameter changes (Table 8.2).  Control Map in 40%
embryos was 4.1 mmHg while heart rate (fH) was 89 beats*min
-1 (Fig 8.2).  Mean
arterial pressure remained constant over the next 40% of incubation rising
significantly (p<0.05) during the last 20% of embryonic development (Fig 8.2).
Heart rate was initially elevated at 40% of incubation, averaging 89 beats*min
-1,
then fell over the remainder of development reaching 67 beats*min
-1 at 90 % of
incubation, a level that was significantly different (p<0.05) than the first 30% of
the study period (Fig 8.2).
Cholinergic tone
Treatment with 50 µl of 10-5 M atropine produced no significant change in
any cardiovascular parameter measured (Table 8.2).  Cholinergic receptor
presence and function on the embryonic cardiovascular system was tested in
pilot studies.  These studies established that acetylcholine 10-4 M injection
stopped the embryonic heart (Fig 8.1A).  This response was eliminated by
treatment with atropine indicating receptors were present and atropine was
effective at blocking responses.
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Intra-arterial injections of atropine 10-4 M concentration produced
significant reductions in Map from 70% to 95% of total incubation (Fig 8.3).
These reductions ranged from 0.1 to 1.1 mmHg over the interval of action.  Heart
rate was constant over all intervals tested with the exception of the 60% interval
during which injections produced a slight fall (Fig 8.3).
β-Adrenergic
β-Blockade with 10-5 M propranolol produced an increase in Map that
became significant during the 70% incubation interval (Table 8.4).  This change
ranged from 0.6 to 2.7 mmHg over the period of significant response (p<0.05).
Heart rate was consistently reduced following treatment with 10-5 M propranolol
over the period of study (Table 8.4).  This reaction in fH was transiently significant
from 60 to 90% of incubation with a reduction of 4 beats*min
-1 on average over
this period (Table 8.4).  Pilot studies with isoproterenol injections verified this
level of b-blockade was sufficient to eliminating cardiovascular responses.
Mean arterial pressure responses to 10-4 M propranolol injection was
significantly (p<0.05) elevated from 80% to 95% of incubation (Fig 8.4).  Over this
incubation interval, pressure increases ranged from 1.6 to 4.3 mmHg following
drug injections.  Heart rate was altered over the same interval as noted for the





Mean arterial pressure fell following injection of 10-5 M sodium
nitroprusside (SNP) during all incubation intervals tested (Table 8.7).  These
pressure changes were significant (p<0.05) over the final 50% of tortoise
development with an average change ranging from 0.1 to 4.3 mmHg.  While
treatment altered pressure, heart rate was relatively unaffected by this level of
sodium nitroprusside treatment (Table 8.7).  Injection of 10-4 M sodium
nitroprusside accentuated the decreased in Map demonstrated for the initial
dosage. Pressure reduction ranged from 0.4 to 4.1 mmHg following
administration of 10-4 M sodium nitroprusside and the period of significant
response was extended to include 40% of incubation (Fig 8.5).  Average heart
rate response was minimal following drug injection, with the exception of a
significant increase (p<0.05) at 70% of tortoise incubation (Fig 8.5).
Treatment with 10-5 M concentration of the α−agonist phenylephrine
resulted in a general increase in Map over the period of study.  This increase
ranged from 0.5 to 1.8 mmHg and was significant (p<0.05) at 40,50,70 and 80%
of tortoise incubation (Table 8.9).  Following injection of the second concentration
of phenylephrine Map was elevated significantly (p<0.05) during all incubation
intervals tested, with increases ranging from 0.06 to 1.8 mmHg (Fig 8.6).  Heart
rate was relatively unaltered by drug treatment throughout the incubation interval




Cardiovascular development has been intensively investigated in
mammalian models, in an effort to characterize and understand potential
pathologies that may occur during human gestation.  While this has been
essential work, the understanding of CV development in other vertebrate groups
has remained poorly characterized.  Given the clear differences between ex-
utero and in-utero development there are compelling reasons to believe this
process may differ between vertebrate groups.  This study has characterized
changes in cardiovascular function during the development of a reptilian species,
a vertebrate group that is poorly understood.  In addition, fundamental
cardiovascular regulatory mechanisms were assessed to establish the potential
for embryonic response to environmental stress.  Utilizing pharmacology, this
work determined that arterial pressure responses to selective agonists and
antagonist were similar to those demonstrated in chicken embryos.  All
responses were simply accentuated by the increase in drug concentration.
Further, β-adrenergic tone on the cardiovascular system of embryonic reptiles
was in place at 60% on development, while cholinergic tone was absent
throughout incubation.  As established in Ch 2 of this thesis, cholinergic tone
must become functional very late in tortoise development or sometime in the
beginning of hatchling life.
Cardiovascular Patterns
General cardiovascular function exhibited a unique developmental pattern
during the incubation of the desert tortoise.   Mechanical cardiovascular
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development in the desert tortoise mimicked that of embryonic chickens, with
arterial pressures starting low and rising to a maximum at hatch. However,
several differences were apparent when a stage by stage analysis of pressure
change was conducted.  In the desert tortoise, Map remained constant until the
final 20% of incubation (Fig 8.2).  This pattern was very different from that
exhibited by chicken embryos which, during a comparable period, show a 10-fold
increase in mean pressure (Girard 1973).  In addition, average maximal pressure
at each given percentage of tortoise incubation was consistently lower than
pressure values demonstrated by chicken embryos at similar times (Girard
1973).  Therefore, there are fundamental mechanical differences in
cardiovascular function between the two species during their development.
Developmental heart rate patterns further illustrated the differences
between the two species as gestation progressed.  Embryonic chickens exhibit
an increase in heart rate over the first 50% of incubation which then remains
constant until the animal hatches (Girard 1973).  The pattern exhibited by desert
tortoise embryos differs, with an initial rise from 30 to 40% of incubation followed
by a fall over the remainder of development (Fig 2). This trend has also been
shown in embryos of the african brown house snake (Lamprophis fuliginosis) and
the common snapping turtle (Chelydra serpentina), suggesting a bell pattern in
heart rate change may be common among reptiles (Crossley unpublished,
Birchard and Reiber 1996). Thus, there are basic developmental differences in
cardiovascular function between chickens and reptiles during incubation.  Further
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analysis is needed to determine the functional basis behind this difference.
However, changes in peripheral resistance may account for a portion of these
findings.
Cholinergic tone
Cholinergic tone was absent throughout embryonic development in the
desert tortoise (Fig 8.4) a characteristic that is identical to that found in chicken
embryos.  Fundamental anatomical and cellular developmental studies, which
have been conducted on chicken embryos, are lacking in embryonic reptiles,
thus limiting the interpretation of the present findings.  If it is assumed that
cholinergic receptors and nerve terminals reach the cardiovascular system prior
to hatch, as occurs in chickens, then clearly cholinergic tone is nonfunctional
during development in the desert tortoise.  It could be argued that embryonic
muscarinic receptors are insensitive to cholinergic blockade during tortoise
development.  This scenario could be a potential concern however, since the
chronotropic effects of acetylcholine could be successfully eliminated via pre-
treatment with atropine it is unlikely (Fig 8.1).  Therefore, resting cardiovascular
function in the embryonic tortoise is maintained without tonic cholinergic input as
determined in chicken embryos.  Collectively these data indicate that vagal tone
is absent during the development of terrestrial ex-utero developing species.
β-Adrenergic tone
Unlike the CV responses to cholinergic blockade, a pronounced negative
chronotropic action of β-blockade was evident over the latter 40% of tortoise
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incubation (Fig 8.4).  Upon initial comparison, this could be interpreted as a
fundamental difference between chickens (which exhibit a strong β-tone at 40%
of development) and desert tortoise embryos.  However, due to the tremendous
mortality evident following drug treatment at 40 and 50% of incubation, this
interpretation could be inaccurate.  In addition, because of experimental
techniques utilized in this work, changes in sensitivity to antagonist during
development were undetermined.  However, the finding presented here clearly
indicate β-adrenergic tone is important for the maintenance of resting
chronotropic action in developing desert tortoise (Fig 8.4).
β-Adrenergic vascular tone was first evident at 80% of incubation in the
desert tortoise (Fig 8.4).  Thus, as in embryonic chickens, β-adrenoreceptors are
an integral component which maintains a relative vasodilated state during the
final 20% of development.  A portion of the pressure increase demonstrated
following propranolol treatment might be directly attributed to chronotropic
changes resulting in an increase in output pressure.  Due to the general
administration techniques used in this work, a proper distinction between cardiac
and vascular changes is difficult. However, it is clear that embryos of the desert
tortoise, as with chicken embryos, respond to β-blockade in a way that is similar
to that of most other vertebrates. While the cardiac β-adrenergic tone seems to
be almost universal in vertebrates, the degree of hemodynamic changes due to
β-adrenoreceptor vasodilation might be accentuated in embryos, especially if the
chorioallantoic vasculature has an active population of β-adrenergic receptors.
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This has been suggested to be the case in the placenta of the fetal lamb during
the latter third of gestation (Carter 1993).  Therefore, β-adrenergic receptors may
become important regulators of vascular tone during the latter 20% of desert
tortoise development.  Preliminary study of the isolated chorioallantoic
membrane vasculature from chicken embryos suggests that a significant
vasodilation can be induced via β-adrenergic stimulation (Crossley, Altimiras and
Burggren in prep).  These finding further suggest that a resting β-adrenergic tone
on the vasculature is possible during the later 20% of desert tortoise incubation.
α−Adrenergic response
A predominant pressure increase following α−adrenoreceptor stimulation
was evident over the final 50% of tortoise incubation, with limited chronotropic
action (Fig 8.6).  This response was similar to those shown in chicken embryos
over a similar period of development (Tazawa et al. 1992).  It is important to
recognize that while this study indicated the cardiovascular system of the desert
tortoise is responsive to α−stimulation, the question of tonic control was
unanswered.  Given the pronounced α−tone found in embryonic chickens and
fetal sheep, each with a hypertensive reaction to α−stimulation, the desert
tortoise may also rely on an α−tone during incubation (Tazawa et al. 1992, Assali
et al. 1978).  In addition, possible changes in α−adrenergic sensitivity were
undetermined due to the constant volume technique used in this study.   Further
192
study is needed to determine if the cardiovascular system of embryonic desert
tortoise relies on an α−adrenoreceptor tone during development.
Nitric Oxide effects
In the present study, injections of sodium nitroprusside, a nitric oxide
donor, decreased arterial pressure throughout the development of the desert
tortoise (Fig 8.5).  Cardiovascular responses to nitric oxide (NO) treatment were
primarily manifested as reductions in arterial pressure with little change in heart
rate (Fig 8.5).  These effects were similar to those shown in various adult reptiles
and embryonic chickens (Millard and Moalli 1980, Stephens et al. 1983, Crossley
et al. in review).  Thus, the nitric oxide pathway is present at 50% of tortoise
development as previously shown in embryonic chickens.  While the role of nitric
oxide tone during tortoise development was undetermined, this work established
that vascular smooth muscle is responsive to nitric oxide.  Prior study has shown
that multiple cellular components are required for the transudation of the nitric
oxide signal from the endothelium to vascular smooth muscle (Moncada and
Higgins 1993).  Thus, the hypotension exhibited by desert tortoise embryos
following sodium nitroprusside injection suggests an important cardiovascular
function during development.  An in depth study is needed to determine whether
desert tortoise embryos rely on an NO tone during development or if this system
is activated by selective cardiovascular challenges.
Conclusion
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Our understanding of cardiovascular maturation during reptilian
development has previously been based on limited morphological descriptive
studies with few attempts to quantify physiological changes.  The current study
has characterized general hemodynamic changes during the final 60% of
incubation in a representative reptilian species.  Embryos of the desert tortoise
exhibit a constant arterial pressure over the majority of development.  This
pattern differs dramatically from that known to occur in embryos of the domestic
chicken, suggesting fundamental mechanical differences between the two
species.  While these species may differ mechanically during development,
regulatory components are similar.
As previously shown in chickens, cholinergic tone on the cardiovascular
system of desert tortoise embryos is absent during development.  Thus, basal
cardiovascular performance and maturation is achieved without tonic vagal input
during tortoise incubation.  This finding contrasts the tonic vagal control of
cardiovascular function that has been established in adult turtles (Burggren
1976).  Thus, vagal function must become operational sometime during the
hatchling life period.  As indicated in chapter 2, parasympathetic tone may
therefore be nonessential for normal cardiovascular development of terrestrial
egg laying species.  However, to definitively determine this, extensive multi-
species comparisons must be conducted.
While vagal tone was absent throughout incubation of the desert tortoise,
a clear β-adrenergic tone on cardiovascular function was operational.  In
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addition, α−adrenoreceptor stimulation suggested that an important α−tone might
also be present.  The interpretation of these findings should be limited given that
critical information on anatomical integrity is needed.  Collectively, these findings
suggest that adrenergic components, either neural or humoral in origin, are
important for cardiovascular development in the desert tortoise.  Further study is
needed to determine the role that adrenergic systems play in cardiovascular
development of the desert tortoise as well as other egg laying terrestrial
vertebrates.
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Table 8.1.  The change in hematocrit (Hct) as incubation progressed.  Number










Table 8.2.  Change in mean arterial pressure (Map) systolic pressure (Sys),
diastolic pressures (Dia) and heart rate (fH) during the percentage of incubation
noted.  Number (N) of eggs used at each portion of development is noted.  Data
are presented as mean ± sem.
% N Map Sys Dia fH
40 8 4.1±0.3 4.9±0.4 3.3±0.4 89±6
50 5 4.1±0.6 4.9±0.6 3.4±0.5 84±6
60 6 4.5±0.3 5.2±0.4 3.7±0.2 79±4
70 9 4.6±0.4 5.7±0.4 3.5±0.5 80±3
80 6 5.7±0.8 8.3±1.0 3.6±0.6 77±3
90 7 9.6±0.8 13.7±1.2 4.9±1.0 67±2
95 14 11.3±0.6 14.8±0.8 8.2±0.6 72±2
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Table 8.3.  The change in mean arterial pressures (Map) systolic pressures
(Sys), diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of 10-
5 M atropine into embryos at the given percentage (%) of incubation.  The paired
Student t-test between control (C) and drug treatment (T) revealed drug
produced no response.  Egg numbers (N) are presented. Data are presented as
mean ± sem.
% N Map Sys Dia fH
40 C 4 3.0±0.5 3.7±0.6 2.4±0.4 94±5
T 3.1±3.8 3.8±0.5 2.5±0.2 84±9
50 C 3 3.4±4.1 4.1±0.6 2.7±0.3 86±8
T 4.0±4.9 4.9±1.1 3.2±0.8 83±8
60 C 5 5.4±6.4 6.5±0.6 4.5±0.4 77±6
T 5.2±6.4 6.4±0.3 4.3±0.3 75±7
70 C 9 5.5±0.4 6.7±0.6 4.3±0.4 80±3
T 5.4±0.4 6.7±0.5 4.3±0.4 80±3
80 C 11 6.9±0.7 9.9±0.9 4.5±0.5 74±2
T 7.1±0.7 10.2±1 4.5±0.5 73±1
90 C 11 12.2±1.2 16.9±1.5 8.0±1.0 68±2
T 12.0±1.2 16.7±1.5 8.0±0.9 68±2
95 C 3 19.7±6.1 24.7±8.1 14.7±4.5 61±5
T 19.8±5.8 24.8±7.6 15.1±4.5 65±5
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Table 8.4.  The change in mean arterial (Map) systolic (Sys), diastolic (Dia)
pressures and heart rate (fH) following a 50 µl injection of 10-4 M atropine into
embryos at the given percentage (%) of incubation.  Asterisk indicates significant
result (p<0.05) the paired Student t-test between control (C) and drug treatment
(T).  Egg number (N) is presented. Data are presented as mean ± sem.
% N Map Sys Dia fH
40 C 6 3.5±0.5 4.2±0.6 3.1±0.4 72±8
T 3.5±0.5 4±0.7 3.1±0.5 61±14
50 C 4 4.1±0.7 4.8±0.8 3.5±0.7 83±4
T 4±0.6 4.8±0.7 3.4±0.6 83±6
60 C 5 5±0.4 5.9±0.5 4.2±0.3 77±6
T 4.8±0.4 5.8±0.5 4.1±0.4 76±6 *
70 C 9 5.4±0.4 6.8±0.5 4.2±0.4 79±3
T 5.3±0.4 * 6.6±0.5 4.1±0.4 78±3
80 C 10 7.3±0.7 10.6±0.9 4.7±0.5 73±1
T 7.1±0.6 * 10.3±0.8 * 4.5±0.5 * 72±1
90 C 12 11.6±1.2 16.1±1.5 7.6±1 67±2
T 11±1.2 * 15.2±1.5 7.2±1 * 67±2
95 C 11 15.8±1.7 20.7±2 11.4±1.5 64±2
T 14.5±1.5 * 19.5±1.8 * 10.1±1.2 * 64±2
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Table 8.5.  The change in mean arterial pressures (Map) systolic pressures
(Sys), diastolic pressures (Dia) and heart rate (fH) following a 50µl injection of 10-
5 M propranolol into embryos at the given percentage (%) of incubation.  Asterisk
indicates significant result (p<0.05) the paired Student t-test between control (C)
and drug treatment (T).  Egg number (N) is presented. Data are presented as
mean ± sem.
% N Map Sys Dia fH
40 C 2 2.8±0.1 3.5±0.1 2.3±0.2 95±13
T 2 2.9±0.3 3.5±0.4 2.5±0.3 90±12
50 C 2 3.5±0.4 4.4±0.8 2.8±0 87±14
T 2 3.3±1.1 4±1.7 2.6±0.5 68±3
60 C 5 5.1±0.4 6.1±0.5 4.2±0.3 74±7
T 5 5.6±0.4 6.6±0.6 4.7±0.3 70±6 *
70 C 9 5.1±0.5 6.5±0.5 4±0.4 78±3
T 9 5.7±0.5 * 7.1±0.6 * 4.4±0.5 * 75±3 *
80 C 8 7.5±0.7 10.6±1 4.9±0.6 73±2
T 8 8.5±0.9 * 12.1±1.2 * 5.5±0.6 * 71±2 *
90 C 10 10.6±1.2 15.1±1.3 6.8±1 68±2
T 10 13.4±1.2 * 18.4±1.6 * 9±1 * 65±2 *
95 C 4 17.4±3.5 21.6±4.8 12.9±2.1 64±4
T 4 20.1±4.5 24.6±5.7 15.6±3 61±6
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Table 8.6.  The change in mean arterial pressures (Map) systolic pressures
(Sys), diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of 10-
4 M propranolol into embryos at the given percentage (%) of incubation.  Asterisk
indicates significant result (p<0.05) of the paired Student t-test between control
(C) and drug treatment (T).  Egg number (N) is presented. Data are presented as
mean ± sem.
% N Map Sys Dia fH
40 C 5 4±0.5 4.7±0.6 3.4±0.5 84±11
T 5 4.2±0.5 4.9±0.7 3.6±0.5 56±18
50 C 4 4.8±0.5 5.7±0.6 4±0.4 78±2
T 4 4.7±0.8 5.6±1 3.9±0.6 51±17
60 C 6 5.1±0.4 6±0.5 4.3±0.3 71±5
T 6 5±0.3 5.9±0.5 4.3±0.2 65±5 *
70 C 8 5.5±0.6 6.9±0.7 4.3±0.6 77±3
T 8 5.4±0.6 6.8±0.7 4.3±0.6 71±3 *
80 C 13 7.1±0.8 10.2±1.1 4.5±0.6 73±1
T 13 8.7±0.9 * 12.6±1.2 * 5.5±0.6 * 66±1 *
90 C 12 12.6±1.3 17.3±1.6 8.3±1 64±2
T 12 14.6±1.4 * 20.2±1.9 * 9.9±1.1 * 58±2 *
95 C 12 15.3±1.9 19.2±2.1 11.3±1.6 67±3
T 12 19.6±1.9 * 24.9±2.3 * 14.7±1.5 * 60±2 *
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Table 8.7. The change in mean arterial pressures (Map) systolic pressures (Sys),
diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of 10–5 M
sodium nitroprusside.  Asterisk indicates significant result (p<0.05) of the paired
Student t-test between control (C) and drug treatment (T).  Egg number (N) is
presented. Data are presented as mean ± sem.
% N Map Sys Dia fH
40 C 6 3.9±0.5 4.6±0.4 3.3±0.5 93±7
T 3.7±0.5 4.3±0.5 3.2±0.5 90±7
50 C 5 4.4±0.5 5.2±0.6 3.6±0.5 87±6
T 3.6±0.5 * 4.3±0.5 * 3.1±0.5 * 86±6
60 C 5 4.8±0.1 5.6±0.1 4.1±0.2 77±6
T 4.1±0.2 * 4.8±0.2 * 3.6±0.3 * 77±7
70 C 9 4.5±0.4 5.7±0.4 3.5±0.4 81±4
T 3.7±0.5 * 4.7±0.5 * 2.9±0.5 * 82±3
80 C 12 5.6±0.5 8.3±0.7 3.5±0.3 74±2
T 4.5±0.3 * 6.7±0.5 * 2.8±0.2 * 74±2 *
90 C 12 9±0.5 13±0.8 5.4±0.4 67±2
T 7.1±0.4 * 10.6±0.6 * 4.2±0.3 * 67±2
95 C 6 12.8±2.3 16.9±3.1 8.9±1.6 64±3
T 9.6±1.4 * 13.1±2.1 * 6.6±1 * 64±4
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Table 8.8. The change in mean arterial pressures (Map) systolic pressures (Sys),
diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of 10–4 M
sodium nitroprusside.  Asterisk indicate significant result (p<0.05) of the paired
Student t-test between control (C) and drug treatment (T).  Egg number (N) is
presented. Data are presented as mean ± sem.
% N Map Sys Dia fH
40 C 6 4.1±0.4 4.9±0.4 3.5±0.4 77±5
T 3.6±0.4 * 4.2±0.4 * 3.2±0.4 77±5
50 C 4 4±0.6 4.8±0.6 3.3±0.6 87±8
T 2.9±0.5 * 3.5±0.6 * 2.5±0.6 * 86±9
60 C 7 4.4±0.4 5.2±0.4 3.7±0.4 77±5
T 3.3±0.3 * 3.8±0.3 * 2.9±0.4 * 79±5
70 C 16 5.3±0.4 7.3±0.6 3.6±0.3 77±2
T 3.7±0.4 * 5.1±0.5 * 2.7±0.3 * 78±2 *
80 C 5 5.5±0.6 8.3±1 3.3±0.4 74±2
T 3.9±0.7 * 5.9±1.2 * 2.4±0.4 * 76±3
90 C 13 8.8±0.5 12.8±0.8 5.3±0.3 66±2
T 6±0.3 * 8.9±0.5 * 3.7±0.2 * 67±2
95 C 18 11.6±0.8 15.6±1.1 8±0.6 68±2
T 7.7±0.6 * 10.6±0.9 * 5.3±0.3 * 70±2
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Table 8.9.  The change in mean arterial pressures (Map) systolic pressures
(Sys), diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of
10–5 M phenylephrine.  Asterisk indicates significant result (p<0.05) of the paired
Student t-test between control (C) and drug treatment (T).  Egg number (N) is
presented. Data are presented as mean ± sem.
% N Map Sys Dia fH
40 C 6 3.5±0.4 4.1±0.4 3±0.4 78±6
T 4±0.3 * 4.7±0.4 * 3.5±0.4 * 88±9
50 C 5 3.5±0.4 4.1±0.5 2.9±0.4 86±7
T 4.4±0.4 * 5.4±0.4 * 3.6±0.4 * 89±8
60 C 4 4.1±0.2 4.9±0.3 3.4±0.1 76±8
T 5.1±0.5 6.2±0.8 4.2±0.4 74±8
70 C 9 5±0.4 6.3±0.4 3.9±0.4 79±3
T 6.8±0.5 * 8.8±0.7 * 5.1±0.5 * 78±3
80 C 12 5.7±0.6 8.3±0.8 3.5±0.4 75±2
T 6.6±0.7 * 9.8±0.9 * 3.9±0.5 * 73±2
90 C 11 9.2±0.6 13.4±0.9 5.6±0.5 64±2
T 10±0.7 14.4±0.9 5.9±0.5 64±2
95 C 10 13.2±1.4 17.3±2.2 9.5±1 66±3
T 14.9±1.6 19.2±2 11±1.5 66±3
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Table 8.10. The change in mean arterial pressures (Map) systolic pressures
(Sys), diastolic pressures (Dia) and heart rate (fH) following a 50 µl injection of
10–4 M phenylephrine.  Asterisk indicates significant result (p<0.05) the paired
Student t-test between control (C) and drug treatment (T).  Egg number (N) is
presented. Data are presented as mean ± sem.
% N Map Sys Dia fH
40 C 6 3.1±0.4 3.8±0.4 2.4±0.5 93±9
T 6 3.7±0.3 * 4.5±0.4 2.9±0.4 96±9
50 C 5 4.4±0.6 5.3±0.6 3.7±0.6 81±6
T 5 5±0.6 * 6.1±0.7 * 4.1±0.5 87±6
60 C 5 3.8±0.5 4.6±0.6 3.2±0.5 72±4
T 5 4.6±0.6 * 5.7±0.7 * 3.6±0.6 * 73±4
70 C 6 5.4±0.6 6.6±0.7 4.3±0.6 79±3
T 6 7±0.7 * 8.8±0.8 * 5.5±0.7 * 79±3
80 C 11 6.5±0.6 9.5±0.8 4±0.5 74±2
T 11 8.1±0.8 * 12±1.1 * 4.9±0.6 * 72±1
90 C 13 9.4±0.7 13.5±0.7 5.7±0.4 65±2 *
T 13 11.2±0.7 * 16.1±0.7 * 6.9±0.4 * 64±2
95 C 10 13.3±2 18.5±2 8.6±0.8 63±2




Representative traces demonstrating arterial pressure (P) and heart rate (fH)
responses to various drug treatments in an 80% desert tortoise embryo.  Trace A
illustrates P and fH response to acetylcholine (1) atropine (2) and repeated
acetylcholine (3).  Trace B shows that cardiovascular response to atropine
treatment of 10-5 M (1) and 10-4 M (2).   Trace C illustrates cardiovascular
responses to propranolol treatment of 10-5 M (1) and 10-4 M (2).
Figure 8.2.
Change in control fH and Map during tortoise incubation.  Letters indicate the
result of an ANOVA with differing letters indicating significant (p<0.05) difference
between percentages of incubation. Data are presented as mean ± s.e.m.
Figure 8.3.
Response of embryonic fH and Map to injection of 10
-4 M atropine during desert
tortoise incubation.  Each percentage of development responses are presented
as control (open bar) and treatment (closed bar) with differences indicated by
asterisk. Data are presented as mean ± s.e.m.
Figure 8.4.
Response of embryonic fH and Map to injection of 10
-4 M propranolol during
desert tortoise incubation.  Each percentage of development responses are
presented as control (open bar) and treatment (closed bar) with differences
indicated by asterisk. Data are presented as mean ± s.e.m.
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Figure 8.5.
Response of embryonic fH and Map to injection of 10
-4 M soduim nitroprusside
during desert tortoise incubation.  Each percentage of development responses
are presented as control (open bar) and treatment (closed bar) with differences
indicated by asterisk. Data are presented as mean ± s.e.m.
Figure 8.6.
Response of embryonic fH and Map to injection of 10
-4 M phentolamine during
desert tortoise incubation.  Each percentage of development responses are
presented as control (open bar) and treatment (closed bar) with differences















CARDIOVASCULAR REGULATORY SYSTEMS IN AN AVIAN EMBRYO
Summary
Collectively, the findings compiled in these studies have characterized
cardiovascular control mechanisms that are available to developing embryonic
chickens.  In addition, windows during which adult cardiovascular regulatory
systems become operational were established.  Embryonic chickens rely on
circulating catecholamines to maintain cardiovascular function during
intermediate development.  Acute bouts of selective cardiovascular stress
produce a general hemodynamic compromise, to which intermediate embryonic
chickens are unable to respond.  While the potential for regulatory contributions
from other humoral or local mechanisms during development stress remains, it
was clear that autonomic regulation is absent prior to day 18 of chicken
incubation.
Sympathetically mediated changes in heart rate and arterial pressure were
evident on day 18 of incubation, while the parasympathetic system remain
inactive.  This was surprising, given the pronounced role the parasympathetic
system plays in basal cardiovascular function in adults.  The predominance of
adrenergic systems during development has been established in fetal sheep, as
well as embryos of the desert tortoise suggesting that, in vertebrates,
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cardiovascular maturation occurs without vagal tone.  Hypoxic stress induced a
pronounced depression of cardiovascular function, with changes mediated in part
by sympathetic action as well as an augmented humoral catecholamine action on
the cardiovascular system.  Further, the baroreflex response begins to operate
during late development of embryonic chickens.  Therefore, a critical period
exists between days 18 and 21, during which adult regulatory systems begin to
function.  Given some of the differences in hypoxic response exhibited by
chickens in late embryonic development, there is a potential for regulatory
mechanisms that are uniquely embryonic which are lacking in adult animals.
These general patterns were also demonstrated in embryonic desert tortoise
during development.
A comparative study of desert tortoise embryos illustrated similarities, as
well as differences, to chicken maturation of cardiovascular function and
regulation during development.  Mechanically, embryos of the desert tortoise and
domestic chicken differ dramatically during development.  However, from the
perspective of embryonic cardiovascular regulation the desert tortoise has a
pronounced adrenergic tone, with the notable absence of vagal tone during
embryonic development that is evident in chickens.  While further cross taxa
comparisons are needed to fully delineate the extent of similarities between
these species, the lack of a vagal tone might represent a universal pattern for
terrestrial egg laying vertebrates.
Future Studies
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Studies presented in Chapters 2-8 have provided a necessary foundation
for the development of a general model of embryonic cardiovascular regulation.
They have also established a timeline during which adult systems become
functional, as well as their patterns of maturation.  The following investigations
should provide the needed information to solidify the developmental model of
cardiovascular regulation in terrestrial egg laying vertebrates.
Experiment 1.
Changes in peripheral resistance which accompanies documented
cardiovascular responses to alteration of ambient gas composition must be
determined in embryonic chickens.  Several of the findings suggest that during
hypoxic stress embryos utilize selective alteration of vascular tone within different
organs to maintain oxygen delivery to vital systems.  Simultaneous measurement
of "umbilical" and systemic blood flow changes during hypoxia will provide
important information on mechanisms that allow possible changes in cardiac
output distribution.
Experiment 2.
Determination of plasma catecholamine levels pre- and post- exposure to
a hemodynamic stress, will further delineate periods when catecholamine
mobilization is the primary embryonic response mechanism.  The current studies
have provided evidence that a transition occurs between days 15 and 18 during
which an adrenergic response to hypoxia becomes operational.  Determination of
plasma catecholamine levels would provide further support for this hypothesis.
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Experiment 3.
Direct neural recording and stimulation will provide the data necessary to
determine the role of centrally mediated regulation of cardiovascular function
during chicken incubation.  Prior work, including the studies presented here,
utilized agonist and antagonist pharmacology to deduce potential periods when
autonomic regulation of cardiovascular function becomes active.  Vagal as well
as sympathetic stimulation and recording will provide important data on the
operation of these autonomic divisions during development.
Experiment 4.
These proposed investigations, coupled with previous work, will contribute
substantially to the general model of neural control of embryonic cardiovascular
function.  Research utilizing selective blockade of other humoral and locally
released vasoactive substances is needed to further characterize embryonic
mechanisms of altering cardiovascular function.  In fetal sheep, components
such as angiotensin, vasopressin and prostaglandin’s are important for fetal
cardiovascular adjustments to hypoxia.  Therefore, these substances could be
important mechanisms utilized by embryonic chickens to maintain gas transport
during bouts of altered ambient gas concentrations.
Experiment 5.
These, as well as completed studies should be repeated during the final 4
days of chicken incubation, in a time dependent manner.  An intensive study of
time windows within each of the final four days of chicken incubation will allow
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the isolation of periods when adult systems become operational.  Environmental
manipulation studies during these windows will demonstrate the degree to which
adult function is altered by challenge during these critical periods.
Experiment 6.
Completion of these studies will further our understanding of
cardiovascular regulation in embryonic chickens.  However, due to selective
breeding and domestication of Gallus gallus findings might be limited in their
application to other egg laying vertebrates.  Thus, additional bird species with
different degrees of out of egg development should be tested to determine
species which exhibit different developmental patterns and the possible causes
which underlie them.
Closing
This collection of studies has filled an important gap in our understanding
of cardiovascular regulation in developing vertebrates other than mammals.
Further, essential information has been produced that will allow future study to
established the contributions of specific cardiovascular regulatory systems during
embryonic development.  One basic assumption, while not specifically addressed
by individual investigations, was collectively addressed in this text.  That
assumption was, embryos will respond to stress conditions by altering
cardiovascular function, as well as other actions, in an effort to tolarate the period
of stress.  This appears to be an incorrect assumption during early chicken
development.  Embryonic chickens, prior to day 18, either tolarate periods of
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environmental challenge or the embryo dies.  In either case an embryo is unable
to alter function of the cardiovascular system via central or adrenergic
mechanisms to improve chances of survival.  Further, study is needed to
determine if some, as yet undetermined, system is activated during periods of
stress which provides some benefit to developing embryonic chickens.
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